Investigation of Sarcopenia in a Murine Model: Symptoms of Age-Related Neuromuscular Decline and  Resistance Training Intervention by Graber, Ted
Investigation of Sarcopenia in a Murine Model: 
Symptoms of Age-Related Neuromuscular Decline 
and  
Resistance Training Intervention 
 
A Dissertation 
submitted to the faculty of the University of Minnesota 
By 
Theodore G. Graber 
In partial fulfillment of the requirements 
for the degree of 
Doctor of Philosophy 
LaDora V. Thompson, advisor 
March 2015 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Theodore G Graber, 2015. All rights reserved. © 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Acknowledgements 
 
The author wishes to acknowledge the contributions of the following co-authors 
on the included manuscripts (Chapters 2-5): Dr. LaDora V. Thompson (guarantor 
of studies), Dr. Jong-Hee Kim (scientific review), Dr. Lisa Ferguson-Stegall (study 
design/scientific review), Dr. Linda K. McLoon (training in data collection for 
physiology/scientific review), Dr. Robert W. Grange (in vitro physiology 
methodology training/scientific review), and Katie F. Fandrey (correlation of 
collected data on training physiology/manuscript review). 
 
In addition, thank you to my F31AG044108 advisory committee:  
Dr. Edgar Arriaga (proteomics), Dr. Don Ingram (behavioral testing), Dr. Don 
Dengel (exercise science), Dr. Andy Mugglin (statistics), and adjunct member Dr. 
Linda McLoon (histology/physiology). 
 
Finally, thank you to my committee members for their guidance and support:  
Dr. LeAnn Snow, Dr. Deborah Ferrington, Dr. Dawn Lowe, Dr. Walter Low, and 
of course, my advisor, Dr. LaDora Thompson. 
 
Additional acknowledgements will be made in each chapter for funding and any 
technical assistance. In addition, author contribution will be delineated where 
appropriate. Ted G. Graber is first author of all 4 manuscripts in this thesis and 
LaDora V. Thompson is the corresponding and final author. 
 i 
 
Dedication 
I dedicate this work to my wife, Kathleen Bowman-Graber, who stood alongside 
me throughout the difficult years that my returning to school brought to our family, 
“We did it!” 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 ii 
 
Abstract 
 
 
The world population demographic is rapidly aging. With advancing age comes 
the onset of age-related diseases and syndromes such as sarcopenia, the age-
associated loss of muscle mass and strength. Sarcopenia leads to a multitude of 
adverse outcomes including a reduced quality of life, increased mortality, 
functional disability, and eventual loss of independence. Currently no cure for 
sarcopenia exists and its etiology is still largely undefined. Thus, there is a need 
for animal models for preclinical investigation of novel interventions. The overall 
purpose was to first investigate, characterize, and describe the neuromuscular 
healthspan of the C57BL/6 mouse, a common animal model of aging, and then to 
subsequently create a treatment model for sarcopenia by producing and 
validating a voluntary resistance training protocol for mice. The first research 
chapters (2 and 3) investigate and define the neuromuscular healthspan and the 
age-related decline of contractile parameters in the mouse. Chapter 2 outlines 
the neuromuscular healthspan scoring system, a composite score consisting of 
two functional measures combined with in vitro maximum isometric force of the 
extensor digitorum longus (EDL). This composite outcome measurement 
increased the power to detect change beyond the capacity of the individual 
component measures alone. Chapter 3 examines unique aspects of contractile 
velocity and power production in the soleus and EDL, revealing that age has a 
greater effect on concentric contraction performed at higher percentages of 
maximum force. Because the only consensus treatment for sarcopenia is 
resistance exercise, in Chapter 4 a mouse model of voluntary resistance training 
was designed and validated. The protocol was designed using human principles 
of weight training and was assessed with a comprehensive battery of outcome 
measurements. The outcomes were selected to test whether the mice had the 
same type of adaptations as would be observed in humans undergoing a similar 
training intervention. In Chapter 5, the resistance training protocol was applied to 
a cohort of aged mice to test if signs of anabolic resistance would be detected. 
Overall, the thesis tells the story of age-related neuromuscular dysfunction that 
can be partially rescued though exercise and creates a novel preclinical animal 
model of voluntary resistance training. 
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Introduction 
The global population of older adults continues to grow at an exponential rate. In 
1950 there were 205 million persons over the age of 60, in 2010 this population 
was estimated to be almost 810 billion, and by 2050 it is estimated that over 2 
billion people will more than 60 years old (UNDESA, 2013). At the same time the 
birthrate has more or less flat-lined (UNDESA, 2013), thus there will be fewer 
younger people per older individual than in the past. The United States had 40.3 
million people over 65 in 2010, or 13% of the population, which is about 12 times 
as many at those ages as were alive in 1900, about 4% of the total (US Census 
Bureau, 2011). By 2050, the US Census Bureau estimates that, at current rates 
of growth, the over-65 population will stand at 20.9%. About 38% of these older 
individuals in 2010 presented with at least 1 form of disability (mobility and 
activities of daily living challenges being the most common). Thus, this new 
demographic wave of older adults, many of whom will be potentially disabled 
and/or presenting with numerous comorbidities such as diabetes, heart disease, 
and cognitive dysfunction (or other age related conditions) will be supported by a 
proportionately sinking level of younger workers in the tax base. Obviously this 
will strain the economic capacity, and the will, of our society as we attempt to 
provide for the needs of this population. Addressing health concerns of the 
elderly now, before it is too late, with an eye towards designing invention 
strategies to reduce the debilitating effects of chronic conditions, is an absolute 
imperative. 
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With increasing age comes the onset of sarcopenia. Sarcopenia, the age-related 
loss of muscle mass and strength, is a major health concern that contributes to 
the onset of frailty (Marzetti, 2006; Sundell, 2011). Frailty is a multifactorial 
syndrome that has been characterized by low functional reserve, loss of muscle 
mass and strength, decreased mobility, increased weakness, and low energy 
expenditure (Fried, 2001). Sarcopenia (and by extension frailty) leads to falls, a 
deteriorating quality of life, difficulty performing activities of daily living, eventual 
loss of independence, and is a major predictor of poor prognoses after 
procedures and increased mortality (Landi, 2012; Rolland, 2008; Breen, 2011; 
Janssen, 2002). Loss of independence is a huge blow to the quality of life of the 
individual and a huge cost for society, so to find strategies to extend the 
independent life of seniors is critical. Combined with the high disability rates and 
often multiple comorbidities of the elderly, sarcopenia must be seen as major 
health challenge as the older population continues to grow. Therefore, it is in our 
best interest as a society to invest resources into investigating intervention 
strategies to mitigate sarcopenia and, by extension, frailty.  
 
At present there is no cure for either sarcopenia or frailty. Exercise, however, is 
an accepted intervention that has been demonstrated to improve these 
conditions. Progressive resistance training with weights is a well-accepted 
intervention to mediate sarcopenia in humans (Marini, 2008; Fiatarone, 1990; 
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 Pillard, 2011). This form of exercise reduces age-related myofiber apoptosis 
(Marzetti, 2006), induces gains in strength and muscle mass (Fiatarone, 1990; 
Latham, 2004), improves functional outcome measurements (Marini, et al. 2008; 
Capodaglio, 2007; Fiatarone, 1990), and confers positive metabolic changes 
(Sundell, 2011). While the strategy of resistance training has many benefits, this 
form of intervention does not totally reverse sarcopenia. In fact, many other 
interventions show some benefit (e.g., hormonal, nutritional, ergogenic and 
pharmaceutical supplementation); however, total mitigation of sarcopenia has not 
been achieved with a single therapy. Most likely multiple cellular mechanisms are 
responsible for the inability of the individual therapies to be effective (e.g., 
lowered rates of protein synthesis, blunted response to amino acid feeding, 
impaired cellular signaling) (Narici, 2010). Anabolic stimuli, such as exercise or 
nutrient intake, have been shown to have a lessened effect in older individuals, 
and this has been termed anabolic resistance. 
 
There are multiple physiological levels and signaling pathways that potentially 
contribute to anabolic resistance (Burd, 2013). It had long been presumed that 
there was an overall reduced capacity, in response to anabolic stimuli, for protein 
synthesis in older animals (Fry, 2011, Koopman, 2009). This has been tested by 
examining nutrient signaling and response to exercise, both of which resulted in 
reduced adaptations with age (Kumar, 2009; Degens, 2003). Recently, some 
evidence has emerged that challenged this paradigm. It may be that older 
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 individuals have the same capacity for protein synthesis after feeding (Symons, 
2011). In Symons, et al. older and younger adults both increased protein 
synthesis 108% from baseline after an acute bout of resistance training followed 
by a high protein meal (340 g of beef). It is also possible that older individuals 
may require a larger minimum signal to initiate transcription and translation at the 
same level as younger adults. In one recent example, a study of muscle protein 
synthesis rates after protein feeding found that more protein was required in the 
older adults to achieve the same level as the younger subjects (Moore, 2015). In 
a study of maintaining training adaptations, it was found that younger adults 
could maintain benefits received from exercise with lower dose of maintenance 
exercise than the older adults (Bickel, 2011). Acute bouts of resistance training 
have been shown to result in a reduced level of phosphorylation of key protein 
mTOR synthesis pathway proteins (p70S6K, for example) in older subjects (Fry, 
2011). However, a study combining resistance training and post-exercise protein 
feeding found that phosphorylated p70S6K (marker of protein translation) was 
elevated in both an older and younger cohort at the acute level, but was blunted 
in the older group after a training program (Farnfield, 2012). This is in contrast to 
previous research showing no added benefit of protein ingestion combined with 
resistance exercise in the elderly (Verdijk, 2009). Current consensus in the field 
is that more research is needed to understand potential etiology of the various 
forms of anabolic resistance and to develop therapies.  
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 The systemic physiological environment may be less conducive towards muscle 
hypertrophy in the elderly, thus contributing to anabolic resistance. One example 
is the hormonal changes, as evidenced by the decline in testosterone and growth 
hormone with age (both potent anabolic agents) (Sipila, 2013; Valenti, 2010; 
Gray, 1991; Van den Beld, 2000). Meta-analysis of testosterone replacement 
therapy has demonstrated increasing strength and mass with treatment 
(Ottenbacher, 2006; Neto, 2015). Much research into hormone replacement 
therapy has been done and this continues to be controversial with the risk/benefit 
analysis ongoing and new therapies being tested (Jusuja, 2014; Garnick, 2014). 
A second example is age-associated global inflammation, which has been linked 
to reduced capacity to respond to exercise (Merritt, 2013). Many of the repair 
mechanisms in muscle that would be activated after a vigorous exercise routine 
rely upon inflammatory signaling to activate response (Evans, 1991). Thus, a 
high level of background noise (global elevation of inflammatory signaling) may 
obscure the normal repair signaling response, thus limiting adaptation (Jo, 2012). 
Disruption and impairment of cellular processes involved in nutrient sensing, 
signaling cascades for protein translation/synthesis, and satellite cell biology also 
could be contributors to lower anabolic response with age. Chapter 1 
Background Section F. Anabolic Resistance Etiology provides a more in depth 
discussion of some potential mechanisms of anabolic resistance. 
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 Designing interventions that have the potential to target the age-impaired 
anabolic processes may synergize with the positive benefits of resistance 
training. Combining timed nutrient ingestion or other interventions (e.g. ergogenic 
aids such as creatine monohydrate) with resistance training to overcome 
anabolic resistance and improve exercise response in older individuals may 
successfully prevent, attenuate, and/or reverse the age-associated loss of 
muscle mass and strength (Devries, 2014; Forbes, 2012; Candow, 2012). A 
multiplex approach may eventually succeed in attenuating sarcopenia, whereas 
individual therapies cannot. 
 
A first step in developing treatments is to create an animal model for pre-clinical 
analysis. The C57BL/6 mouse is a commonly used model of aging. In previous 
work we developed a frailty phenotype index for mice (Liu, 2014) based upon the 
Fried frailty phenotype (Fried, 2001). In a follow-up study we investigated the 
effect of a short-term voluntary aerobic exercise intervention and found that one 
month of wheel running was sufficient to reverse frailty in mice (Graber, 2014). 
The gold standard for sarcopenia intervention, however, is weight training not 
aerobic training, and we thus next produced and validated a mouse model of 
human weight training (Chapter 4). 
 
The overall purpose of this thesis was to first investigate, characterize, and 
describe the neuromuscular healthspan of this mouse model; subsequently 
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 creating a treatment model for sarcopenia. The first two research chapters (2 and 
3) investigate the neuromuscular healthspan and the age-related decline of 
contractile parameters in the C57BL/6 mouse. Because the only consensus 
treatment for sarcopenia is resistance exercise, in Chapter 4 a mouse model of 
voluntary resistance training was designed and validated. The protocol was 
designed using human principles of weight training (Garber, 2011) and assessed 
with a comprehensive battery of outcome measurements. The outcomes were 
selected to test whether the mice had the same type of adaptations as would be 
observed in humans undergoing a similar training intervention (Kraemer, 2000). 
Finally, In Chapter 5, the resistance training protocol was applied to a cohort of 
aged mice to test the if signs of anabolic resistance would be detectable. 
 
  
7 
 
 Prelude 
 
The second chapter consists of the “C57BL/6 Neuromuscular Healthspan 
Scoring System”. Because there is a vast amount of individual variability in 
outcome measurements commonly used for function in aging studies (rotarod, 
grip test, physiology), the purpose of this study was to create a system that would 
serve to reduce the effect of this variability in order to increase the ability to 
detect changes resulting from interventions. Therefore, this study describes the 
C57BL/6 adult neuromuscular healthspan (5-32 months of age) using the 
performance measurements of rotarod and grip test and in vitro contractile 
physiology to measure the peak tetanic force of the EDL. These scores were 
combined in a mathematical construct (using multiple regression predicted 
scores and the means of the cohorts) that was able to greatly improve the 
statistical power of the individual outcome measures.  
 
Because peak tetanic force is static, but animals move in life using power, in 
chapter 3, “C57BL/6 Lifespan Study: Age-Related Declines in Muscle Power 
Production and Contractile Velocity”, contractile velocity and power output over 
the lifespan of the mouse was characterized in both the soleus and EDL. Power 
is a critical determinant of functional ability and declines with age at a more rapid 
rate than force alone. Not only was a decline in function found, but that there was 
also a load-modulated age effect (the mice demonstrated increased age-related 
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 dysfunction at measurements taken at higher percentages of maximum force). 
This finding has possible translational importance because power and velocity 
training may be one way to increase functional ability and to prevent disability in 
seniors. The more difficult tasks such as opening a sealed jar, getting up from a 
chair or preventing a fall require power production at the upper levels of 
maximum force. Therefore, since this part of the power curves declines more 
rapidly with age, we need to investigate interventions to help alleviate that loss. 
That could ultimately improve quality of life and extend independent years in the 
older population.  
 
To date, strength training has been the gold standard to combat sarcopenia (with 
the goal of increasing strength and building muscle mass). Because there is not 
a mouse model that truly mimics human weightlifting as it would be performed in 
the gym, following the observations from the prior two studies, in the fourth 
chapter, “Voluntary Resistance Training in Adult Mice”, a novel resistance 
training protocol using custom equipment (a powered running wheel and weight 
harness) and utilizing human weight training principles was developed and 
validated in an initial study using adult mice (12 months old at endpoint). One 
main question was, “Would training increase power and velocity, as well as 
functional performance and strength?” Using a carefully selected battery of 
outcome measures designed to test whether or not changes in function, 
physiology and morphology occurred as would be expected after following a 
9 
 
 resistance training regimen, the protocol was determined to be a valid mimic of 
human weight lifting or resistance training. 
 
Chapter 5, “Voluntary Resistance Training in Elderly Mice and Signs of Anabolic 
Resistance”, investigated the efficacy of the training protocol described in 
Chapter 4 to improve outcomes in an elderly population (28 months at the 
endpoint). While some of the same measurements improved as in the younger 
mice, others did not, or to a lesser extent. Thus, there was some evidence of 
anabolic resistance in the older mice. 
 
Chapter 1 contains background information that is pertinent to the four main 
chapters, but that is not absolutely needed for understanding the individual 
research chapters. Each research chapter contains its own introduction 
explaining needed background and has a discussion explaining the context of the 
research to existing literature. 
 
In summary, this is the story of age-related neuromuscular decline in 
performance and physiological function in that can be partially rescued through 
exercise. The effect of exercise was modulated by the age of the animal. Future 
work will investigate the genetic basis of the responder/non-responder 
differences, and adding synergistic interventions to complement exercise training 
10 
 
 (nutritional supplementation of branched chain amino acids, for example) to 
improve exercise response in non-responders and older mice. 
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 Chapter 1 Background Information 
A. Aging Demographics 
A rapidly aging population has caused a world-wide demographic change that 
presents multiple challenges for the socio-economic sustainability of the medical 
establishment. The so-called “greying of the population” stands to test the 
resolve and solvency of the healthcare system and governmental/societal 
resources. In 1900, the average age for survival was 477  and 4% of the 
population was over the age of 65 (3.1 million people). By the middle of the 20th 
century, median survival had grown to 68 and the number of people over the age 
of 65 in the United States was 12.3 million or about 8% of the overall population.   
In 2007 the life expectancy at birth was 77.9 years8. The estimated population of 
the United States, as of 02/20/12, is 313,052,188 2. The projected population in 
2030 is 373,504,0009. However, between 2010 and 2030 the percentage of 
traditional working age Americans (18-64 years of age) will decline from 63% to 
57% while a concurrent increase in the number of Americans over the age of 65 
increasing from 13-19%. Furthermore, the percentage of Americans over the age 
of 85 will increase by 25% and the percentage of centurions will double. 
Projections for 2030 do not include any radical technological biomedical 
advances that could even further increase lifespan; only actuarial data 
7 http://www.cdc.gov/nchs/data/nvsr/nvsr59/nvsr5909.pdf 
8 http://www.census.gov/ 
9 http://www.census.gov/population/www/projections/summarytables.html 
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 projections. The actual estimated (1900-2008) and projected (2010-2050) 
number of older Americans is displayed in Figure 110. 
 
What are the implications of the aging of society? Beyond the obvious problems 
such as an actual net percentage loss in the number of working age tax paying 
citizens (which will result in a crippled ability to sustain Medicare and social 
security in the current tax/benefit structure), there are a host of quality of life 
issues to consider. Long-term health care facilities such as nursing homes are 
incredibly expensive. One hope is that along with the increasing aged population 
will come advances in biomedical technology that will allow a compression of 
mortality—people will not only live longer, but they will stay healthier longer and 
the end-of-life time of disability, loss of independence and sickness will be 
shorter. Interventions at the social level will also be vastly important—programs 
such as the non-profit Meals on Wheels that delivers nutritious food to 
homebound elderly clients (and has seen some erosion of funding in recent 
years)11. To be able to allow more of the elderly to maintain their independence 
longer by preventing or stalling the onset of sarcopenia and frailty will be critical 
to successfully managing this transitional period in which the 65+ elderly 
demographic is expected to become 25% or more of the total population by 
2050.   
10 http://www.agingstats.gov/Main_Site/Data/2010_Documents/images/Indicator-1_Num_of_OA_left.gif 
 
11 http://meals-on-wheels.com/326 
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 B. Sarcopenia 
Sarcopenia, the age-related loss of skeletal muscle mass and strength, will 
become a vastly important condition as more people live longer and quality of life 
(healthspan) becomes more important than lifespan extension. Muscle mass 
typically peaks by the mid-20s-30s and then declines steadily after the mid-40s 
(Jansen, 2002). By the age of 80, people have lost about 40% of their peak 
muscle mass (Deschenes, 2004). The most serious cases of sarcopenia affect 
about 8% of older adults and are severe enough to cause functional disability 
(Jansen, 2002), such as the inability to perform necessary daily tasks such as 
dressing, bathing, cooking or even walking without aid. 
 
Sarcopenia can ultimately cause the elderly to lose their independence and 
contribute to the onset of frailty—costing billions of dollars per year (direct cost of 
sarcopenia was $18.5 billion in 2002) (Jannsen, 2004). It is in the best interest of 
society, both financially and as a quality of life issue, to find successful 
interventions for this muscle wasting condition. The development of animal model 
systems that have the ability to assess neuromuscular healthspan is critical to 
monitor potential interventions for sarcopenia and frailty prevention.  
 
A common definition of sarcopenia is an age-related decline in strength and 
muscle mass (Nair, 2005). Frailty is a little more difficult to define. One idea is 
that frailty is the loss of ability of the body to thrive and/or maintain homeostasis, 
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 especially after illness or injury (Cooper, 2012). One recent clinical definition of 
frailty that has been developed for humans is having 3 of the 5 determinants 
(unexplained weight loss of >10 pounds, low grip strength, low energy level, slow 
gait speed and low activity) qualifies one as being frail (2 of 5 is equivalent to 
“pre-frailty”) (Fried, 2001). Neuromuscular dysfunction and sarcopenia play a 
large role in the clinical manifestation of frailty (Fairhall, 2011, Cooper, 2012). 
 
Much research has delved into the etiology of sarcopenia, and the condition has 
a multi-factorial basis, some examples being: denervation, disuse atrophy, 
lowering of muscle quality (at multiple levels: from connective tissue dysfunction 
to fat intrusion to contractile protein damage), impaired signaling pathways 
regulating protein synthesis and catabolism, and lowered response to anabolic 
stimuli (Ryall, 2008; Thompson, 2009; Narici, 2010; Fielding, 2011).  
 
Studies show that fewer than 2% of middle-aged and elderly people regularly 
(more often than once per week) participate in weight-bearing exercise (Jansen, 
2002). Though only about a five percent loss of fibers is seen by age 50 (with a 
rapid increase in percentage lost after age 60) (Deschenes, 2004); the more 
muscle built in youth and maintained throughout life, the more mass there is to 
be lost as sarcopenia begins. Even master athlete weight lifters and marathon 
runners (defined as elderly people who have trained for decades) decline in 
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 performance an average of 50% between the age of 40 and 80 (Faulkner, 2007).  
Sarcopenia can be treated, but not cured.   
 
Many studies have shown that resistance exercise is successful in increasing 
muscle mass and strength in the elderly, with the additional side effects of bone 
density increase, body composition improvements, and better metabolic function 
(Melov, 2007; Fiaterone, 1990; Frontera, 1988; Aagard, 2007; Phillips 2007, 
Kalapotharakas, 2005). Beyond the issue of the loss of mass, muscle quality 
(contractile power of individual fibers) declines from a weakening of the 
contractile strength of the actin/myosin network—this has been shown to be 
reversible to a degree with exercise (Snow, 2004). Functional strength and 
quality of daily life can be improved and/or maintained with exercise (Phillips, 
2007; Kalapotharakas, 2005). Frailty can be avoided and independence 
maintained (Borst, 2004).  
 
Yet another consequence of reduced strength is decreased mobility, and by 
extension, independence (Jansen, 2002; Kauffman, 2007). Often the energy and 
strength necessary to perform routine daily tasks is lacking, leading to removal 
from independent living and the resulting transition into managed care. Overall, 
the loss of muscle mass in the later stages of life contributes to a lower quality of 
life (Kaufmann, 2007).  
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Beyond quality of life issues, there are legitimate health concerns involved with 
the decrease of muscle mass, strength and power (Phillips, 2007). For example, 
skeletal muscle is the single largest metabolic engine burning vast quantities of 
glucose (and by default fats), outside of the liver (Phillips, 2007)). The basal 
metabolic rate is the amount of energy burned by an individual at rest. A person 
with more muscle burns more energy, even when not exercising than a person 
with less muscle, because fat cells are mostly metabolically inert in comparison 
to muscle cells (Whitney, 2005). Therefore, loss of muscle mass lends to a 
decrease in metabolic rate and, without strict caloric restriction, results in an 
increase of stored body fat. An increase in body fat percentage and BMI (Body 
Mass Index) has been correlated with an increased risk for metabolic syndrome 
and all of its attendant consequences (increased risk of cardio-pulmonary 
disease, diabetes, etc.) (Whitney, 2005). Many other effects, such as increased 
pressure on overtaxed joints and self-esteem/image issues also result from fat 
gain (Whitney, 2005). 
 
Another example of sarcopenia related health issues is falls. With age, there is 
also decrease in the effectiveness of the inner ear balancing mechanism, the 
vestibular system (Kaufmann, 2007). When stimulated, the hair cells that line the 
inner ear release neurotransmitters to the attendant axons, or nerve cells. They 
are surrounded by a gelatinous material (which constantly pulls the hairs in 
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 response to gravity, thus causing a sense of up and down) that is heavier than 
the endolymph filling the semicircular canal, the utricle and saccule. These three 
parts of the area of the inner ear are separated from the cochlea by the “oval 
window”, and are responsible for balance and spatial orientation. These hairs 
become less sensitive to the changing motion of the inner ear fluid (endolymph) 
as they become senescent; and, thus, the body has a harder time orienting itself 
in space (Campbell, 2005). This vestibular system decline, as well some 
prescribed medications and blood pressure problems, can cause a decrease in 
balance in the elderly. Along with a loss of strength and power (power being the 
application of force over time) due to sarcopenia, the tendons connecting the 
muscle to the bone decrease in elastic modulus and stiffness, resulting in a 
reduced and slowed transmission of force (McCarthy, 2014; LaCroix, 2013, 
Narici, 2008). The neural connection from the brain to the muscle cells declines 
in effectiveness from an age-associated reduction in nerve conduction velocity 
due to age-associated demyelination of the peripheral nerve (Manini, 2013).  
When an individual begins to lose balance, they attempt to regain it by increasing 
force, for example, in one leg. The little used motor program for “arrest fall!” 
signals the remaining motor neurons (after age-related denervation) to send an 
action potential to stimulate motor units made up of smaller numbers of muscles 
fibers than in younger people. These smaller motor units are more type 1 than 
type 2 (better at powerful movements) and the available fibers are also smaller 
and of lesser quality (weaker per unit cross-sectional area) than what would be 
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 available in a young person attempting to stop a fall. After the fibers in the motor 
unit are activated, there is a further delay in response at the joint because the 
tendon is not taut and the muscle force is delayed in reaching the needed pivot 
point (Phillips, 2007). By this time, the person has fallen and perhaps risked 
serious injury. Falls that result in severe injury form the leading edge of a 
downward spiral of failing health leading to mortality (Borst, 2004).  
 
Attempting to find treatments to combat sarcopenia has been less than 
successful. Many therapies have shown some promise on a limited scale 
(nutritional, pharmacological and ergogenic) but no single therapy has proven 
overwhelmingly effective (Candow, 2011). To date, the best and most accepted 
therapy for sarcopenia is resistance exercise, weight training in particular 
(Fiaterone, 1990; Capodaglio, 2007). In the future, a multi-prong approach 
utilizing a number of different therapeutic strategies in synergy with resistance 
exercise will prove to be the answer to address the attenuation of sarcopenia. 
 
Prevalence of Sarcopenia 
Progressive loss of muscle mass and strength with age may be inescapable with 
current medical technology. Whether this loss is termed sarcopenia or not is at 
the level of semantics, but does the condition impact functional ability? There has 
been an international effort to find a clinical definition of sarcopenia. One 
definition is that after seeing manifestations of phenotypical symptoms 
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 (weakness, difficulty in performing activities of daily living, etc.) that the patient be 
evaluated via DEXA (dual energy x-ray absorptiometry). Individuals who present 
at less than the 20th percentile of lean appendicular mass of healthy young adults 
and who have functional impairment can be diagnosed with sarcopenia (Fielding, 
2011). 
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 C. Effects of Aging on Muscle 
Age-related changes to muscle cells are many and varied and occur on a variety 
of levels. Sarcopenia is the result of muscle atrophy (often related to disuse), 
denervation and loss of muscle fibers as well as a reduction in muscle quality 
(defined as the ability of a given volume of muscle to produce force or power) 
(Thompson, 2006). With age, there is a decrease in muscle cross sectional size, 
and in the overall number of muscle fibers, an increase in fat deposits and 
connective tissue within the cells, and disruption of many important signaling 
pathways (Porter, 1995). 
 
Lifestyle changes in older adults, in particularly lower activity levels, contribute to 
decline in functional ability (Marini, 2008). Many of the support systems that help 
to maintain muscle function are negatively affected by age. For example, the 
endocrine system produces fewer neurotropic growth factorsproduction of 
growth hormone declines, which in turns causes a reduction in production of IGF-
1, the major growth factor affecting skeletal muscle. Less anabolic hormone 
production (i.e. free testosterone levels decline) and a corresponding increase in 
catabolic hormones, e.g. cortisol, results in decreased anabolic capability 
(Stenholm, 2010). Excess inflammation and the resulting catabolic response 
have been attributed as one of the many causes of sarcopenia (Deschenes, 
2004). Neuromuscular decline in the peripheral nervous system could result from 
decreased activity (Deschenes, 1994). The cardiovascular system declines in 
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 ability—from reduced cardiac output to a lessening of capillary connection to 
muscle fibers--reducing muscle function by limiting nutrient and oxygen 
availability to cells (Guarner-Lans, 2011). Nutrient absorption is also negatively 
affected by age, resulting in a need for increasing levels of micro and macro-
nutrients in the diet to provide need building blocks for muscles (protein intake 
must be increased in the elderly for example) (Koopman, 2009; Breen, 2011). 
Reduced insulin response in older adults causes a lessened ability to uptake 
glucose. Neurological changes also contribute to the overall decline of the 
system as some α-motor neurons begin to decay and denervate muscle cells—
ultimately resulting in cell atrophy and apoptosis.  
 
Denervation consists of the loss of motor units and the subsequent atrophy and 
apoptosis (cell death) of the muscle fibers associated with the motor unit 
(Faulkner, 2007). This process occurs disproportionately in fast twitch muscle 
cells (cell designed for rapid contraction, power and anaerobic metabolism). The 
fiber, after losing its neural connection, is either connected to a neighboring 
(often slow-twitch) motor unit network through axonal sprouting (which then 
converts the fiber to a slow twitch), or it atrophies and dies (Koopman, 2009; 
Breen, 2011, Ryall, 2008). Denervation, and subsequent reinnervation (whether 
by another branch from the denervating neuron, or with a new branch from a 
neighboring neuron), are balanced in youth, but become unbalanced in favor of 
denervation in older adults, resulting a net loss of fibers. Between age 50 and 80, 
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 approximately 50% of muscle cells are lost (Faulkner, 2007). Much remains to be 
investigated concerning this process. IGF-1 (insulin-like growth factor 1) 
upregulation, for example, was found to prevent the loss of fast twitch motor units 
in rats (Messi, 2003).  
 
Other reasons for decreasing muscle mass are related to a decrease in the size 
of the existing muscle fibers. This is often measured using the cross sectional 
area of the fibers. Some reasons given for the age-related decrease in fiber size 
include: signaling pathways disruption resulting in reduced response to anabolic 
stimuli, increased expression of catabolic hormones, lessened production of 
hormones (growth, androgenic and anabolic), oxidative stress damage to muscle 
cell organelles and structure (perhaps also contributing to apoptosis), and disuse 
atrophy (Ryall, 2008; Faulkner, 2007).  
 
Age-related changes in the endocrine system possibly contribute to anabolic 
resistance. Anabolic hormones are critical to muscle building hypertrophy (Gao, 
2007). The decline in production of testosterone, and its precursors, such as 
DHEA (dehydroepiandrosterone), is termed andropause, and occurs in both 
males and females (documented as being up to 64% and 28%, respectively for 
testosterone) (Van der Beld, 2000). Testosterone production in men begins to 
decline in the mid-to late-20’s.    
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 At the tissue level, reduced stem cell proliferative capacity provides a declining 
ability of elderly muscle tissue to repair damage by reducing the ability of satellite 
cells to self-replicate and to differentiate into nuclei that fuse to muscle fibers 
(Jones, 2011). The muscle has intrusion of fat and connective tissue where 
contractile element used to exist, reducing muscle quality (Addison, 2014). Both 
innervation and blood supply control are reduced or less effective, further 
causing declining function (Narici, 2008; Payne, 2004, Payne, 2006; Procter, 
2006). Paracrine emission of cyto/myokines by aging muscle change to 
negatively affect growth and repair ability, and enhance atrophy (Pratesi, 2013). 
Connective tissue required to transmit force from muscles also have age-related 
changes, such as reduced tendon elastic modulus, that negatively affect 
movement (Onambele, 2006). Joints also suffer deterioration and loss of function 
(Lanza, 2003). In essence, the whole neuro-skeletal-muscle system declines in 
functional ability with age (Faulkner, 2007; Porter, 1995). 
 
At the cellular level, many changes occur with age. Some changes happen 
because of cellular level or biochemical processes. A good example of this is 
damage from oxidative stress. If a muscle, a post-mitotic tissue, is continually 
bombarded with reactive oxygen species (byproducts of cellular respiration), 
eventually accumulated damage will occur beyond the capacity of the cell to 
repair. This results in a backlog of damaged proteins that may be dysfunctional 
or nonfunctional. Damage and/or misfolded proteins result in lessened enzymatic 
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 capability and can affect varied cellular processes from glycolysis to force 
production. While many of these proteins are cleared out by the action of 
proteases (proteasome for example) or repaired by heat shock proteins, some 
may result in ultimately causing the demise of organelles or will cluster to form 
aggregates that resist the ability of the cell to recycle or repair. Repair and 
recycling mechanisms also decline over time, so a vicious cycle is set up. 
Mitochondria, for instance, may become dysfunctional over time (mitophagy 
clears out many but not all “broken” mitochondria) and the accumulation of 
nonfunctional organelles within the cell reduce volume available for contractile 
elements (hence a reduction in muscle quality). 
 
Another problem is DNA damage (from ROS or spontaneous mutation over time) 
which can result in mitochondria dysfunction when mitochondrial DNA is 
damaged or even dysfunction nuclei, which can then have transcription 
problems. Ribosomal protein synthesis ability is also lessened over time, so 
translation of new proteins to replace damaged proteins becomes an issue. In 
general, it appears that there is reduced rate of protein synthesis seen with age 
(Breen, 2011); therefore maintaining the homeostasis of the cell by balancing 
production of new proteins with the catabolism of old proteins may become more 
difficult. Of course, ROS influenced post-translational modifications could be 
theorized to reduce function at many different levels. 
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 Molecularly, the ability of the myofiber to function may also become impaired with 
age. For many of the aforementioned reasons, certain integral processes to 
muscle function might become compromised with age. Many examples abound. 
The cross-bridge cycle, which produces force in the muscle, relies upon 
numerous aspects of cell biology to function at an optimal level, and deleterious 
changes in membrane excitability and calcium handling contribute to age-related 
dysfunction in muscle (Payne, 2009).  
 
The actions of the dihydropyridine receptor (DHPR) and the ryanodine receptor 
(RYR) in response to the depolarization of the action potential (AP) must make 
enough calcium available in sufficient amount to load onto and saturate troponin 
c. This causes a conformational change in the troponin complex that moves 
tropomyosin off of the myosin binding sites on the actin thin filament, thus 
allowing the myosin head to engage and strongly bind to the actin filament—
initiating the cross-bridge cycle. DHPR are voltage-gated complexes that change 
conformation in response to the depolarization of the action potential and 
physically interact with RYR, causing the RYR to open their channels to release 
a flood of calcium from storage in the sarcoplasmic reticulum. A reduction in the 
density of DHPR with age could result in fewer RYR in contact with DHPR, thus 
resulting in a lessened ability for calcium from the sarcoplasmic reticulum to be 
released in response to a given AP (Delbono, 2011). 
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 A reduced ability of motor neurons to provide acetylcholine (smaller and more 
disorganized endplates occur with age) results in weaker AP which can further 
contribute to calcium handling dysfunction (Tudorascu, 2014). ATP must be 
available in sufficient quantity to phosphorylate myosin and to activate the 
calcium ATPase pump to reuptake calcium into the sarcoplasmic reticulum 
during relaxation.  
  
One very important additional alteration with age is the change in myosin heavy 
chain and myosin light chain (MLC) isoform distribution. Aging is associated with 
a reduction in MHC2 overall, and in the faster isoforms such MHC2b (See 
Chapter 2 results). These heavy chains cross-bridge faster than MHC1 and so 
can produce more power. Furthermore, MLC come in numerous isoforms (fast 
fibers have MLC1f and MLC3f) as well. These MLC isoforms also influence the 
speed of cross-bridging, MLC3f being the fastest. Age sees a reduction in 
MLC.3f content (See Chapter 3 results), thereby further slowing the type two 
fibers. 
 
  
27 
 
 D. Aging, Muscles and Resistance Training 
There is hope to attenuate much of age-related muscle dysfunction. Exercise 
provides nearly universal benefits to help recover function and to slow declining 
ability, regardless of the starting capacity of the individual. Even the frailest of the 
elderly benefit from increased activity (Fiatarone, 1990; Galvao, 2005).   
 
Two types of training are often advocated: aerobic and resistance. Aerobic 
training can be further subdivided into weight bearing and non-weight bearing 
motifs. Examples of weight bearing aerobic exercise include walking or jogging. 
Non-weight bearing exercise might include stationary bike riding and swimming 
(although swimming is also mildly resistive in nature). Hybrids also are seen 
(partial weight bearing) such as water aerobics. The main benefits derived from 
aerobic-style exercise, as the name implies, are to aerobics systems such as the 
cardio-vascular system. A huge list of benefits to overall physiologic health occur 
with aerobic exercise including, but not limited to: improved body composition, 
fatty acid oxidation and insulin sensitivity; increased VO2max; better fatigue 
resistance, increased bone mass at weight bearing areas, improvement in joint 
function and some limited hypertrophy of type one muscles (Allen, 2011). Many 
of these changes benefit the overall environment of the body and can help 
contribute to increased mobility. While a sedentary individual will see great 
improvement from any sort of increase in activity, aerobic included; to truly 
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 improve muscle function and attenuate sarcopenia, resistance training is 
required. 
 
Resistance training includes weight bearing calisthenics and weight lifting. 
Weight lifting is the gold standard in improving muscle function. Muscle 
hypertrophy resulting in increased muscle mass and strength is the main 
advantage that resistance training has over aerobic training. In addition, 
resistance training also provides many of the same type of benefits as derived 
from aerobic exercise, albeit at a lower level (Phillips, 2007). Improved fatty acid 
oxidation, body composition, insulin response, increased capillary density and so 
forth all derive from weight lifting as well. While these benefits may be received at 
a high level in aerobic style exercise, aerobic exercise does little to increase 
force production and muscle mass (it primarily acts upon type 1 muscle and to a 
limited extent upon type 2a). Since problems with type 2 muscles are generally 
the plague of the elderly (slow twitch muscle being generally more resistant to 
age-related dysfunction) (Thompson, 1994), resistance training is the best hope 
to improve the type 2 motor units. Much of the atrophy seen in the elderly may be 
disuse atrophy resulting from lifestyle changes and decades of a sedentary 
lifestyle (denervation of type two muscle may also have a disuse component. 
Therefore, to combat muscle loss that results in lower power output and 
movement dysfunction, a program of weight lifting is ideal.  
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 Many of the adverse age-related changes to the muscle can be at least partially 
reversed by implementing a well-designed program exercising all of the major 
muscle groups using progressive resistance and sufficient intensity, duration and 
frequency (Chodco, 2009). While exercise response is blunted in the elderly in 
comparison to younger people (Hunter, 2004; Leiter, 2011), it still can cause 
increases in anabolic hormone, growth factor and paracrine/autocrine production, 
cause muscle cell remodeling and hypertrophy (clearing out old damaged 
proteins and adding new, fresh proteins and contractile elements), increase 
strength and power production thereby improving functional ability, an increased 
satellite cell pool with improved proliferative capacity and many other positive 
changes to both the muscle fiber, whole muscle, muscle environment and 
support systems (Hunter, 2004; Leiter, 2011). Of course, adequate nutrition is 
important as well—older people generally require more protein and nutrient 
signaling pathways are somewhat disrupted requiring a careful attention to 
nutrient intake (Koopman, 2009). 
 
In conclusion, with respect to increasing mobility and to help restore functional 
ability in the elderly, any exercise is good exercise. The best prescription is for a 
combined approach, such outlined in the American College of Sports Medicine 
position statement on exercise and older individuals, with aerobic, resistance 
training and flexibility training all playing a part (ACSM, 2008). The greatest 
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 benefit for improving skeletal muscle function itself comes from resistance 
exercise. 
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 E. PI3kAktmTORc1p70S6K Signaling Cascade 
One of the main pathway of protein synthesis associated with skeletal muscle 
hypertrophy begins with the activation of PI3k (phosphoinostisol-3 kinase) by 
Figure 1 Simplified Growth FactorPI3kAktmTORC1p70s6k Signaling Cascade. Akt 
is phosphorylated at the Threonine 308 site, then downstream mTORC1 is phosphorylated at the 
Serine 2448 site, and p70s6k is phosphorylated at Threonine 389 (one of many sites on p70S6K, 
but which is required for protein translation). p70S6K phosphorylates ribosomal protein S6 and 
eIF4B (eukaryotic translation initation factor 4B), afterwhich the ribosomal complex can form and 
translation of mRNAs can begin, ultimately resulting in protein synthesis. 
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 growth factors which then eventually downstream turns on Akt by 
phosphorylation, which then goes through the mammalian target of rapamycin 
complex 1 (mTORC1) to turn on translation, in part by phosphorylating p70S6K 
(Glass, 2010). There are a number of important regulators upstream of 
mTORC1. Important external signaling mechanisms are growth factors (insulin-
like growth factor 1—IGF-1—for example), nutrient signaling (e.g. branched 
chain amino acids, leucine in particular, upregulated mTOR), and negative 
signaling molecules such as myostatin.  
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 F. Etiology of Anabolic Resistance 
Age-Associated Systemic Physiological Changes 
Hormonal 
Anabolic hormone production declines with age and may be one root case of 
sarcopenia out of many (Sipila, 2013, Valenti, 2010). Testosterone is a highly 
anabolic hormone produced by both men and women, though to a much larger 
level in men. Testosterone production in men begins to decline in the mid-to late-
20’s and then continues to declines, on average, 1% per year after age 40 in 
men (Gray, 1991). Testosterone is only bioactive in its free state, not when 
bound to SHBG—sex hormone-binding globulin. SHBG increases more than 2-
fold in quantity with age (Van den Beld, 2000). The decline in testosterone  
production, in both males and females, has been documented as being up to 
64% and 28%, respectively (Van der Beld, 2000). There has been research into 
utilizing anabolic steroids and/or supplemental testosterone (or precursors) in 
aging men to restore vitality and muscle mass. Anabolic steroids, and exogenous 
testosterone, definitively work to increase lean muscle mass (Myhall, 1998). A 
meta-analysis of testosterone therapy showed a clear benefit of increasing 
strength (Ottenbacher, 2006). One major confounder is that neither exercise nor 
diet was prescribed or controlled for in most of the studies. This would limit the 
potential for therapeutic benefit to be gained by improving the anabolic 
environment (with anabolic hormonal supplementation) but not providing a potent 
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 anabolic stimulus (resistance training, and protein ingestion). Perhaps combining 
resistance training with anabolic supplementation could be a winning strategy. In 
addition, most of these studies involve restoring hypogonadic males to age-
normal levels of testosterone, restoring to high-normal levels of young men or to 
slightly super-physiological levels would have a greater impact (Deschenes, 
2004). There has been funding shortage for investigating hormone replacement 
therapy (Lynch, 2004a) and its association with so-called aging-clinics has 
lowered respect for the field. Most studies now conclude that, while effective, 
dosage levels and side effects incurred, as well as adverse reactions seen in 
limited form, require much more study to be made in order to formulate effective 
clinical strategies for administration of steroids as an anti-sarcopenia strategy. 
   
Somatopause (similar to andropause- the reduction of testosterone) is the 
lowering of blood borne levels of growth hormone (somatotropin). Generally men 
begin to have a gradual decline in GH levels starting in the early 30’s that 
progresses (Sattler, 2013). GH has effects that are expressed downstream 
through the liver produced IGF-1 pathway but it also affects muscle in a direct 
fashion. GH has a connection to numerous important metabolic functions 
including: mitochondrial efficiency, improving overall body composition by 
increasing fat metabolism and increasing resistance to fatigue (Ryall, 2008; 
Sattler, 2013). Growth hormone administration in great excess of therapeutic 
levels leads to fluid retention, growth of soft tissue such as the cartilage in the 
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 nose and jaw, and organ growth. To date, it has not been proven to be an 
effective strategy to use GH to stimulate muscle mass increase (Lynch, 2004b) 
or strength (Borst, 2004), though GH has been shown to improve body 
composition and general well-being (Sattler, 2014).  
  
Insulin and insulin-like growth factors (IGF-1 and 2) are also powerful anabolic 
agents. Much IGF is produced in the liver and is controlled by growth hormone. 
Other IGF-1 is produced and used locally inside the muscles. There are at least 
two splice variants produced in the muscle itself, IGF-1Eb (sometimes referred to 
as MGF, or mechano growth factor) and is released in response to physical 
stimulation (Ryhall, 2008). The other splice variant (IGF-IEa) is nearly identical to 
the liver-produced splice variant. Active IGF-1, after post-translational 
modification, is identical, no matter which splicing it originated from. However, the 
regulation of IGF-1 by binding proteins and regulation of intra-muscular 
production has not been fully elucidated. Some forms of IGF-1 binding proteins 
are more prevalent in older individuals than in younger (Ryhall, 2008). Some 
evidence exists that IGF-1 plays an insignificant role in contraction-mediated 
protein synthesis (Hornberger, 2011; You, 2014). However, IGF is important in 
regulating apoptosis and denervation (Messi, 2003), as well as in satellite cell 
activation and differentiation. More research is needed to examine the role of 
IGF-1 in anabolic resistance. 
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 Thyroid hormone production also changes with age (Aggarwal, 2013). Thyroid 
hormones are responsible for many metabolic functions, many of which either 
directly or indirectly affect skeletal muscles. Hypo-thyroid predicates changes in 
muscle fiber phenotype (from fast twitch to slow twitch forms) and in control of 
calcium ion transfer across the sarcoplasmic reticulum (Ryhall, 2008).  
 
Thus, the age-altered hormone levels may play a role in the systemic 
environment contributing to anabolic resistance. In addition to declining hormone 
levels, another possibly potent mediator of anabolic resistance at the systemic-
level is global inflammation. Some studies have linked age-associated global 
inflammation to reduced capacity to respond to exercise (Merritt, 2013, Lawler, 
2011). Much of the repair mechanisms in muscle that would be activated after a 
vigorous exercise routine rely upon inflammatory signaling to activate response. 
Thus, it is conceivable that a high level of background noise (global elevation of 
inflammatory signaling) may obscure the normal repair signaling response, thus 
limiting adaptation.  
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 Age-Associated Changes to the Cellular Environment 
Satellite Cells 
Satellite cell are muscle stem cells that perform a critical function in repair of 
damaged muscle fibers, and have long been thought to contribute to hypertrophy 
by fusing to existing muscle fibers. There is a reduced capacity for satellite cell 
functioning in older subject (Conboy, 2005; Gopinath, 2008). Despite some 
recent data showing that satellite cell function may not necessary for 
hypertrophy, at least as far as maintaining the myonuclear domain (Jackson, 
2012), there is no question that older subjects have a decline in 
proliferative/differential capacity which certainly hinder injury recovery, and 
possibly exercise response. More research is needed in this area. 
 
Impaired Protein Synthesis Pathways 
Anabolic signaling pathways are stimulated by growth factor (IGF-1 for example), 
nutrients (for example the branch chain amino acids leucine stimulates the mTor 
pathway) but may not as responsive in the elderly as in younger individuals 
(Burd, 2013). Protein synthesis rates also decline with age in response to nutrient 
signaling (Walker, 2011). There is some evidence that amino acid transporters 
play a role in the age-related reduced anabolic response to protein feeding 
(Dickinson, 2013). Evidence has recently been discovered that mechanical 
stimulation increases protein translation via an Akt independent mTOR signaling 
mechanism involving diaglycerol kinase (Hornberger, 2011). More research is 
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 needed to investigate whether this mechanical stimulation anabolic signal is 
blunted in the elderly.   
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 G. Measuring Skeletal Muscle Contractile Physiology:  The Basics 
This section is not meant by any means to be an exhaustive review of muscle 
physiology, it is simply a brief overview of the cascade of events that occur from 
the moment a motor neuron fires down to the eventual application of force across 
a joint—in the context of the difference between measuring contractile 
parameters in vivo or in vitro. Skeletal muscle is voluntary muscle (i.e. can be 
controlled with conscious thought). Therefore, once the decision has been made 
by the central nervous system to use a muscle and the signal from the cerebral 
cortex is conveyed and refined through the motor cortex and sent out to the 
spinal cord, an action potential is generated at the cell body of an alpha motor 
neuron and conveyed down the axon to eventually reach each neuromuscular 
junction associated with that motor unit. This action potential causes a release of 
acetylcholine, stored in synaptic vesicles in the nerve ending. The acetylcholine 
then diffuses across the synaptic cleft to the end plate (invaginated sarcolemma 
side of the neuromuscular junction) and attaches to the acetylcholine receptor, 
opening its ion channel, the resulting influx of ions then opens associated 
voltage-gated sodium/potassium ion channels initiating a local depolarization in 
the sarcolemma. This local depolarization becomes an action potential and 
travels along the sarcolemma and deep into the cell via the transverse tubules. 
The action potential then stimulates the calcium handling proteins initiating 
excitation/contraction coupling and force generation (discussed in depth below).  
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 The depolarization process is where the essential difference between the 
isolated preparation and the in vivo state begins. 
 
The absolute main difference between muscle contraction in vivo and the 
isolated muscle prep is that in vivo the muscle is innervated and in the isolated 
muscle prep (in vitro), for all intents and purposes, there is no nerve involvement 
in the generation of the action potential. Therefore, both the method and process 
of depolarization is different. In the in vivo model, the action potentials flowing 
down the motor neuron to the neuromuscular junction (generally in the center of 
the muscle cell) must result in releasing enough acetylcholine (2 molecules for 
each receptor) into the synaptic cleft (for the underlying acetylcholine receptors 
(AChR) to allow a small amount of potassium out and larger amount of sodium 
(both traveling down their concentration gradient) into the cell to cause a local 
depolarization (known as the end plate potential). This local depolarization 
causes nearby voltage gated sodium channels to open causing a flood of sodium 
into the cell which amplifies the depolarization and sends it propagating outwards 
as an action potential (AP).  Acetylcholine esterase (AChE) is an enzyme located 
in the basement membrane that captures some acetylcholine (ACh) on the way 
down to the AChR, but since they are far less abundant than the AChR, most of 
the ACh gets through. After the AChR pores open and the ACh molecules are 
released, the AChE captures the diffusing ACh and hydrolyzes them, ending the 
synaptic transmission.   
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 The AP then propagates through the rest of the myofiber by traveling along the 
membrane and into the interior of the cell via the transverse tubules 
(invaginations of the sarcolemma continuous with the exterior of the cell). In the 
in vitro prep, the muscle sits a temperature controlled bath containing a solution 
such as Krebs buffer (containing electrolytes like sodium, potassium and 
magnesium at physiological concentrations of interstitial fluid along with a pH 
buffer and sugar) in between two electrodes with the tendons attached to force 
transducer/length controller or a static point via suture line tied at the 
myotendinous junction. The electrodes are stimulated to emit enough electricity 
at a given amperage and voltage at a certain pulse of a particular amplitude, 
length and frequency to maximally depolarize the entire muscle. Thus, ACh plays 
no part in the story for membrane depolarization in the in vitro prep—the voltage 
gated channels all open due to the external electrically impulses being applied. 
At this point, the in vivo and in vitro situations begin to become similar.  
 
The AP traveling down the transverse tubule and depolarizing the local 
environment acts upon a voltage sensitive ion channel, the dihydropyridine 
receptor (DHPR). In response to the depolarization, the DHP is activated and 
changes conformation. Extending out of the sarcoplasmic reticulum and into the 
sarcoplasmic space between the SR and transverse tubule is a massive protein 
complex, the ryanodine receptor (RYR)--a type of calcium channel. There is a 
tetrad of DHPRs sitting directly over every other RYR and connected 
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 mechanically to the RYR. One theory of how the RYR is activated involves the 
physical interaction between DHP and RYR. The conformational change of the 
DHPR activates the ryanodine receptor thereby opening a calcium channel 
(Felder, 2002). Calcium floods down its concentration gradient (thousands of 
times higher in the sarcoplasmic reticulum in comparison to the cytosol) from the 
calcium stored within the lateral sacs of the sarcoplasmic reticulum and out 
through the pores of the RYR into the cytosol of the muscle fiber. The calcium 
acts to both as a positive feedback loop to induce more calcium release in the 
short term (Ca2+ induced Ca2+ release) and diffuses to the contractile elements of 
the cell where it binds to troponin C initiating a conformational shifting of the 
troponin complex--thus allowing tropomyosin to move and the myosin binding 
sites on the actin thin filament to become exposed allowing cross-bridge cycling 
to occur. This ultimately results in force production and the process is known as 
excitation-contraction coupling (Delhunty, 2006). 
 
Therefore, in essence, everything is the same in both preparations as far as 
excitation-contraction coupling goes. What is different is how the excitation 
portion is initiated. The process of membrane depolarization is marked different 
in the two systems as is noted above. Interestingly, this causes overall 
differences in a physiologic level above the individual cell. The entire muscle in 
vivo consists of numerous myofibers of whatever various types (I, IIa, IIb, IIx and 
hybrids) organized into motor units each innervated by an individual α-motor 
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 neuron of a particular type (i.e. only type I motor neurons innervate type I fibers). 
When a muscle begins to contract, fibers are recruited to perform the task 
required based upon the size principle: smaller fibers and motor units are 
recruited first with progressively larger units held in reserve unless needed. This 
has the practical application of type I motor units being recruited first for “light 
weight” tasks (which the fatigue resistant fibers can perform for long periods) with 
multiple units being rotated with time to maintain force of necessary. If the force 
requirement for the task is great enough the motor units for larger, more powerful 
(and more fatigueable) type II muscles will be brought to bear. Thus, the 
innervation serves a mechanism to regulate gain in the system and modulate 
energy expenditure to produce only as much force as needed. In the situation of 
the in vitro preparation, the influence of the motor units have been replaced with 
an “all or nothing” firing pattern—the entire muscle contracts at once, maximally, 
because every fiber of every motor unit is depolarized at the same time by the 
electrical impulse stimulation. This has implications in the application of electrical 
pulses during the in vitro prep to stimulate the increased amount of calcium 
present in the cytosol of the cell necessary to produce tetanus rather than just a 
single twitch. 
   
Consciously inducing a single twitch in a muscle, in vivo, is a difficult concept. In 
vitro, a single pulse of energy, maximally potentiated to fully depolarize the 
muscles in the prep, will produce a twitch. This twitch represents the ability of the 
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 muscle to release calcium as well as the ability of troponin to bind it. In an EDL of 
a mouse, for example, a typical system might stimulate the muscle with 1 amp at 
30 volts in a 300 ml bath with a single pulse of 200-microsecond duration. This 
pulse will depolarize the muscle cells, causing the DPHR  to act upon the RYR 
and release calcium sufficient for the muscle to produce a twitch force of perhaps 
to a maximum of around 90 milliNewtons (mN). The muscle is set to its optimal 
length (the length at which the highest peak twitch force is produced or Pt). If, 
instead of a single pulse, a charge train of ten hertz frequency of 1 second 
duration is sent through the electrodes, ten individual twitches will be produced. 
This is because the frequency of the pulses are not high enough to produce a 
greater outflow of calcium from the RYR than can be pumped back into the SR 
by the SERCA (sarcoplasmic/endoplasmic reticulum calcium ATPase—a pump 
that uses ATP to actively push calcium into the SR form the cytosol against its 
concentration gradient and which is aided by calsequestrin, a calcium binding 
protein in the SR that helps to store the calcium) or pumped out of the cytoplasm 
by other calcium pumps. If, however, the frequency is increased to around 80 
hertz the amount of calcium released is greater than what can be pumped back 
in the given time period and the subsequent stimulations occur before complete 
relaxation of the muscle is achieved and a fused tetanus occurs—resulting in a 
far greater production of force over a longer period of time (perhaps to a 
maximum of around 300 mN). With increasing hertz, the muscle will produce 
increasing force until a plateau is reached where total calcium saturation of the 
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 troponin molecules is achieved. Of course, this plateau is individual to the muscle 
and depends upon many factors including the size of the fibers, the temperature 
of the bath and so on. It is often achieved between 120 and 180 hertz in the 
situation described above and the force generated varies individually as well. 
 
The great advantage of the in vitro methodology resides in the ability to remove 
the outside influences of the physiological system and to simplify the number of 
confounders inherent to force production. There is no aspect of the environment 
that is not under the control of the researcher (temperature, ionic conditions, 
hormones, nutrient supply, etc.) and the concept of motor unit and neuron 
innervation does not come into play. The researcher easily controls the 
depolarization and the calcium handling of the muscles through the electrical 
stimulator. However, this advantage could also be looked as a disadvantage 
when results of experiments are extrapolated to in vivo systems where the 
complex interplay of numerous factors exterior to the muscle cells themselves 
are important regulators of force production. General Muscle Physiology 
background in this section referenced from Mackintosh, Gardiner and McComas, 
2006. 
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Abstract: 
Developing a scoring system based on physiological and functional 
measurements is critical to test the efficacy of potential interventions for 
sarcopenia and frailty in aging animal models, therefore, the aim of this study 
was to develop a neuromuscular healthspan scoring system (NMHSS). We 
examined three ages of the male C57BL/6 mouse: adults (6-7 months old, 100% 
survival), old (23-25 months old, 75% survival) and elderly (28+ months old, 
≤50% survival) mice --as well as mice along this age continuum. Functional 
performance (as determined by the Rota-Rod and inverted-cling grip test) and in 
vitro muscle contractility were the determinants. A raw score was derived for 
each determinant and the NMHSS was then derived as the sum of the individual 
determinant scores. In comparison to individual determinants, the NMHSS 
reduced the effect of individual variability within age groups, thus potentially 
providing an enhanced ability to detect treatment effects in future studies.   
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 Introduction: 
The rapidly aging population has caused a worldwide demographic shift that 
presents multiple challenges for the socio-economic sustainability of the medical 
establishment (Herrell, 1980; Peterson, 1999). Sarcopenia, the age-related loss 
of skeletal muscle mass and strength, has become a more prevalent condition as 
more people live longer. Furthermore, quality of life during aging, or healthspan, 
becomes an important concern. Sarcopenia can ultimately cause the elderly to 
lose their independence and contribute to the onset of frailty—costing billions of 
dollars per year (direct cost of sarcopenia was estimated at $18.5 billion in 2002) 
(Janssen, 2002; Janssen, 2004). It is in the best interest of society, both from a 
financial standpoint and as a quality of life issue, to find successful interventions 
for this age-associated muscle-wasting condition.  
 
Biogerontology research has traditionally focused on mechanisms to extend 
lifespan (Sierra, 2009). Recently, however, there has been a paradigm shift 
towards improving healthspan being as or even more important than increasing 
lifespan (Sierra, 2009; Murphy, 2011; Fries, 1980). In order to address the 
translation of therapies from the bench to bedside, critical elements must be in 
place such as animal models, experimental protocols, and assessment tools that 
evaluate interventions designed to improve healthspan (Kirkland, 2009). 
Moreover, to date, there is no assessment tool to evaluate neuromuscular 
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 function in the mouse (healthspan), which would address the component of 
sarcopenia. 
 
A common challenge in interpreting aging research is the wide statistical 
variability within outcome measurement data. The standard deviation (SD), 
commonly used to measure data variability, is a component of the standard error 
(SE), which plays a major role in determining statistically significant differences 
between experimental groups.  The coefficient of variation (CV) is defined as the 
SD divided by the mean of the measurement. The CV thus describes the spread 
of the data in relation to the mean. However, mathematical constructs, such as 
multiple regressions, are used to reduce the effect of data spread by limiting the 
impact of covariates. Therefore, creating mathematical constructs to ameliorate 
statistical variation is one way to address wide data spread within groups in aging 
studies.  
 
The primary purpose of this study was to develop a NeuroMuscular Healthspan 
Scoring System (NMHSS) that described healthspan in the C57BL/6 mouse and 
reduced the effect of variability within the selected outcome measures. 
Specifically, we hypothesized that the large individual variability of an outcome 
measure within groups that is often a bane to detecting treatment effects in aging 
studies would be attenuated by this scoring system. Therefore, the first step was 
to evaluate the performance and muscle contractility changes that occur with age 
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 in the mouse model to select the determinants of the scoring system. Then, we 
constructed the scoring system based upon the age-group means and scores 
predicted by equations developed from multiple linear regression analysis of 
each determinant. Utilizing these multiple regression equations as a component 
within the scoring system allowed us to lower the CV of the NMHSS in 
comparison to the individual determinants.  
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 Methods: 
Animals: 
Male C57BL/6 mice, from the NIA aging colony, of three specific age groups 
(adults, n=20, 100% survival, 6-7 months old; old, n=12, 75% survival, 24-26 
months; and elderly, n=23, <50% survival, 28+ months) were selected for initial 
analysis (NIA, 2012; Miller, 2000). These age groups are translatable to human 
ages of young adult, middle age and elderly (NIA, 2012; Arias, 2007).  Additional 
ages (from 2-32 months) were used to establish the multiple linear regression 
models for the NMHSS. In total, 70 animals were tested for contractile physiology 
and 99 for each of the performance tests (Rota-Rod and grip test). Animals were 
housed in a central specific pathogen free facility and experiments were 
conducted under IUCAC approved protocols ensuring optimal ethical and 
humane treatment. Because of animals lost to natural death and other variables, 
not all animals were tested in all parameters. Body and heart mass were 
determined on day of sacrifice. 
 
Functional Measurements: 
Rota-Rod:  
Rota-Rod testing is a well-established measure of overall motor function (Ingram, 
1986; Ingram, 1982). The mice are placed on a rotating cylinder (Pan Lab Lsi 
Rota-rod /RS Model 8200) and the time spent or duration, prior to falling is 
recorded. The device is set to either a run (static revolutions per minute-RPM) or 
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 an accelerating (RPM consistently increases over time--accelerates from 4 to 40 
RPM in 30 seconds, 2, 5 or 10 minutes) protocol. The mice were acclimated to 
the Rota-Rod prior to testing in order to familiarize the mice with the device and 
test protocols. Briefly, each mouse was acclimated on the Rota-Rod device for 
three trials per day on three consecutive days. On day 4, the performance of the 
mouse was tested using an accelerating protocol (5-minute slope to a max of 40 
rpm) and the time the mouse remained on the Rota-Rod was recorded. This 
accelerating protocol was performed 3 times and the average of the 3 trials was 
calculated.  
Inverted Cling Grip Test:  
The inverted cling grip test is a measure of overall strength and muscular 
endurance of the mouse (Brooks, 2009). This test consisted of placing the mouse 
on a cage-like wire grid and then inverting the grid (over a padded surface).  
 
A custom-designed device was constructed for the grip test to ensure 
consistency between trials. The mice were placed on the grid, which was located 
on the hinged lid of the device. The grid was held perpendicular to the device for 
3 seconds, and then the lid was closed so that the mouse was inverted. The time 
the mouse held on before falling to the padded surface at the bottom of the 
device was recorded to a maximum of 180 seconds. The results were averaged 
between two trials.  
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Whole Muscle Physiology:   
An in vitro isolated muscle preparation was used to measure the contractile 
properties of the extensor digitorum longus (EDL) muscles. Immediately after 
being weighed (massed), the EDL muscle was placed into a tissue bath filled 
with Krebs-Ringer buffer (115 mM NaCl, 5.9 mM KCl, 1.2 mM MgCl2, 1.2 mM 
NaH2PO4, 1.2 mM Na2SO4, 2.5 mM CaCl2, 25 mM NaHCO3, 10 mM glucose, pH 
7.3), oxygenated (carboxygen: 5% CO2 and 95% oxygen) and maintained at 
25°C via a circulating water system. The muscle, viewed under a 1.75x swing 
arm magnifying glass, was tied with #4 suture line at both myotendinous 
junctions and then suspended from a force transducer and static clamp between 
two platinum electrodes in an oxygenated bath filled with Krebs buffer. The 
muscle was then tested for contractile function.  
 
Equipment and Settings for Measuring Muscle Contractile Function:  
A dual bath physiology system (Aurora Scientific, Aurora, Ontario, Canada) was 
used to measure isolated whole muscle contractility. This system consisted of  
two force transducers (0.5 N, Model 300B), two stimulators (Model 701B), one 
Dual Lever A/D Interface (Model 604B), one Dual System Signal Interface, 
customized Aurora software [Dynamic Muscle Control (DMC, version 4.1.4.6), 
Dynamic Muscle Analysis (DMA, version 3.2), and a temperature control with 
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 water bath unit (Model 912 Polyscience Inc., Niles, IL). The physiological system 
was controlled from a dedicated Windows compatible computer. The stimulators 
were set to bi-phase modality and the electrical output to 1000 milliAmps at 30 
Volts.   
 
Determination of Muscle Optimal Length: 
Optimal muscle length (L0) was determined using the peak twitch force-length 
curve. Briefly, the muscle length was increased until the peak twitch force (Pt) 
was achieved. Subsequently, the muscle length was measured from 
myotendinous junction to myotendinous junction using calipers. This 
measurement is L0 (optimal length). L0 is the muscle length where the 
sarcomeres are at optimal length to produce maximal force (Brooks, 1988). 
 
Determination of Maximum Isometric Force: 
The force-frequency curve was used to obtain the maximum or peak isometric 
force. Briefly, isometric force, with the muscle set at L0, was determined at 
various frequencies (hertz, Hz): a single pulse (twitch), 10 Hz, 40 Hz, 80 Hz, 120 
Hz, 150 Hz, 180 Hz and then again for a single twitch. The pulse length was 300 
microseconds, software controlled by DMC. Each contraction was preceded by a 
one-minute rest period. The maximum isometric force (P0) was defined as the 
peak force generated and was generally achieved at 150 Hz for the EDL. 
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Neuromuscular Healthspan Scoring System:  
The NMHSS is an index comprised of a composite of three scores from the 
individual outcome determinants (Rota-Rod, grip test and EDL maximum 
isometric force). Prior to determining the composite of scores for the NMHSS, it 
was necessary to determine two important mathematical terms: (1) the statistical 
mean of each outcome determinant by age group, defined as the mean, and (2) 
the predicted outcome measurement for each determinant, which was calculated 
using a multiple linear regression equation. Next, the score for each outcome 
determinant was calculated from two components. The first component was the 
ratio of the actual measurement/mean for the age group and the second 
component was the ratio of the actual measurement/predicted measurement for 
the age group. Subsequently, the score for each determinant was defined as the 
mean of the two ratios. Finally, the overall healthspan score (NMHSS) was the 
sum of the three individual outcome scores (Rota-Rod, grip test and EDL 
maximum isometric force). Figure 1 shows an example of how to create a Rota-
Rod score using a representative mouse from the elderly age group. 
 
The NMHSS identifies how different the animal’s actual performance was from 
the group mean, identifies how far the animal’s actual performance is from the 
predicted, and accounts for variability within each outcome measure. An animal 
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 whose performance score is at the mean for all three determinants (actual 
measurement=mean and actual measurement=predicted measurement) will 
have a NMHSS of “3”. NMHSS > than 3 would suggest a healthier animal 
compared to an animal with a NMHSS < 3. Table 1 illustrates the use of the 
Healthspan Scoring System with two examples of “old” mice (one with a low grip 
test and one with a high grip test) from our actual population and a fictitious 
average old mouse. The data for the fictitious average old mouse were derived 
from our reference group for each parameter.  
 
Statistical Analysis:  
Statistical differences between means were determined by One-way ANOVA and 
ANCOVA. Data are presented as means ± standard error (SEM) when 
appropriate. Significance was set at α=0.05 for ANOVA, ANCOVA, logistic 
regressions and simple/multiple linear regressions. The post-hoc test for ANOVA 
was Tukey-Kramer Honestly Significant Difference and a Bonferroni Correction 
was used for ANCOVA. Factor analysis using a promax rotation to determine 
principle components contributing to the variability of each set of outcome 
measures was performed. SPSS (IBM Corporation, Armonk, New York) used for 
statistical analysis aside from the power analyses (for a 3x2 ANOVA to detect a 
15% treatment effect at 80% power), which were conducted with the PASS 
software package (from NCSS LLC, Kaysville, Utah). 
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 Results: 
Functional Measurements:  
Rota-Rod:  
The effect of age on overall motor function is summarized in Figures 2, 3, and 4. 
The mean Rota-Rod performance, the time spent on the rod during an 
accelerating protocol, declined 40% across the age groups (adult versus elderly 
p= 0.002; old versus elderly p=0.037, Figure 2). Moreover, there is a negative 
correlation between age and Rota-Rod performance (R= -0.373 p=0.001, Figure 
3) explaining 14% of the variability (r2=0.137). Figure 3 shows poor Rota-Rod 
performance, represented as a ‘dip’, in mice between the ages of 12 and 20 
months. Although the simple linear regression showed a negative correlation 
between age and Rota-Rod performance, the 3rd degree polynomial regression 
better explained the reduced performance at the middle age groups and the 
increased performance at the youngest and oldest ages.  
 
In order to determine if Rota-Rod performance predicts the age of the mouse, a 
simple logistic regression (r2=0.19, Χ2=12.1, p=0.002) was calculated. The 
regression model was Adult (1) =reference group, Old (2): 1.734 - 0.014*Rota-
Rod time, Elderly (3): 2.903 - 0.042*Rota-Rod time.  The logistic regression 
correctly classified the mice into their proper age groups 57% of the time. 
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 Figure 4 highlights the variability between individual mice and shows the broad 
range of ability to stay on the Rota-Rod within each of the age groups. Adult mice 
were able to remain on the accelerating Rota-Rod from 31 to 167 seconds, 
whereas the elderly mice remain from 1 to 116 seconds. To determine the major 
contributors to the variability, factor analysis and hierarchical multiple regression 
analysis were performed among all the experimental parameters. The multiple 
linear regression analysis showed that 52% of the Rota-Rod variability could be 
explained by body mass and heart mass ([n=35, R=0.720, r2=0.518, p<0.001, 
model equation: Rota-Rod (s) = 237.951 - 1.798 body mass (g) -291.995 heart 
mass (mg)]). There was a positive correlation between age and body mass 
(R=0.429, p=0.010) in the animals that were Rota-Rod tested. 
 
Using body mass as a covariant (ANCOVA, F=5.94 and p= 0.006) Rota-Rod 
performance was found to be statistically different between adult and old mice 
(Bonferroni-adjusted post-hoc test p=0.0332) and between adult and elderly mice 
(p= 0.011). There was no statistical difference between the old and elderly group. 
 
Grip Test: 
The effect of age on overall muscle strength, as measured by the inverted cling 
grip test, is summarized in Figures 5, 6, and 7.  Using a one-way ANOVA to test 
the difference in mean performances, a significant age-related decline in grip 
strength was found between the adult and the elderly mice (61% reduction, 
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 p=0.006) and between the adult and the old mice (39% reduction, p=0.002); 
however, there was no significant difference in performance between the old and 
elderly groups (Figure 5).  
 
Using simple linear regression, grip test performance was found to be negatively 
correlated with age in months (R=-0.419) and 18% of the variability could be 
accounted for (r2=0.176, p=0.001). The linear regression equation used was grip 
test (s) = -1.876 age (m) + 99.699 (Figure 6). 
 
Figure 7 highlights the wide individual variability within each age group. In the 
adult group, the lowest functioning mouse held onto the grid for 41.5 seconds 
whereas the highest functioning mice held on for the maximum (180 seconds). In 
contrast to the adult group, the best performing mouse in the elderly group held 
on for only 94 seconds and the weakest mouse for 8.5 seconds. To determine 
whether the grip test performance can be used to classify the mice into their 
respective age groups even with this wide variation, without using any adjuster, a 
simple logistic regression was performed (Figure 7). The regression model used 
was: Adult (1) = reference group, Old (2) = 1.686 - 0.018*grip, Elderly (3) = 1.760 
– 0.036*grip). The results indicate that the age group of the mouse is predicted 
correctly 56.6% of the time (r2= 0.24, Χ2=12.5, p=0.002). 
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 To determine the major contributors to the variability in grip test, factor analysis 
and hierarchical multiple regression analysis were performed among all the 
experimental parameters. Age and body mass were the major sources of the 
variability. When corrected for age and body mass, 22% of the variability is 
accounted for [multiple linear regression, n=29, R=0.471; r2=0.222; p=0.038, 
model equation: Grip Test(s) = 213.024 – 1.240 age @ grip test (m) -3.332 body 
mass (g)].  
 
Muscle Contractile Physiology:  
Utilizing in vitro methodology, we documented contractile properties for the EDL 
muscles, in the three age groups and along our healthspan continuum (2-32 
months).  The main contractile property investigated was peak tetanic force (P0) 
of the EDL.    
 
EDL Peak Tetanic Force (P0):  
EDL P0 declined significantly with age (28%, p<0.001), from a mean of 388 mN in 
adult to a mean of 281 mN in the elderly (Figure 8). The decline from adult to old 
(mean 319 mN) trended towards significance (-18%, p=0.09), with no significant 
difference between the old and elderly (-12%, p=0.43). There was a correlation 
between age and EDL P0 (R=-0.569). A simple linear regression of peak tetanic 
force of the EDL with the age in months (n=53, R=-0.569, r²=0.324, p<0.001; with 
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 the equation:  P0 = -4.452 age (m) + 420.128) showed that age accounted for 
32% of the variability (Figure 9). 
 
Figure 10 highlights the wide variability of EDL P0 within each specific age group. 
For instance, the P0 of the EDL from the adult group ranged from a high of 481 
mN to a low of 286 mN, whereas the P0 of the EDL muscles from the elderly 
group ranged from a high of 427 mN to a low of 182 mN.  Notably, 35% of the 
mice from the elderly group performed better than the average mouse in the old 
group. Furthermore, 27% of the mice from the adult group performed worse than 
the average mouse in the old group.  
 
To test whether the EDL P0 was predictive of the mouse age group, a simple 
logistic regression was performed (r2= 0.39, X2=17.25, p<0.001). P0 classified the 
animal into the elderly age group correctly 90% of the time using the following 
model equations: Adult (1) = reference group, Old (2): not significant, Elderly (3): 
8.13 – 0.023*P0. In contrast, this regression model was not able to significantly 
classify the animal into the old age group. When using the old group as the 
reference, however, the regression model classifies the adult group 66% of the 
time. 
 
In order to explain the individual variability within each age group a factor 
analysis was performed followed by a multiple linear regression using muscle 
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 length and age as covariates. 46% of the variance (adjusted r squared = 0.46) 
was explained by the P0 multiple regression equation [P0 (mN) = 117.484 - 4.976 
age (m) + 26.094 L0 (mm)].  
 
Relationship between the Outcome Measurements: 
A simple linear regression of the determinants is shown in Figure 11, 
demonstrating that there was no significant correlation between Rota-Rod and 
EDL P0 (or between force and grip test).  There is a weak correlation, however, 
between Rota-Rod and grip test (r2 =0.11). The three outcome measures are 
relatively independent measurements of neuromuscular health, each 
representing different or unique aspects of the mouse performance ability. 
 
Neuromuscular Healthspan Scoring System:  
 
The NMHSS for a cohort of mice is demonstrated in Figure 12 (n=15 adult, n=5 
old and n=19 elderly). The mean NMHSS score for the adult animals was 3.01 
and ranged from 1.68 to 4.70 (standard error=0.196). The mean NMHSS score 
for the elderly animals was 3.05 and ranged from 1.71 to 4.44 (SE=0.154). In 
contrast, however, the mean NMHSS score for the old animals was 2.67 and 
ranged from 2.14 to 3.24 (SE= 0.211). Figure 1 shows how the NMHSS is 
determined, using a single Rota-Rod raw score as an example. 
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 In order to quantify and compare the amount of individual variability inherent 
within each age group, coefficients of variations (standard deviation/mean) were 
evaluated. When comparing the coefficient of variation of the NMHSS with the 
CV of our outcome measures, there was a reduction in variation of 2-fold for 
Rota-Rod and 3.7 fold for grip test; although there was a slight increase (0.23) 
from P0.  
 
To demonstrate the utility of the NMHSS ability to reduce variability, we 
compared power analyses (80% power to detect a 15% difference in a 3x2 
ANOVA—designed as three age groups each with two treatment groups) using 
the mean of the elderly age group for each outcome measure (Rota-Rod, grip 
test, P0).  Table 2 summarizes the results of the power analyses and the CVs. 
Notably, the number of animals needed for detection of the 15% difference is 
reduced by 77%, 87%, and 21% (for Rota-Rod, grip test, and P0, respectively).  
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 Discussion: 
The purpose of this study was to develop a neuromuscular healthspan scoring 
system that will be used to evaluate treatments for sarcopenia. We hypothesized 
the wide variability within groups, which is often a bane to detecting treatment 
effects in aging studies, will be attenuated by this scoring system. The scoring 
system consisted of a mathematical construct designed as an index of 
determinants, which both compared the means of relevant outcome 
measurements and utilized multiple regressions to alleviate the effect of 
covariates.  The main findings included a significant reduction in coefficient of 
variation with the NMHSS compared to the coefficients of variation of two of the 
outcome measures (Rota-Rod and grip test). This resulted in an increased ability 
to detect differences between groups, reflected by a reduction in the number of 
animals needed to detect a difference of 15% at 80% power in a 3x2 ANOVA in 
the NMHSS as compared to all three determinants alone. As expected, the main 
outcome measures (determinants: Rota-Rod, grip test, EDL P0) declined with age 
(from adult to elderly--40%, -61% and -28%, respectively). 
 
Scoring indices or testing batteries have been developed to measure frailty and 
to predict lifespan in the mouse (Ingram, 1986; Parks, 2012). In humans, there 
are multiple types of testing regimens designed to measure disability, frailty, 
mental health status and predict biological age (Whetstone, 2001; Pialoux, 2012; 
Cheung, 2012; Borkan, 1980). However, a neuromuscular healthspan scoring 
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 system has not been developed. Neuromuscular health is defined as muscle 
force production combined with functional performance. This ability decreases, 
on average, in an age-dependent manner (Brooks, 1991; Narici, 2010; Wright, 
2008). In the current study, our definition of neuromuscular healthspan is the 
ability to maintain an optimal level of performance (e.g., running, jumping) and 
strength/power output over the lifespan adequate to perform activities of daily 
living. Hence, the scoring system we developed quantifies neuromuscular 
healthspan within age groups.   
 
The components of the NMHSS combine to present an overall picture of the 
neuromuscular health of the animal--both in comparison to the peers within its 
age group and in respect to what level of ability would be predicted by the 
multiple linear regression equation at the animals given age. Our mathematical 
construct (the mean of the ratios of the actual/mean and actual/predicted values) 
was a successful way to reduce variability of the individual determinants (Rota-
Rod, grip test, P0) by removing the effect of covariates using multiple linear 
regression (r2= 0.52, 0.22, and 0.46 for Rota-Rod, grip test and P0 respectively). 
 
One significant outcome of reducing variability is lowering the effective SD by 
reducing the spread of data, which then reduces the se. This makes it easier to 
detect differences between group means because the 95% confidence interval 
around the mean becomes smaller—thus it becomes easier to achieve statistical 
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 significance. Instead of reducing variability (SD), often the number of animals 
used (n) is increased to help achieve the same effect. In the current study, 
summarized in Table 2 and with data taken from the actual cohort of elderly 
animals (Figure 12), the marked reduction in animals needed (sample size) is 
evident. Specifically, Table 2 documents a power analysis by using NMHSS, for 
a 3x2 ANOVA to detect a 15% treatment effect at 80% power in the actual elderly 
group. 
 
As noted in the Methods section, the NMHSS identifies how far the animal’s 
actual performance is from the age group mean, identifies how far the animal’s 
actual performance is from the predicted, and accounts for variability of each set 
of outcome measures. Assessing the relative neuromuscular health is another 
advantage of using the NMHSS. An animal whose performance score is at the 
mean for all three determinants (actual measurement=mean and actual 
measurement=predicted measurement) will have a NMHSS of “3”. NMHSS > 
than 3 would suggest a healthier animal compared to an animal with a NMHSS < 
3.  
 
As highlighted in Figure 12, the mean NMHSS of the adult, old and elderly from 
the test cohort were 3.01, 2.67 and 3.05 respectively. The adult and elderly 
means indicated that the groups themselves tended to perform, on average, very 
close to what would be predicted. The old animals lower than 3 score can be 
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 interpreted that the old group of animals performed, on average, at a lower than 
expected level.  
 
Collectively, in the current study our young and elderly performed as expected 
whereas the old group was less capable.  A unique application of the NMHSS is 
as assessment tool to describe the collective neuromuscular health of the age 
group cohorts and to describe the relative neuromuscular health of an individual 
mouse. Thus, there is a potential is to assess frailty within a group, by setting a 
cut-off value—below which an animal is considered frail or weak. For example, 
two standard deviations below the mean cohort NMHSS could be used to declare 
an animal a weak specimen within the group, whereas, two standard deviations 
below the average value of an age group (i.e. the old average animal NMHSS is 
2.89, from Table 1) could be used to declare an animal frail. 
  
Determinant Validity: Rota-Rod, Grip Test, EDL Peak Tetanic Force 
One necessary component of scoring systems is the use of outcome 
measurements that ensure validity (Dodds, 1993; Sim, 1993, Ingram, 1983). 
Validity is defined as accurately measuring the intended measurement (Ingram, 
1983). The determinants of the NMHSS were carefully selected and vetted to 
ensure maximum validity. 
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 Rota-Rod and Neuromuscular Healthspan 
We chose the Rota-Rod as our first determinant to measure overall motor 
function because it is one of the most common functional tests traditionally used 
for neuromuscular evaluation (Ingram, 1986; Ingram, 1982; Brooks, 2009). The 
outcome measurement is how long the animal can stay on the device. The mode 
of the Rota-Rod operation that we chose (acceleration) requires the animals to 
not only keep their balance and run on a spinning rod, but also to continually 
produce more power to keep up with the acceleration of the device. Because the 
animals will also tire from the exertion of the effort required to keep up with 
spinning rod, the measurement also contains a component of endurance. 
Therefore, this device demonstrates both face and content validity for our desired 
measurements (overall motor function: balance, coordination, gait speed, 
endurance) with only one measurement (time in seconds on device) because the 
time on the device directly correlates with the linear acceleration of the RPM. 
This outcome measure is similar to gait speed or timed-up-and-go testing used in 
humans, which are both used to document disability and frailty in humans 
(Whetstone, 2001). 
 
We used the two variables, body and heart mass, that contributed most to the 
variability in the multiple linear regression. These two adjustors are appropriate 
and valid contributors to variability. Heart mass may very well be an indicator of 
underlying cardiovascular conditions. For example, an enlarged heart may signify 
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 heart valve problems, cardiomyopathy, coronary artery disease or 
hypertension—any of which has potential to negatively affect cardiovascular 
performance (one aspect of the Rota-Rod test component that encompasses 
endurance) (Mackackova, 2006; Widmaier, 2006). Controlling for heart mass has 
the advantage of reducing the effect of these potential conditions on the outcome 
measurement. Bodyweight has obvious implications on performance because a 
large and/or obese mouse may not be as agile or as fatigue resistant in 
comparison to a mouse of normal weight. 
 
Rota-Rod and the Survivor Effect 
There was a clear dip in performance evidenced on Figure 3. The survivor effect 
may play a role in this dip. The survivor effect theory suggests that the strongest 
and healthiest animals will live to the oldest ages (less healthy/robust animals will 
succumb to disease prior to reaching the oldest ages); therefore, in some cases 
the performance of the older individuals will exceed that of their younger 
counterparts (Murphy, 2011).  
 
Grip Test and Neuromuscular Healthspan 
Another well-characterized measurement of neuromuscular ability is the grip test 
(Ingram, 1986; Ingram, 1982; Brooks, 2009). There are different ways to 
measure grip strength, including the use of force transducers attached to trapeze 
arms (the animal grasps the bar and is pulled backwards by the tail, outcome 
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 being the force measured when the animal lets go) and suspending the mice 
from a grid and measuring how long they can hold on before they fall. While the 
former measurement has less involvement of muscle stamina and more directly 
measures strength, the latter gives information about both strength and 
endurance.  
 
We therefore chose the inverted cling grip test to be our second functional test 
and built a custom testing device to ensure that the reliability of the test was 
maximized by making the conditions of each test identical. The face and content 
validity of the test are evident in that the outcome measurement (e.g., how long 
can the mouse suspend itself before falling) measures the ability of the mouse to 
support its body weight (strength) for a given amount of time (endurance). This 
outcome measure would be similar to a human pull-up test.  
 
 
EDL Contractility and Neuromuscular Healthspan 
One advantage of using the mouse model is that we can isolate individual 
muscles for whole muscle in vitro contractile physiology measurement. The EDL 
is primarily a fast fiber type muscle and thus is more sensitive to age-related 
muscle dysfunction (Brunner, 2007). P0 represents raw force production—an 
absolute measurement of strength. This outcome measure is therefore 
somewhat comparable to a one-repetition maximum measurement of a weight 
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 lifting exercise, but may be more reliable and valid because the muscle receives 
maximum stimulation since there is no voluntary component.  
 
Conclusions:  
Both functional ability and strength are impaired with age in the C57BL/6 mouse 
as evidenced by declines in grip test, Rota-Rod and EDL P0. This was in 
agreement with other investigations (Ingram, 1986; Ingram, 1982; Brooks, 1988; 
Fahlstrom, 2012). There is, however, wide variation in the ability of individual 
animals. NMHSS, as a mathematical construct, is a much more sensitive 
instrument than the outcome measurements alone—due to lower coefficients of 
variation. This leads to an increase in power that allows detection of differences 
in means with ANOVA, while using far fewer animals than would be needed to 
detect the same difference in the separate outcome measures. The 
Neuromuscular Healthspan Scoring System may well become a very valuable 
tool for researchers to assess interventions in future studies. 
 
In summary, the NMHSS reduces variability, increases power and serves as an 
assessment tool for neuromuscular ability. We postulate that in future 
investigations, the principles of the NMHSS may be adapted to producing other 
types of scoring systems in addition to providing researchers with a tool to 
assess sarcopenia interventions. By substituting other outcome measurements 
and by carefully considering validity, other types of scoring systems (e.g., 
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 cardiovascular, immune response, and others) could be produced using the 
principles behind the NMHSS. 
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 Legends 
Figure 1:  Production of Rota-Rod Raw Score. The figure shows an example of how 
to create a Rota-Rod raw score using a representative animal from the elderly age group 
(>28 months of age).  Numbers in italics are the unique values associated with this 
animal. The first term of the equation is produced by taking the actual score of the 
animal in the test (115 seconds, s) and then dividing by the mean score for the age 
group (60), which in this case equals 1.92. The second term of the equation consists of 
the actual score on the test (115 s) divided by the predicted score (127.9 s), which is 
produced by the model described by the multiple linear regression [n=35, R=0.720; 
r
2
=0.518; p<0.001: model:  Rota-Rod(s) = 237.951 - 1.798 Body Mass (31.3g) -291.995 
Heart Mass (0.184mg) = 127.86], which equals 0.899. Both terms are then added 
(1.92+0.899 = 2.819) and divided by two to get the mean, 1.41. This raw score for Rota-
Rod, 1.41, is then added to the raw score for grip test and EDL force to obtain the overall 
NMHSS score. The same process is performed for each outcome measure. In the case 
of this particular mouse the grip test raw score was 0.709 and the EDL force raw score 
was 0.783.  The total NMHSS score of this particular mouse was 2.902. 
 
Figure 2: Rota-Rod performance declines with age. Rota-Rod performance, the time 
before falling, is defined as the average time in seconds (s) of three trials. The number of 
mice per group were 20, 32 and 13 for the adult (6 months, m), old (24 months, m) and 
elderly (>28 months, m), respectively. Values are means (100, 86, 60) for adult, old and 
elderly) ± SEM.  Results are from a one-way ANOVA (F=6.3, p=0.003) with a Tukey-
Kramer HSD post-hoc analysis. *: elderly significantly different from adult (p=0.002) and 
old (p=0.037).   
 
Figure 3: Rota-Rod performance declines with age. This graph shows both a simple 
linear regression (r=-0.373, R²=0.139, p=0.001, n=99; equation:  y = -1.876x + 99.699), 
which explains 14% of the variability, and a 3
rd
 degree polynomial regression (R=0.588, 
r² = 0.3453, p<0.001, n=99; equation: y = -0.0157x
3
 + 1.1005x
2
 - 22.375x + 193.66), in 
which 35% of the variation is explained. The 3
rd
 degree polynomial regression 
demonstrates the survivor effect (animals at the oldest ages are healthier than some 
animals in middle age—i.e. 16-20 months). Note the dip in performance of the 16-20 
month animals. 
 
Figure 4: Large variability in Rota-Rod performance within each age group.  Rota-
Rod performance ranges from 31 to 167s in adult, 40 to 140s in old, and 1 to 116s in 
elderly mice.  s: the average time in seconds (of three trials) spent on Rota-Rod before 
falling. 100, 86 and 60 represent the mean and the bar represents ± SEM. m: months 
old. *: elderly significantly different from adult (p=0.002) and old (p=0.037).   
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 Figure 5: Performance on grip test declines with age. Grip test is defined as the 
average time (duration in seconds, s) before falling from the grid. The numbers of 
animals per group were: 18, 20 and 8 for the adult (6 months old, m), old (24 months old, 
m) and elderly (>28 months old, m), respectively. Values are means (112, 68, 47 for 
adult, old and elderly) ± SEM. Results from a One-way ANOVA (F=6.8, p=0.003) with a 
Tukey-Kramer HSD post-hoc analysis show: *: Adult different from Old (p=0.002) and 
from Elderly (p=0.006).  
 
Figure 6: Grip Test declines with age. This graph shows a simple linear regression 
(R=-0.419, r² = 0.176, p=0.001, n=99; equation: Grip (s) = -1.876 age (m) + 99.699), in 
which age explains 18% of the variation. s: seconds. m: months. 
 
Figure 7: Grip test performance shows wide individual variation within each age 
group. Grip test performance ranges from 41.5 seconds (s) to the maximum 180s 
(adult), 3s to the maximum 180s (old), and 8.5s to 94s in the elderly group. 112, 68 and 
47 represent the mean and the bar represents ± SEM. m: months old. *: significantly 
different (from adult) mean (p<0.05). 
 
Figure 8: The peak force produced by the EDL muscle declines with age. The 
numbers of animals per group were 15, 7 and 20 for the adult, old and elderly 
(respectively). Means (in milliNewtons, mN) were 388, 319, 281 for adult, old and elderly 
± SEM. Results are from a one-way ANOVA (F= 10.16, p<0.001) with a Tukey-Kramer 
HSD post-hoc analysis: adult different from old (#: p=0.09) and from elderly (*: p<0.001). 
m: months. 
 
Figure 9: Force Generation by the EDL Muscle Declines with Age. This graph shows 
a simple linear regression (n=53, R=-0.569, r²=0.324, p<0.001) with the equation: P0 = -
4.452 age (m) + 420.128, in which age explains 32% of the variability of P0. mN: 
milliNewtons m: months. 
 
Figure 10: Force Generation of the EDL shows wide variability within age groups. 
The P0 ranges from 286 to 482, 174 to 392, and from 182 to 427 in the adult, old and 
elderly groups respectively. 388, 319, 281 represent the mean and the bar represents ± 
SEM for adult, old and elderly, respectively. m: months, mN: milliNewtons. *: significantly 
different (p<0.05) from adult.  
 
Figure 11: Little Correlation Between Outcome Measures of Rota-Rod, Grip Test, 
and EDL Force. mN: milliNewtons and s: seconds. Panel A: Grip test and Rota-Rod are 
weakly correlated. Rota-Rod/Grip Test regression (n=66): Rota-Rod (s)= 0.281 Grip (s) + 
55.078 R=0.334, r²=0.111, p=0.007. Panel B: Rota-Rod is not significantly correlated 
with EDL force. Rota-Rod /EDL force regression (n=27): P0(mN) = -0.3107 Rota-Rod (s) 
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 + 382.84, R=0.232, r² =0.054, p=0.244. Panel C: Grip test is not significantly correlated 
with EDL force. Grip test/EDL force regression (n=30): P0 (mN) = 0.1124 Grip (s) + 
351.64 R=0.10, r²=0.01, p=0.606. 
 
Figure 12: NMHSS Scores for Adult, Old and Elderly Mice. NMHSS ranges from 1.68 
to 4.7 (adult), 2.14 to 3.24 (old), and 1.7 to 4.44 in the elderly group. 3.01, 2.67 and 3.05 
represent the mean and the bar represents ± SEM. m: months old. 
 
Table 1:  Comparison of NMMHS Score Construction. A: The table shows a 
comparison of the scores that comprise the NMHSS in two actual examples of mice from 
the old cohort (both 24 month old mice), one with a low performance in grip test and the 
other with a high performance. The first two columns describe the values that would be 
obtained by putting the mean values for the age group into the NMHSS equation. The 
derivation for each component of the NMHSS index follows the formula given in Figure 
1. B: The values for the covariates used in multiple linear regression equations to 
produce the predicted terms are shown in this table. mm: millimeters. g: grams. * It 
should be noted that the fictional old mouse has values different from the mean of the 
old mouse cohort in Figure 12 because the values given are from the means for the 
entire sample of the population, not just the cohort described in Figure 12.  
 
Table 2 NMHSS Reduces Effect of Variability. The coefficient of variation, CV, of the 
NMHSS is lower (0.22) than the CV of either the Rota-Rod (0.45) or the grip test (0.59). 
The end result is that the number of animals needed to achieve an 80% power (using 
means and SDs from the elderly cohort from Figure 12 in a 3x2 ANOVA at α=0.05 with 
the desired detectable difference being 15%) is much lower using the NMHSS (11) than 
the other tests (48, 82 and 14 for the Rota-Rod, grip and EDL P0, respectively). 
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 Table 1:  Comparison of NMMHS Score Construction. A: The table shows a 
comparison of the scores that comprise the NMHSS in two actual examples of mice from 
the old cohort (both 24 month old mice), one with a low performance in grip test and the 
other with a high performance. The first two columns describe the values that would be 
obtained by putting the mean values for the age group into the NMHSS equation. The 
derivation for each component of the NMHSS index follows the formula given in Figure 
1. B: The values for the covariates used in multiple linear regression equations to 
produce the predicted terms are shown in this table. mm: millimeters. g: grams. * It 
should be noted that the fictional old mouse has values different from the mean of the 
old mouse cohort in Figure 12 because the values given are from the means for the 
entire sample of the population, not just the cohort described in Figure 12.  
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 Table 2 NMHSS Reduces Effect of Variability. The coefficient of variation, CV, of the 
NMHSS is lower (0.22) than the CV of either the Rota-Rod (0.45) or the grip test (0.59). 
The end result is that the number of animals needed to achieve an 80% power (using 
means and SDs from the elderly cohort from Figure 12 in a 3x2 ANOVA at α=0.05 with 
the desired detectable difference being 15%) is much lower using the NMHSS (11) than 
the other tests (48, 82 and 14 for the Rota-Rod, grip and EDL P0, respectively). 
Elderly Mice SD mean CV n (@ 80% power) 
  
NMHSS 0.67 3.05 0.22 11 
Rota-Rod 30.8 68.3 0.45 48 
Grip  35.3 59.8 0.59 82 
P0  62.3 285.6 0.17 14 
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Figure 1:  Production of Rota-Rod Raw Score. The figure shows an example of how 
to create a Rota-Rod raw score using a representative animal from the elderly age group 
(>28 months of age).  Numbers in italics are the unique values associated with this 
animal. The first term of the equation is produced by taking the actual score of the 
animal in the test (115 seconds, s) and then dividing by the mean score for the age 
group (60), which in this case equals 1.92. The second term of the equation consists of 
the actual score on the test (115 s) divided by the predicted score (127.9 s), which is 
produced by the model described by the multiple linear regression [n=35, R=0.720; 
r
2
=0.518; p<0.001: model:  Rota-Rod(s) = 237.951 - 1.798 Body Mass (31.3g) -291.995 
Heart Mass (0.184mg) = 127.86], which equals 0.899. Both terms are then added 
(1.92+0.899 = 2.819) and divided by two to get the mean, 1.41. This raw score for Rota-
Rod, 1.41, is then added to the raw score for grip test and EDL force to obtain the overall 
NMHSS score. The same process is performed for each outcome measure. In the case 
of this particular mouse the grip test raw score was 0.709 and the EDL force raw score 
was 0.783.  The total NMHSS score of this particular mouse was 2.902. 
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Figure 2: Rota-Rod performance declines with age. Rota-Rod performance, the time 
before falling, is defined as the average time in seconds (s) of three trials. The number of 
mice per group were 20, 32 and 13 for the adult (6 months, m), old (24 months, m) and 
elderly (>28 months, m), respectively. Values are means (100, 86, 60) for adult, old and 
elderly) ± SEM.  Results are from a one-way ANOVA (F=6.3, p=0.003) with a Tukey-
Kramer HSD post-hoc analysis. *: elderly significantly different from adult (p=0.002) and 
old (p=0.037).   
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Figure 3: Rota-Rod performance declines with age. This graph shows both a simple 
linear regression (r=-0.373, R²=0.139, p=0.001, n=99; equation:  y = -1.876x + 99.699), 
which explains 14% of the variability, and a 3
rd
 degree polynomial regression (R=0.588, 
r² = 0.3453, p<0.001, n=99; equation: y = -0.0157x
3
 + 1.1005x
2
 - 22.375x + 193.66), in 
which 35% of the variation is explained. The 3
rd
 degree polynomial regression 
demonstrates the survivor effect (animals at the oldest ages are healthier than some 
animals in middle age—i.e. 16-20 months). Note the dip in performance of the 16-20 
month animals. 
 
  
82 
 
  
Figure 4: Large variability in Rota-Rod performance within each age group.  Rota-
Rod performance ranges from 31 to 167s in adult, 40 to 140s in old, and 1 to 116s in 
elderly mice.  s: the average time in seconds (of three trials) spent on Rota-Rod before 
falling. 100, 86 and 60 represent the mean and the bar represents ± SEM. m: months 
old. *: elderly significantly different from adult (p=0.002) and old (p=0.037).   
 
  
83 
 
  
Figure 5: Performance on grip test declines with age. Grip test is defined as the 
average time (duration in seconds, s) before falling from the grid. The numbers of 
animals per group were: 18, 20 and 8 for the adult (6 months old, m), old (24 months old, 
m) and elderly (>28 months old, m), respectively. Values are means (112, 68, 47 for 
adult, old and elderly) ± SEM. Results from a One-way ANOVA (F=6.8, p=0.003) with a 
Tukey-Kramer HSD post-hoc analysis show: *: Adult different from Old (p=0.002) and 
from Elderly (p=0.006).  
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Figure 6: Grip Test declines with age. This graph shows a simple linear regression 
(R=-0.419, r² = 0.176, p=0.001, n=99; equation: Grip (s) = -1.876 age (m) + 99.699), in 
which age explains 18% of the variation. s: seconds. m: months. 
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Figure 7: Grip test performance shows wide individual variation within each age 
group. Grip test performance ranges from 41.5 seconds (s) to the maximum 180s 
(adult), 3s to the maximum 180s (old), and 8.5s to 94s in the elderly group. 112, 68 and 
47 represent the mean and the bar represents ± SEM. m: months old. *: significantly 
different (from adult) mean (p<0.05). 
 
  
86 
 
  
Figure 8: The peak force produced by the EDL muscle declines with age. The 
numbers of animals per group were 15, 7 and 20 for the adult, old and elderly 
(respectively). Means (in milliNewtons, mN) were 388, 319, 281 for adult, old and elderly 
± SEM. Results are from a one-way ANOVA (F= 10.16, p<0.001) with a Tukey-Kramer 
HSD post-hoc analysis: adult different from old (#: p=0.09) and from elderly (*: p<0.001). 
m: months. 
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Figure 9: Force Generation by the EDL Muscle Declines with Age. This graph shows 
a simple linear regression (n=53, R=-0.569, r²=0.324, p<0.001) with the equation: P0 = -
4.452 age (m) + 420.128, in which age explains 32% of the variability of P0. mN: 
milliNewtons m: months. 
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Figure 10: Force Generation of the EDL shows wide variability within age groups. 
The P0 ranges from 286 to 482, 174 to 392, and from 182 to 427 in the adult, old and 
elderly groups respectively. 388, 319, 281 represent the mean and the bar represents ± 
SEM for adult, old and elderly, respectively. m: months, mN: milliNewtons. *: significantly 
different (p<0.05) from adult.  
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Figure 11: Little Correlation 
between Outcome Measures of 
Rota-Rod, Grip Test, and EDL 
Force. mN: milliNewtons and s: 
seconds. Panel A: Grip test and 
Rota-Rod are weakly correlated. 
Rota-Rod/Grip Test regression 
(n=66): Rota-Rod (s)= 0.281 Grip 
(s) + 55.078 R=0.334, r²=0.111, 
p=0.007. Panel B: Rota-Rod is 
not significantly correlated with EDL 
force. Rota-Rod /EDL force 
regression (n=27): P0(mN) = -
0.3107 Rota-Rod (s) + 382.84, 
R=0.232, r² =0.054, p=0.244. 
Panel C: Grip test is not 
significantly correlated with EDL 
force. Grip test/EDL force 
regression (n=30): P0 (mN) = 
0.1124 Grip (s) + 351.64 R=0.10, 
r²=0.01, p=0.606. 
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Figure 12: NMHSS Scores for Adult, Old and Elderly Mice. NMHSS ranges from 1.68 
to 4.7 (adult), 2.14 to 3.24 (old), and 1.7 to 4.44 in the elderly group. 3.01, 2.67 and 3.05 
represent the mean and the bar represents ± SEM. m: months old. 
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 Interlude 1 Neuromuscular Healthspan and Contractile Dysfunction 
 
In the previous chapter we learned that neuromotor function declined with age. 
There were age-associated deficits in maximum isometric force production (P0), 
in the EDL, and lower times recorded on the rotarod and grip tests. However, 
there was individual variability that statistically obscured the ability to detect 
changes. Thus, the NeuroMuscular Healthspan Scoring System (NMHSS) was 
designed to reduce the effect of this variability. The NMHSS combined the three 
outcomes into a composite score. To produce the mathematical construct of the 
composite score each measurement was rated in relation to the mean predicted 
by a multiple regression analysis. The NMHSS greatly increased the power to 
detect change beyond that of the individual component outcome measurements 
alone.  
 
Animals move with power (force multiplied by velocity), not force, thus the next 
part of this story was to investigate the effect of age on contractile velocity and 
power production. We hypothesized age-associated deficits in both power and 
velocity and we suspected the age-related dysfunction would become 
disproportionately larger in more difficult tasks (concentric contraction at 
percentages of P0--above 50%). Most previous studies examined velocity of 
contraction at ≤50% of P0 to find maximum unloaded velocity and used Vopt 
(velocity of contraction that produced Pmax) to find Pmax. Chapter 3 expands upon 
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 the literature by probing into these unanswered questions (i.e. the effect of age 
on contraction under heavier loads) and extends our knowledge from Chapter 2 
about the extent of contractile dysfunction with age, its possible etiology, and 
implications. 
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 Chapter 2 
This is a pre-copy-editing, author-produced PDF of an article submitted for 
publication following peer review. 
 
C57BL/6 Lifespan Study: Age-Related Declines in 
Muscle Power Production and Contractile Velocity 
 
Ted G. Graber1, Jong-Hee Kim1, Robert W. Grange2, Linda K. McLoon3, 
LaDora V. Thompson1 
 
1University of Minnesota Medical School, Minneapolis, Minnesota 55455 
Dept. of Physical Medicine and Rehabilitation 
 
2 Virginia Tech University, Blacksburg, Virginia 24061 
Dept. of Human Nutrition, Foods, and Exercise 
 
3University of Minnesota Medical School, Minneapolis, Minnesota 55455 
Dept. of Ophthalmology and Visual Neurosciences 
 
Corresponding Author: 
LaDora V Thompson, thomp067@umn.edu, 612-626-5271 (office), 612-624-
2436 (fax) 
University of Minnesota Medical School 
Department of Physical Medicine and Rehabilitation 
Program in Physical Therapy  
Rm 366A Children’s Rehab Center 
426 Church Street SE 
Minneapolis, MN 55455 
 
 
Running Title: Power and Velocity Decline With Age in Mice 
94 
 
 Abstract: 
Quantification of key outcome measures in animal models of aging is an 
important step preceding intervention testing. One such measurement, skeletal 
muscle power generation (force * velocity) is critical for dynamic movement. Prior 
research focused on maximum power (Pmax), which occurs around 30-40% of 
maximum load. However, movement occurs over the entire load range. Thus, the 
primary purpose of this study was to determine the effect of age on power 
generation during concentric contractions in the EDL and soleus muscles over 
the load range from 10-90% of peak isometric tetanic force (P0). Adult, old and 
elderly male C57BL/6 mice were examined for contractile function (6-7 months 
old, 100% survival; ~24 months and 75%; and ~28 months, <50%, respectively). 
Mice at other ages (5-32 months) were also tested for regression modeling. We 
hypothesized, and found, that power decreased with age, not only at Pmax, but 
also, over the load range. Importantly, we found greater age-associated deficits 
in both power and velocity when the muscles were contracting concentrically 
against heavy loads (>50% P0). The shape of the force-velocity curve also 
altered with age (a/P0 increased). In addition, there were increased contraction 
times to maximum force and shifts in the distribution of the myosin light and 
heavy chain isoforms in the EDL. The results demonstrate that age-associated 
difficulty in movement during challenging tasks is likely due, in addition to overall 
reduced force output, to an accelerated deterioration of power production and 
contractile velocity under heavily loaded conditions.  
 
Key Words: Mice, Sarcopenia, Muscle, Contractile Physiology, Power, Velocity
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Introduction 
One major health challenge facing our aging population is sarcopenia, the age-
related loss of muscle mass and strength (Thompson, 2009). Sarcopenia not 
only decreases quality of life and makes activities of daily living more difficult, but 
it leads to loss of independence and is a major component of frailty (Landi, 2013; 
Fielding, 2011). Frailty is a syndrome characterized by low health reserve, 
decreased strength, generally poor prognosis for outcomes after medical 
procedures and increased mortality (Mackley, 2013). There is no cure for 
sarcopenia, though exercise (resistance training in particular) does show promise 
as a treatment because it increases muscle mass, strength, and function 
(Chodzko, 2009; Fiaterone, 1990; Evans, 1998). Movement requires skeletal 
muscle power generation. Skeletal muscle power is the product of two contractile 
parameters: force and velocity. 
 
Research in mice to determine contractile properties in vitro has traditionally 
focused on P0 (maximum isometric force production), Vmax (a non-physiological 
measure of unloaded velocity derived from curve-fitting force-velocity data with 
the Hill equation), and Pmax (maximum power, generally achieved at 30-40% P0). 
P0 and Pmax decline with age (Lynch, 2001; Brooks, 1988 A, B), whereas an age-
associated decrease in Vmax has not been reported (Brooks, 1988 A). Similar to 
mice, Pmax and maximum torque (strength) decline with age in humans, when 
measured as a joint movement (Reid, 2014; Narici, 1991). Plantar flexor motion 
demonstrates a decrease in both power and angular velocity with age in humans 
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 (Clemencon, 2008). Therefore, it has been suggested that the loss of power 
production in the elderly is due to declines in both angular velocity and torque 
(Power, 2013). Human studies are necessarily performed in vivo, but in the 
mouse model it is possible to reduce the complexity of the in vivo system to a 
single muscle using the in vitro method.  
 
Pmax occurs within a narrow range of %P0, which does not encompass all types of 
dynamic movement. The force-power curve of a muscle is a hyperbola that 
peaks at 30-40 %P0 (Pmax). Zero power is produced at zero load (0%P0), a 
hypothetical value because a muscle is always physiologically loaded. Power 
production is also 0 at 100% of P0 (isometric contraction). Movement and 
physical performance require power production, and in the elderly a decline in 
power production represents an important indicator of physical function (Reid, 
2012). Many functional activities require power production that spans the breadth 
of the force-power curve. Examples of human movement at the low range of the 
force-power curve include picking up a cup of coffee, or folding a shirt; whereas, 
at the high end activities such as opening a tightly sealed jar or arresting a fall 
require power production at forces closer to maximal P0. 
 
The emphasis on power production over the full force-power curve, by 
determining contractile velocity from 10-90% P0, is an important expansion of the 
previously published in vitro contractility literature. For instance, Lynch et al. 2001 
determined Pmax using Vopt (maximum contractile velocity that produces the 
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 maximum power output) and Brooks et al. 1988 determined contractile velocity at 
<50% P0 in order to determine Vmax. Therefore, the primary purpose of the current 
study was to investigate power production in concentric muscle contractions 
against loads from light (10% P0) to heavy (90% P0) across the lifespan of the 
male C57BL/6 mouse, a commonly used aging model. The overall hypothesis 
was that power would decrease over the entire load range with age, with an age-
associated loss of velocity, along with an overall reduction in force, both 
contributing to power reduction. Characterizing the effects of age on skeletal 
muscle power production over the entire load range and over the lifespan of the 
mouse will provide the foundation to design interventions for pre-clinical 
sarcopenia models. 
 
To test our hypothesis, the maximum force (P0) and the force-velocity 
relationship of both the soleus (SOL) and the extensor digitorum longus (EDL) 
were determined in vitro. The SOL is comprised of ~40% type 1 and 60% type 2 
muscle fibers (Burkholder, 1994). The EDL is comprised of mainly type 2 muscle 
fibers (Burkholder, 1994). The force-power curve was then derived from the 
force-velocity relation. In addition, we tested for an age-related change in the 
distribution of myosin isoforms (myosin heavy chains and myosin light chains), 
since these proteins are major determinants of fiber contractile velocity (Moss, 
1995; Larsson, 1997). 
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 Methods 
Animals: 
Male C57BL/6 mice (n=80), from three age groups were analyzed [Adult (A, 
n=15; 5-7 months old, 100% survival), Old (O, n=14; 22-26 months, ~75% 
survival), and Elderly (E, n=24; 28+ months, <50% survival)] with additional mice 
outside of the 3 age groups used for regression analysis. All animals were aged 
from 5-32 months. The mice were obtained from the NIA aging colony at Charles 
River Laboratories (Charles River, Maryland). Some of these animals (n=50) 
were used in a previous study (Graber, 2013), where we reported peak tetanic 
force, rotarod, and grip test outcome measures. Mouse husbandry was 
performed by core staff in a specific pathogen free facility. IACUC approved 
standard operating procedures were used to assure humane and ethical 
treatment. Body and muscle mass were measured just prior to the physiology 
experiment, and body mass was also assessed 1 week after the mice arrived. 
 
Whole Muscle Physiology: 
Tissue handling, equipment and settings, determination of optimal length, peak 
twitch force, maximum tetanic force, and the force frequency curve are described 
in detail elsewhere (Graber, 2013). In brief, while under deep anesthesia, the 
SOL and EDL muscles were carefully removed from the animal and weighed. 
The muscles were tied with #4 silk suture just above their origin and insertion 
myotendinous junctions, and were attached vertically between platinum 
electrodes to a force transducer (300B, Aurora Scientific Inc. (ASI), Aurora 
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 Ontario Canada) and a static clamp in a tissue chamber. The muscle was then 
submerged in Krebs-Ringer buffer in a vertical oxygenated bath (maintained at 
25°C; Graber 2013). The muscle was stimulated (using 701B Stimulator, 
software controlled with Dynamic Muscle Control version 3.2; ASI) with a single 
pulse of 500 microseconds, at 30 volts and 1 amp, while length was increased 
until optimal length (L0, measured with a caliper) was achieved--the point at 
which the peak twitch force (Pt) was determined. The muscles were then held at 
L0 and stimulated at various frequencies, between 10 - 180 Hz, depending on 
muscle type to determine the peak tetanic force (P0). Physiological cross-
sectional area (PCSA) was determined using the average density of skeletal 
muscle by the formula: PCSA (cm2) = Muscle mass (g) / [L0 (cm) * 1.06 (g/cm3)] 
(Mendez, 1960). 
 
Force-Velocity Curve:  
Using P0 as the reference force, maintaining L0 (optimal fiber length), and 
stimulating at the frequency where P0 was found, the force velocity-curve was 
determined by using the load-clamp technique to measure velocity at various 
percentages of P0 (10-90%). Specifically, the load-clamp technique sets the force 
transducer arm to resist at the %P0, but can travel freely once the muscle 
produces force that exceeds the load on the arm. The action can be thought of 
as moving against resistance, as in weight lifting. The muscle was maximally 
stimulated for 500 milliseconds (ms). The distance the arm moved over the time 
of stimulation was used to compute the maximum velocity at that %P0 by finding 
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 where the first derivative of the time-distance curve equaled 0. The absolute 
measurement of velocity was in millimeters per second (mm/sec) which was 
converted to a normalized measurement of fiber lengths per second (fl/sec) using 
the established ratio values of intact fiber length to muscle length: 0.44 (EDL, 
adult), 0.45 (EDL, old and elderly), and 0.69 (SOL) (Brooks, 1988 A). The force-
velocity curve was constructed, and the values entered into a custom MATLAB 
(Natick, MA) program. The custom MATLAB program fits the data to a curve 
using the Hill equation (Woledge, 1985), (V+b)(P/P0±a/P0)=b(1+a/P0), to 
extrapolate the maximum unloaded velocity (Vmax) and also plots a force-power 
curve (by fitting the data to a 5th degree polynomial curve) to determine both the 
peak power (Pmax) and the percentage of P0 at Pmax (%Pmax).  
 
Force-Power Curve:  
The power at the %P0 loads (force-power curve) was determined at the 
measured percentages of P0 by multiplying force at %P0 and the maximum 
velocity at the %P0, determined as described above.  The Pmax and %Pmax were 
taken from the MATLAB output, by determining the maximum point on the force-
power curve. 
  
Myosin Light Chain and Heavy Chain Isoforms: 
This procedure has been previously described (Thompson, 2006). In brief, 
proteins from EDL and SOL samples, from whole muscle homogenates--made 
from muscles that were stored in skinning solution (which permeabalizes the 
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 individual muscle  fibers), were separated on large format electrophoresis gels at 
12% acrylamide for light chain analysis and 5% for heavy chain analysis, and 
then silver stained. Proteins were positively identified by using tandem mass 
spec./mass spec. on a Thermo Scientific LTQ Orbitrap to identify the proteins on 
the standards. The standards were made from rat whole muscle homogenates 
(TA, SOL and diaphragm). The gels were imaged using a Bio-Rad Gel-Doc XRS 
Imager (Hercules, CA) and the relative protein abundance was calculated with 
densitometry using QuantityOne software (Biorad). 
 
Statistics: 
One-way ANOVA (Tukey-Kramer Honestly Significant Difference post-hoc) or 
Student’s t-test were used to detect differences between means, as appropriate. 
Statistical significance was at p<0.05. Both simple and multiple linear regressions 
were analyzed to examine relationships between variables. General Linear 
model was used to compare slopes of regression lines. Principle component 
analysis using a promax rotation was used to determine the most significant 
variables for multiple regressions. We used SPSS (IBM Corporation, Armonk, 
New York) for all statistical analyses. Data are presented as means ± standard 
error (SEM).  
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 Results: 
Force-Velocity Relationship and Vmax:  
The velocities of contraction under loaded (>0% P0) conditions showed age-
related declines (Figure 1 and Table 1). In the elderly mice, the extent of 
reduction in contractile velocities averaged 21±4% in the EDL (range of 10-34%) 
and 24±2% in the SOL (range of 16-33%); with no significant difference in the 
mean decline between the two muscles [Student’s t-test comparing %reductions 
in velocity in elderly mice from 10-90%P0: EDL and SOL; t=-1.1, p=0.290]. In the 
old mice, EDL velocities at 30-60%P0 showed an age-associated reduction 
compared to the adult. For the old mice, there was slower contraction speed in 
the SOL compared to the adults from 10-80%P0. Since the old mice were not 
significantly different from the elderly in contractile velocity, we report herein, for 
brevity, only the differences in velocity between adult and elderly mice.  
 
Elderly EDL  
The contractile velocities of the elderly, between 20% and 80% Po, were 
significantly slower than the adult EDL group (Figure 1 a, b and Table 1). 
Specifically, at loads <50%P0 (10, 20, 30, 40%) the velocities of the elderly group 
were reduced by 10 (not significant), 13, 15, 20% (p-values=0.051, 0.004, 0.001, 
0.002), respectively. In contrast, at loads of 60, 80, and 90 (not significant) the 
velocities were reduced by 24, 34 and 34% (p-values=<0.001, 0.004, 0.064), 
respectively.  
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 While Vmax (unloaded velocity) did not change, age exerted a greater effect on 
EDL contractile velocity as the muscles contracted under increased loads (simple 
regression of the percent reduction and %P0: %Velocity= 0.33(%P0) + 5.7, 
R=0.985) (data not shown). The mean velocity percentage (average percent 
change at all measured loads) was reduced 2-fold at heavier loads (40-90%P0) 
to 28%, in comparison to lighter loads (reduced 14% from 10-40%P0) (Table 1 
and Figure 2 a). There was an additional age-related decline of 65% (slope of 
simple linear regression lines) at the heavier loads in comparison to the lighter 
loads [from separate linear regressions: %Velocity @ 10-40%P0= 0.23(%P0) + 
8.0, R=0.994; %Velocity @ 40-80%P0= 0.38(%P0) + 2.1; R=0.972]. The slopes of 
these regression lines were different (p=0.003, from the General Linear Model) 
(Figure 2). 
 
Elderly SOL 
The SOL Vmax was not significantly different in the elderly (-16%, ANOVA 
p=0.072, Tukey HSD p=0.061). However, the contraction velocity was 
significantly reduced by 23, 24, and 20%, at loads of 10, 20, and 30%P0, 
respectively. At the higher loads of 40, 60, 80 and 90%P0, the elderly mice 
contracted slower than the adults--27, 33, 33, and 31%, respectively (90%P0 not 
significant, p=0.081) (Table 1 and Figure 1 c, d).  
 
Similar to the EDL, the effect of age became more pronounced at higher loads 
(simple linear regression of the percent reduction and 0-90%P0: %Velocity= 
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 0.23(%P0) + 16.5, R=0.946). The mean percent reduction in contraction velocity 
was 19% from 0-30%P0, but was 30% from 40-90%P0. When analyzing the 
regressions of the no/low load (0-40%P0) and higher load (40-90%P0) separately, 
the slopes of the lines were similar (suggesting a similar rate of effect), and R-
values showed moderate correlation: %Velocity @ 0-40%P0= 0.13(%P0) + 17.3, 
R=0.757; %Velocity @ 40-90%P0= 0.12(%P0) + 16.5; R= 0.567. 
 
Lifespan – Age and Velocities 
In order to assess the effect of age, from 5-32 months, on velocity, we examined 
linear regressions of age with velocity at the various %P0. EDL showed a 
significant negative correlation between age and velocity under loads from 20-
90%P0, whereas the SOL was significant at all loads from 10-90%P0. All the 
linear regression graphs with equations are found in the Online Resource 2 
Supplemental Figures S1 and S2 [future references will use the convention 
“Figure Sx”, representing the figure number in Online Resource 2 Supplemental 
Figures (S1-S7)]. 
 
Shape of Force-Velocity Curve, a/P0:  
To determine if there was a difference in the shape of the EDL and SOL force-
velocity curves, the a/P0 value was evaluated (a: constant from the Hill equation, 
a/P0: describes the shape of the curve, see Methods). There was a downward 
and leftward shift with advancing age in the EDL (one-way ANOVA:  F=19.1, 
p<0.001; Tukey HSD: adult vs. elderly p<0.001; old vs. elderly p=0.005) (Table 
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 1). In contrast, the SOL curves did not exhibit a significant shift with age between 
groups (one-way ANOVA F=3.401, p=0.067) (Table 1). Over the lifespan, 
however, linear regressions showed an increase in a/P0 with age in both the EDL 
and SOL, thus demonstrating that the force-velocity curve is altered with age 
(Figure 3 a, b).  
 
Force-Power Relationship:  
In order to determine the influence of age on power production, we constructed 
and analyzed force-power curves by multiplying the force produced and the 
velocity of contraction for both the SOL and EDL in the three age groups 
between 0-100%P0, and then examined regressions of age (5-32 months) and 
power at all %P0.  
 
Power production declined with age (Table 1, Figure 4, Figures S3 and S4). In 
the elderly mice, the reduction in power averaged 43±3% in the EDL (range of 
33-54%) and 35±3% in the SOL (range of 31-39%), across the loads of 10-
90%P0 but there was no significant difference in percentage power reduction 
between the two muscles [Student’s t-test: t=2.15, p=0.052]. In the old mice, the 
EDL had an overall power reduction of 20% (mean of all loads) and the SOL 
averaged 32% over the higher loads of 60-80%P0. However, in the old SOL the 
decline observed from 10-40%P0 was not significant, so we did not compare the 
old EDL to the old SOL with respect to the average percent change. Elderly mice 
had significantly reduced power at 10-80%P0 (at 90%P0, p=0.052) in the EDL, 
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 averaging 29% and ranging from 25-41%, compared to old EDL. In the SOL, the 
old and elderly power production was not significantly different. In the interest of 
brevity, we will discuss in depth only the specific differences between the adult 
and elderly mice.  
 
The percent reduction in power by the EDL per unit increase in load (%P0) had a 
linear relationship that amounted to -0.26% (R=0.993, p<0.001). Likewise, the 
SOL had a percentage decrease of -0.10 (R=0.810, p=0.003) in power, per unit 
increase in %P0. (Figure 5 a and b)   
 
Elderly EDL  
As noted above, power production was significantly reduced at loads between 
10-90%Po in the elderly EDL group. At loads <50%P0 (10, 20, 30, 40) the power 
was reduced by 36, 38, 39, and 41%, respectively (Table 1, Figures 2 B, 4 a, b 
and Figure 5 a). In contrast, at loads of 60, 80, and 90%, power was reduced by 
46, 53, and 54%, respectively. Age exerted a greater effect on EDL power 
production as the loads increased (simple regression of the percent reduction 
and %P0: %Power Reduction= -0.26(%P0) – 31.3, R=0.991, p<0.001) (Figure 5 
a). Power was reduced 31% more at heavier loads (overall 51% mean reduction 
from 60-90%P0) compared to lighter loads (overall 39% mean reduction from 10-
40%P0).  The age-related decline was 57% more (comparing slopes of regression 
lines) in the heavier loads compared to the lighter loads [from separate linear 
regressions: %Power @ 10-40%P0= 0.16(%P0) + 34.5, R=0.992; %Power @ 40-
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 90%P = 0.28(%P0) + 30.0; R= 0.992 (Figure 2 b, Figure S4). The slopes of the 
regression lines were different (p<0.001, from the General Linear Model). 
 
Elderly SOL 
Specifically, at the lighter loads of 10, 20, and 30%P0, power was reduced by 31, 
32, and 30%, respectively. At the higher loads of 40, 60, 80, and 90%P0, power 
was reduced by 38, 35, 37, and 39%, respectively (Table 1, Figures 4 c, d and 
5 b). As in the EDL, the effect of age became more pronounced at higher loads 
(simple linear regression of the percent reduction and 0-90%P0: %Power= -
0.10(%P0) – 30.1, R=0.656, p=0.003) (Figure 5 B). The mean percent reduction 
in power was 31% from 10-30%P0, but was 37% from 40-90%P0. However, there 
was no indication of an increase in the rate of effect [from separate linear 
regressions of the no/low load (0-40P0) and higher load (40-90%P0), the slopes 
of the lines were similar, and R-values showed a moderately strong correlation: 
%Power @ 0-40%P0 = 0.23(%P0) + 25.5, R=0.769; %Power @ 40-90%P0 = 
0.21(%P0) + 25.9; R= 0.819] (Data not shown). 
 
Lifespan – Age and Power 
To determine correlation and determine predictive equations, we examined linear 
regressions of age (from 5-32 months) with power at the various %P0. Both the 
EDL and SOL showed significant negative correlations between age and power 
under all loads (Figures S3 and S4) 
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Pmax and %P0 @ Pmax 
The EDL Pmax of the elderly and old mice was reduced 40% (p<0.001) and 21% 
(p=0.001), respectively, when compared to the adults (Table 1). EDL Pmax also 
declined 24% between old and elderly mice (p=0.015). Likewise, a simple linear 
regression of the EDL Pmax with age revealed a significant decline [(R=-0.700, 
r2=0.489, p<0.001) with the equation: Pmax (mN * fl/s) = 600.8 – 9.1 * age (m)] 
(Figure S3). The EDL %P0 @ Pmax was reduced 13% (p<0.001) in the elderly 
(33%) and 8% (not significant, p=0.069) in the old (35%) compared to the adult 
(38%).  
 
The SOL Pmax reduced with age, 28% (p=0.009) in the elderly with no reduction 
in the old group (Table 1). Regression of the SOL Pmax with age, however, 
revealed a significant decline over the lifespan (R=-0.301, r2=0.091, p=0.052) 
with the equation: Pmax (mN * FL/s) = 79.5 – 0.7 * age (m) (Figure S4). SOL %P0 
@ Pmax of the adult and elderly mice was not different (29%). 
 
Relationships between Age, Force, Velocity, and Maximum Power 
In order to evaluate the relationship between age, velocity, force and Pmax, we 
examined simple and multiple linear regressions to determine how much 
variability is explained by the velocity and force components of power (equations 
and description of the procedures are found in the Online Resource 1 
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 Appendix). In brief, in the EDL, P0 explained 58% of the individual variability in 
Pmax (P0 + age, 66%), while velocity of contraction explained 23% (velocity + age, 
49%). Both velocity and P0 combined to account for 73% (with age, 75%). In the 
SOL, the P0 could explain 59% of the individual variability in Pmax (P0 + age, not 
significantly different), velocity of contraction 50% (velocity + age, no difference), 
and P0 and velocity combined, 83% (with age, 84%). (Figure S5) 
 
Myosin Heavy and Light Chain Composition:  
In the EDL, the percentage of myosin heavy chain (MHC) isoform 2a/x was 
increased, with the adults at 14% and the older mice at 20% of the total myosin, 
and the 2b isoform (adult 86% and older 80%) decreased by 6% with age, adults 
at 86% and old mice at 80% (bundle electrophoresis) (Student’s t-test, p=0.009 
and 0.010, respectively) (Figure S6). There was also a 21% decrease in the 
percentage of myosin light chain 3f in the EDL of older mice (combined old and 
elderly, n=23, mean age=28) when compared to adult (n=19, mean age=7.5) 
(Figure S7, Student’s t-test, p=0.030). There was no difference in MHC 2a/x 
expression in the SOL (61.8% in adult and 61.0% in older mice, Student’s t-test: 
p=0.670) or in MLC3f expression (11.0% in adult and 9.5% in older mice, 
Student’s t-test: p=0.200) (Figures S6 and S7). 
 
Animal Characteristics: 
Table 2 summarizes the animal characteristics critical to interpreting the effect of 
age on muscle contractile velocity and power production. The body mass of the 
mice in the ~75% survival older group was heavier than both the 100% adult and 
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 <50% elderly survival groups. Specifically, the body mass of the mice in the EDL 
old group was 17% heavier compared to the adults (p=0.008) and 13% greater 
than the elderly EDL group (p=0.018). In the SOL group, the old mice were 33% 
heavier when compared to the adult (p=0.001) and 27% more than the elderly 
(p=0.001). (ANOVA, with Tukey HSD posthoc) 
 
EDL muscle mass and size decreased with age. EDL muscles in the elderly 
group had a 25% reduction in muscle mass (p<0.001) and a 27% reduction of the 
physiological cross-sectional area (PCSA, p<0.001) when compared to the EDL 
muscles in the adult mice. EDL muscle mass in the old group was not 
significantly different (-13%, p=0.085), but there was a 17% reduction in the 
PCSA, (p=0.039) compared to the adult mice. (ANOVA, with Tukey HSD 
posthoc) 
 
When muscle mass was normalized to body mass (mg of muscle mass/grams of 
body mass, or mg/gbm), the reduction was confirmed. The old EDL (0.37±0.01 
mg/gbm) were 25% smaller, and the elderly (0.35±0.01mg/gbm) were 28% 
smaller (ANOVA, p<0.001; Tukey HSD p=<0.001 for both). 
 
In contrast to the EDL, the SOL muscle mass and PCSA did not show the age-
related decrease. However, the normalized muscle mass revealed an age-
related decline such that the SOL muscles from the old mice (0.31±0.03 mg/gbm) 
were 30% lighter, although muscles from the elderly mice (0.36±0.01mg/gbm) 
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 were not significantly different (-29%) when compared to the adult group. 
(ANOVA, p=0.012; Tukey HSD p=0.009 and 0.077, respectively).  
 
Force Production Declined with Age: 
With age, the P0 of the EDL was reduced (Table 2). The elderly produced 28% 
less force (p<0.001) and old mice 22% less (p=0.003), in comparison to the 
adult. EDL P0 normalized to muscle cross sectional area was not different. The 
normalized EDL P0 (to body mass) was lower in both the elderly and old mice 
compared to adult by 29% (p<0.001) and 20% (p<0.001), respectively. In 
contrast, the SOL did not show a significant decline in P0 (p=0.057). SOL also did 
not decline in P0 normalized to muscle cross sectional area. However, after 
normalizing SOL P0 to body mass, there was an age-related decline. The old 
mice (4.8±0.43 mN/gbm) lost 22% of normalized force in comparison to the 
adults (6.1±0.40 mN/gbm), but the elderly (5.1±0.23 mN/gbm) were not 
significantly different from the adults (ANOVA, p=0.042; Tukey HSD: Old p=0.043 
and Elderly p=0.103).  
 
To determine the effects of age on EDL P0 over the lifespan (5-32 months of 
age), a simple linear regression of the P0 with age revealed that age explained 
30% of the variation in P0 [R=0.550, r2=0.302, p<0.001; equation: P0 (mN) = 
425.99 (mN) – 4.45 * age (m)]. This relationship of EDL and age was similar to 
the results we found previously (Graber, 2013). In contrast, neither the simple 
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 regression with age of the SOL P0 nor the normalized SOL P0 were different 
(p=0.121 and 0.140, respectively).  
 
In the EDL, the time to reach maximum force (contraction time, measured at 150 
Hz, average frequency for P0) was 0.159±0.008 sec, 0.178±0.007 sec, and 
0.211±0.010 sec in adult, old and elderly, respectively (Figure 6 shows 
regression in respect to age). There was no difference in the contraction time 
between the adult and old muscles, but the elderly had a contraction time 16% 
longer than the old (p=0.036) and 33% longer than the adult (p<0.001) (One-way 
ANOVA, Tukey HSD post-hoc). Across the lifespan (5-32 months, n=63), age 
had a modest negative correlation with EDL contraction time (R=0.525, p<0.001). 
In the SOL, there was no significant difference in contraction time (measured at 
100 Hz).  
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 Discussion:  
The comprehensive analyses of power output and contractile velocity across the 
lifespan in both the EDL and SOL muscles provide novel insight into age-related 
contractile dysfunction. Overall, we found age-associated declines in power, 
velocity, and force in both the EDL and the SOL. The extent of decline varied 
with respect to %P0, as the velocity and power of both muscles were affected 
more by age when the muscles were contracting against the heavier loads (i.e., 
loads >50%P0). The age-associated loss of both power and velocity at heavy 
loads has important functional implications, particularly in activities in which a 
large proportion of body mass must be moved. Getting up from a chair, 
acceleration of gait, and ascending or descending stairs are examples. Time to 
maximum force in the EDL increased with age, as did a/P0, a measure of the 
shape of the force-velocity curve. In addition, we found that decreases in velocity 
became a predictor of power loss as the load increased from light to heavy. 
Finally, in the EDL, with advancing age, there was a decline in the percentage of 
myosin light chain 3f (old<adult), and a decline in the relative MHC 2b content. 
 
There were three major motivating factors for this investigation. First, although 
maximal power generation occurs at 30-40% P0, functional activities require 
movement that incorporates power generation across a wide load range, 
especially power generation under heavily loaded conditions. Fall prevention is 
one critical heavily loaded condition where the rapid application of power to a 
limb is needed for an individual to regain balance. Other typical activities of daily 
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 living that require power generation at large percentages of maximum force are 
the opening of a stuck jar lid or rising to a standing position from a seat. Such 
activities of daily life are compromised in the older adult (Suzuki, 2001; Raj, 
2010). Indeed, the loss of power has been suggested to be a strong predictor of 
disability (Puthoff, 2007; Suzuki, 2001). Not only does the loss of power 
contribute to disability, but, importantly, the velocity of the contraction itself 
correlates with physical performance, and emphasizes the value of investigating 
this parameter under loaded conditions (Clemencon, 2008). Second, it is now 
well established in humans that resistance training with loads around 80% of 
peak strength maximizes strength gains and is considered the best-practice 
intervention for sarcopenia (Fiaterone, 1990; Evans, 1998; Evans, 1993; Ali, 
2014). Third, studying basic contractile properties over the entire load range and 
how they change over the lifespan is necessary because the information 
obtained provides a better perspective of the activities of daily living that are 
likely impacted, especially those requiring muscle force production >50%Po  (i.e., 
heavy loads). In turn, this knowledge may lead to mechanistic investigations that 
provide targets pertinent to treatment strategies for sarcopenia that reverse 
frailty, increase power production, and improve quality of life in the elderly.  
 
Interventions to prevent, reverse, or slow sarcopenia have mainly focused on 
strength gain and muscle hypertrophy. Based on the findings of this study, and 
assuming the results are translatable to humans, designing training programs for 
muscle power and velocity gains at higher percentages of maximum force would 
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 meaningfully impact performance for the older adult. Previous reports show 
greater improvements in power production when training for velocity of 
contraction, power training, compared to training for strength (Earles, 2001). 
More importantly, functional ability is improved greatly with power training. For 
example, power training in community-dwelling older adults was shown to have a 
greater impact than strength training on functional ability, such as measured by 
the Continuous Scale Physical Functional Performance test (Miszko, 2003). 
Thus, some combination of exercise training strategies that include 
strength/hypertrophy, as well as power and velocity training, may be required to 
maximize functional improvement, and to mitigate sarcopenia/frailty. This 
combined exercise training strategy will likely require additional support through 
ergogenic and nutritional supplementation to assist in overcoming the anabolic 
resistance reported in the elderly and to maximize gains, since anabolic 
resistance has a multi-factorial etiology (Haran, 2012). 
 
Peak values - Pmax, Vmax, and P0: 
Previous studies report the traditionally measured peak values of power (Pmax), 
velocity (Vmax), and force (P0). With age, both Pmax and P0 decline (Lynch, 2001; 
Narici, 2005; Brooks, 1988 A and B; Graber, 2013; Phillips, 1991), whereas Vmax 
(derived from the force-velocity curve) is relatively unaffected (Brooks, 1988 A; 
Lynch, 2001). Peak values in the current study are consistent with these results.  
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 Our study found key differences in two contractility outcome measures, a/P0 and 
contractile velocities over the load range (at both low and high loads). Our 
comprehensive analysis revealed that, with age, there were significant increases 
in the a/P0 ratio, suggesting a change in the force-velocity relationship (Jones, 
2010), as well as decreases in power production and contractile velocity. These 
differences likely are attributed to the age of the animals and to differences in the 
experimental design for evaluation of the force-velocity and force-power curves. 
Our oldest group of mice was 2-3 months older (mean age 30 months) than the 
oldest mice in previous studies (mean ages 27-28 months). In addition, previous 
studies only measured velocity at percentages of P0 less than 50%. 
 
The current study reports other novel findings: the impact of age on both velocity 
and power during heavily loaded contractions; the increased relationship (R 
value) between velocity and power at larger percentages of P0; the reduced 
percentage of maximum force at which  maximum power was produced in the 
EDL as a function of age; the increased contraction time to maximum force in the 
EDL; and the comprehensive characterization of the decline in velocity and 
power over the lifespan (5-32 months) of  C57BL/6 mice via linear regression.  
 
Mechanisms underlying age-related power impairment: 
Any reduction in force or velocity will result in loss of power. The loss of force 
production is generally accepted to be associated with muscle atrophy, motor 
unit loss, and deficits in muscle quality (Raj, 2010). Changes in connective 
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 tissue, such as a decrease in elastic modulus in tendons, (Onambele, 2006) and 
alterations in muscle architecture, such as pennation angle, are also likely to 
influence contractility negatively (Thom, 2007) by diminishing force transmission. 
However, the reduction in force capacity does not entirely explain the accelerated 
loss of power seen with age (Thom, 2005).  
 
Our findings that the a/P0 ratio increased with age also suggest a change in the 
force-velocity relationship (Jones, 2010). Age-related reduction in contraction 
velocity may also contribute to loss of power. In the human and rodent literature 
spanning various experimental technologies, such as single skeletal muscle 
fibers and applied human performance, an age-related loss of velocity has been 
reported (Thompson, 1999; Kim, 2012; Li, 1996; Krivikas, 2001; Larsson,1997; 
Narici, 1991; Thom, 2007), with some disagreement in studies of human single 
muscle fibers (Trappe, 2003). In numerous in vivo human studies, many potential 
contributors to loss of velocity and power have been suggested: neurological 
changes, motor unit recruitment (Narici, 2008), increased proportion of 
fat/connective tissue in older muscle (Addison, 2014), muscle architecture 
changes, including pennation angle and fiber fascicle length reductions (Klein, 
2001), and deleterious joint/range of motion/mobility changes (Lanza, 2003). 
 
Likely candidates for the age-related velocity decline within individual skeletal 
muscle fibers include impaired actin/myosin interactions (Hook, 2001; Raj, 2010) 
and changes in myosin heavy and light chain isoform proportions (Moss, 1995; 
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 Larsson, 1997). The main factor that determines the velocity of a muscle cell 
contraction is the MHC isoform proportion/distribution of the fiber (Schiaffino, 
1990). We found a small but significant age-associated shift in MHC content in 
the EDL with a 6% decline in MHC2b in the elderly mice that might explain some 
of the velocity change. Contractile velocity of a single fiber is also regulated both 
by the phosphorylation state of the regulatory MLC2 and the isoform composition 
of the essential light chains (Grange, 1995), with MLC3f being the fastest (Kim, 
2012). We found a 21% decline in MLC3f relative content in EDL fibers that, 
together with the decrease in MHC2b, might partially explain the reduced 
velocity. In previous work from our laboratory, single fibers from rat 
semimembranosus, showed a 69% decline in %MLC3f content in MHC type II 
fibers with age. However, up-regulation of MLC3f using gene therapy restored 
single-fiber unloaded contractile velocity in older rats to adult levels (Kim, 2012). 
Further investigation is needed to clarify the roles of myosin isoform changes and 
their contributions to velocity and power loss. 
 
Possible Mechanisms of Increased Age-Associated Dysfunction 
at Higher Loads: 
At low loads, the muscle function was better preserved; however, at high loads, 
the impairments in myosin-actin interactions were exacerbated leading to 
reduced contractility. Indeed, myosin working stroke distance and velocity are 
reduced at higher loads (Reconditi, 2004). We believe that age-associated 
changes in actin-myosin cross-bridge kinetics, such as the ratio of strong and 
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 weak structural states, resulted in fewer strong-binding attachments, decreased 
detachment rates, and increased internal drag, play a role in load-associated 
decline of function with age (Prochniewicz, 2005). Further investigation is 
needed. 
 
Our finding of an age-related increase in EDL contraction time to maximum force 
suggests connective tissue dysfunction as an underlying cause of power 
impairment (Narici, 2008). At the tissue level, the tendons, myotendinous 
junction, and other connective tissues responsible for force transmission have 
reduced functionality with age (Onambele, 2006; Zhang, 2014). These age-
related changes result in thickening of the extracellular matrix and detrimental 
mechanical alterations to the tendon, caused by a decrease in elastic modulus 
and stiffness resulting in increased compliance, which negatively alter force 
transmission speed and ultimately contractile velocity (McCarthy, 2014; LaCroix, 
2013, Narici, 2008). We propose that these detrimental modifications in 
connective tissue are manifested at a greater extent and contribute to increased 
dysfunction when the muscle is contracting against higher load. Further 
investigation is needed to delineate the contribution of connective tissue decline 
to loss of contractile efficiency. 
 
It is important to note that lifestyle and behavior may play a role in dysfunctional 
power production at heavy loads. As organisms age, not only does the general 
rate of activity decline, but the tendency to engage in behaviors that require near 
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 maximal exertion declines as well (Jefferis, 2014). For example, muscles used 
for postural activities often have less age-related decline than muscles designed 
for explosive movements (SOL vs. EDL in the current study, for example). In 
addition, motor unit reorganization with age does not favor the maintenance of 
fast-twitch anaerobic activities, due to preferential type 2 motor unit net loss and 
the more general preservation of type 1 myosin muscle fibers with age (Luff, 
1988; Thompson, 2006). 
 
Conclusion: 
There was an age-associated decline in power, velocity, and force in both the 
EDL and SOL muscles of the C57Bl/6 male mouse. Specifically, contractions at 
heavy compared to light loads showed an exacerbated age-associated decline of 
power and velocity. The shape of the force-velocity curve was also altered with 
age, with a/P0 increasing. We also detected a reduction in EDL MLC3f and 
MHC2b content, which may contribute to the declining velocity of contraction. 
Our finding showing an age-related increase in time to maximum force in the 
EDL suggests that, among other potential mechanisms such as impaired calcium 
handling, connective tissue dysfunction may play a role in power and velocity 
loss. Further investigation is needed to determine the specific mechanisms 
underlying age-associated increased dysfunction in muscles contracting 
concentrically under heavy loaded conditions. 
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 Table Legends: 
 
Table 1 Power and Velocity at Percentages of Maximum Force (%P0) Vmax= 
maximum unloaded velocity. Pmax = maximum power. %P0@Pmax = the 
percentage of maximum force where Pmax was produced. mN * fl/s = 
milliNewtons multiplied by fiber lengths per second. P-value was taken from one-
way ANOVA. %Change = % change from adult to elderly. Symbols: a=different 
than adult, b=different than old (p<.05) (marked only on old and elderly). § = Pmax 
values from MatLab data curve-fit, force-power curve derived from the maximum 
instantaneous velocity (at %P0) multiplied by force (at the %P0). In the adult SOL, 
the derived Pmax (81±6) is not statistically different than the derived value for 
power at 30%P0 (82±6). 
 
Table 2 Animal Characteristics for EDL (n=53) and SOL (n=47) Groups Adult 
mice (EDL n=15, SOL n=12) were used as the reference group to the old (EDL 
n=14, SOL n=12) and elderly (EDL n=24, SOL=23). P-value was taken from one-
way ANOVA (Tukey’s HSD post hoc test). PCSA= physiological cross-sectional 
area of muscle. P0= maximum tetanic contractile force. Symbols: a=different than 
adult, b=different than old (p<0.05) marked only on old and elderly. 
 
 
Figure Legends: 
 
Figure 1 Velocity Declines with Age a) EDL Force-Velocity Curve b) Linear 
Regression of EDL velocity at 60%P0 See Figure S1 in the supplement for the 
other velocities. c) SOL Force-Velocity Curve d) Linear Regression of SOL 
velocity at 60%P0. See Figure S2 in the supplement for the other velocities. See 
Table 2 and Text for post-hoc analysis. Each symbol in b and d (diamonds) in the 
regression graphs represents a measurement from an individual mouse at the 
given age. Equation: simple linear regression of velocity (y) as a function of age 
(x). * = p<0.05; p-value from One-Way ANOVA. fl/s= fiber length per second. %P0 
= percentage of maximum isometric force. Age=age in months. 
 
Figure 2 EDL Velocity and Power at Heavier Loads Show Increased Age-
Related Rate of Decline a) Velocity b) Power Equation: simple linear 
regression of %reduction in velocity and power of elderly mice (in comparison to 
adult mice) as a function of load (%P0). Light loads (10-40%P0) are represented 
by diamonds with a dashed regression line and heavy loads (40-90%P0) are 
represented by circles and a solid regression line. 40% P0 is the inflection point 
indicating where the slope changes and as such the point is included in both 
sections of the graph. * = slope of line significantly different, p=0.003 and 
p<0.001 for velocity and power, respectively. 
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 Figure 3 Force-Velocity Curve Alters with Age: a/P0 Increases with Age a) 
EDL b) SOL Equation is a simple linear regression of a/P0, which describes the 
shape of the force-velocity curve, with respect to age of the mouse in months. 
Each symbol represents the a/P0 of one mouse. 
 
Figure 4 Power Declines with Age a) EDL b) Linear Regression of EDL 
power at 60%P0. See Figure 4 for Pmax and Figure S3 in the supplement for 
the other regressions. c) SOL d) Linear Regression of SOL power at 80%P0 
See Figure S4 in the supplement for the other regressions. See Table 2 and Text 
for post-hoc analysis. Each symbol in b and d (diamonds) in the regression 
graphs represents a measurement from an individual mouse at the given age. 
Equation: simple linear regression of power (y) as a function of age (x). * = 
p<0.05, p-value from one-way ANOVA. mN * fl/s= milliNewtons multiplied by fiber 
lengths per second. %P0 = percentage of maximum isometric force. Age= age in 
months. 
 
Figure 5 Further Percent Reduction in Power as %P0 Increases, Comparing 
Elderly to Adult. a) EDL There was a -0.26 percent reduction in power per unit 
increase in load (%P0, percentage of maximum force at which power was 
derived)(R=0.993). b) SOL There was a percentage decrease of -0.10 (R=0.810) 
in power, per unit increase in in %P0. Each diamond represents the difference 
between the mean power production of the entire adult group compared to the 
entire elderly group). Equation = simple linear regression of percent change in 
power from adult to elderly (y) as a function of %P0. 
 
Figure 6 EDL Contraction time to Maximum Force Increases with Age 
Equation is a simple linear regression of time to maximum force is seconds with 
respect to age of the mouse in months. Each symbol represents the contraction 
time of one mouse. 
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Table 1 Power and Velocity at Percentages of Maximum Force (%P0) Vmax= maximum 
unloaded velocity. Pmax = maximum power. %P0@Pmax = the percentage of maximum force where 
Pmax was produced. mN * fl/s = milliNewtons multiplied by fiber lengths per second. P-value was 
taken from one-way ANOVA. %Change = % change from adult to elderly. Symbols: a=different 
than adult, b=different than old (p<.05) (marked only on old and elderly). § = Pmax values from 
MatLab data curve-fit, force-power curve derived from the maximum instantaneous velocity (at 
%P0) multiplied by force (at the %P0). In the adult SOL, the derived Pmax (81±6) is not statistically 
different than the derived value for power at 30%P0 (82±6). 
 
 
 
 
 
 
 Power (mN * fl/s)  : Velocity (fl/s)  
%P0 Adult Old Elderly p-val. %Change : Adult Old Elderly p-val. %Change 
 EDL  
0 (Vmax) 0 0 0   : 11.0±0.3 11.0±0.4 10.8±0.3 0.921 -2 
10 318±16 272±14 204±11ab <0.001 -33 : 8.2±0.2 7.7±0.2 7.4±0.2 0.064 -10 
20 466±23 388±19a 289±16ab <0.001 -38 : 6.0±0.2 5.5±0.1 5.2±0.2a 0.004 -13 
30 531±26 428±21a 322±18ab <0.001 -39 : 4.6±0.1 4.0±0.1a 3.9±0.1a 0.001 -15 
40 539±29 424±23a 316±18ab <0.001 -41 : 3.5±0.1 3.0±0.1a 2.8±0.1a 0.002 -20 
60 476±26 359±25a 259±16ab <0.001 -46 : 2.1±0.1 1.7±0.1a 1.6±0.1a <0.001 -24 
80 295±26 215±27a 139±12ab <0.001 -53 : 0.96±0.08 0.77±0.09 0.63±0.05a 0.004 -34 
90 168±21 132±22 78±10a <0.001 -54 : 0.48±0.07 0.42±0.06 0.32±0.04 0.064 -33 
100 0 0 0   : 0 0 0   
Pmax§ 550±27 437±17a 330±18ab <0.001 -40 :      
%P0@pmax 38±1.1 35±0.9 33±0.6a <0.001 -13 :      
a/P0 0.0058 0.0084 0.012ab <0.001 +106 :      
 SOL  
0 (Vmax) 0 0 0 
 
 : 4.6±0.2 3.9±0.3 3.8±0.2 0.097 -17 
10 58±4 49±5 40±3a 0.006 -31 : 3.1±0.1 2.4±0.1a 2.4±0.1a 0.001 -23 
20 78±5 65±6 53±4a 0.003 -32 : 2.1±0.1 1.6±0.1a 1.6±0.1a <0.001 -24 
30 82±6 69±7 58±4a 0.006 -30 : 1.5±0.1 1.2±0.05a 1.2±0.07a 0.001 -20 
40 81±6 69±6a 51±5a 0.001 -38 : 1.1±0.04 0.8±0.04a 0.8±0.05a 0.001 -27 
60 66±5 51±4 43±3a 0.001 -35 : 0.6±0.02 0.4±0.02a 0.4±0.02a <0.001 -33 
80 38±4 27±3a 24±2a 0.001 -37 : 0.3±0.04 0.2±0.02a 0.2±0.01a 0.002 -33 
90 23±4 15±2 14±1a 0.020 -39 : 0.13±0.02 0.09±0.01 0.09±0.01 0.081 -31 
100 0 0 0   : 0 0 0   
Pmax§ 81±6 70±7 58±4a 0.008 -28 :      
%P0@pmax 31±0.3 29±0.9 29±0.3 0.266 -6 :      
a/P0 0.021 0.024 0.027 0.067 +29 :      
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Adult 
 
Old 
 
 
Elderly 
 
p-value 
EDL 
mean age 
 
6.8±0.1 23.0±0.4 29.9±0.3 
 body 
  
31.7±0.
 
37.1±1.6
 
32.7±0.7   0.006 
mass (mg) 15.4±3.
 
13.4±1.8 11.5±2.3
 
<0.001 
PCSA 
2  
1.23±0.
 
1.02±0.1
 
0.9±0.22
 
<0.001 
P0 (mN) 388±17 356±16a 279±13a,
 
<0.001 
SOL 
mean age 
 
7.0±0.0
 
23.3±0.5 29.9±0.3 
 body 
  
31.1±0.
 
41.5±3.0
 
32.7±0.7
 
<0.001 
mass (mg) 14.0±1.
 
12.2±0.4 11.9±0.6   0.197 
PCSA 
2  
1.16±0.
 
1.04±0.0
 
1.03±0.0
 
  0.431 
P0 (mN) 187±10 195±13 166±7   0.059 
 
Table 2 Animal Characteristics for EDL (n=53) and SOL (n=47) Groups Adult mice (EDL 
n=15, SOL n=12) were used as the reference group to the old (EDL n=14, SOL n=12) and elderly 
(EDL n=24, SOL=23). P-value was taken from one-way ANOVA (Tukey’s HSD post hoc test). 
PCSA= physiological cross-sectional area of muscle. P0= maximum tetanic contractile force. 
Symbols: a=different than adult, b=different than old (p<0.05) marked only on old and elderly. 
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Figure 1 Velocity Declines with Age a) EDL Force-Velocity Curve b) Linear Regression of 
EDL velocity at 60%P0 See Figure S1 in the supplement for the other velocities. c) SOL Force-
Velocity Curve d) Linear Regression of SOL velocity at 60%P0. See Figure S2 in the 
supplement for the other velocities. See Table 2 and Text for post-hoc analysis. Each symbol in b 
and d (diamonds) in the regression graphs represents a measurement from an individual mouse 
at the given age. Equation: simple linear regression of velocity (y) as a function of age (x). * = 
p<0.05; p-value from One-Way ANOVA. fl/s= fiber length per second. %P0 = percentage of 
maximum isometric force. Age=age in months. 
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Figure 2 EDL Velocity and Power at Heavier Loads Show Increased Age-Related Rate of 
Decline a) Velocity b) Power Equation: simple linear regression of %reduction in velocity and 
power of elderly mice (in comparison to adult mice) as a function of load (%P0). Light loads (10-
40%P0) are represented by diamonds with a dashed regression line and heavy loads (40-90%P0) 
are represented by circles and a solid regression line. 40% P0 is the inflection point indicating 
where the slope changes and as such the point is included in both sections of the graph. * = 
slope of line significantly different, p=0.003 and p<0.001 for velocity and power, respectively. 
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Figure 3 Force-Velocity Curve Alters with Age: a/P0 Increases with Age a) EDL b) SOL 
Equation is a simple linear regression of a/P0, which describes the shape of the force-velocity 
curve, with respect to age of the mouse in months. Each symbol represents the a/P0 of one 
mouse. 
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Figure 4 Power Declines with Age a) EDL b) Linear Regression of EDL power at 60%P0. 
See Figure 4 for Pmax and Figure S3 in the supplement for the other regressions. c) SOL d) 
Linear Regression of SOL power at 80%P0 See Figure S4 in the supplement for the other 
regressions. See Table 2 and Text for post-hoc analysis. Each symbol in b and d (diamonds) in 
the regression graphs represents a measurement from an individual mouse at the given age. 
Equation: simple linear regression of power (y) as a function of age (x). * = p<0.05, p-value from 
one-way ANOVA. mN * fl/s= milliNewtons multiplied by fiber lengths per second. %P0 = 
percentage of maximum isometric force. Age= age in months. 
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Figure 5 Further Percent Reduction in Power as %P0 Increases, Comparing Elderly to 
Adult. a) EDL There was a -0.26 percent reduction in power per unit increase in load (%P0, 
percentage of maximum force at which power was derived)(R=0.993). b) SOL There was a 
percentage decrease of -0.10 (R=0.810) in power, per unit increase in in %P0. Each diamond 
represents the difference between the mean power production of the entire adult group compared 
to the entire elderly group). Equation = simple linear regression of percent change in power from 
adult to elderly (y) as a function of %P0. 
  
132 
 
 
Figure 6 
 
 
 
Figure 6 EDL Contraction time to Maximum Force Increases with Age Equation is a simple 
linear regression of time to maximum force is seconds with respect to age of the mouse in 
months. Each symbol represents the contraction time of one mouse. 
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Online Resource 1 
APPENDIX: Relationships between Force, Velocity, and Maximum Power 
In order to evaluate the relationship between velocity, force and maximum power, 
we examined simple and multiple linear regressions to determine how much 
variability is explained by each component of power [P0, velocity, and 
incorporating %P0@Pmax (the percentage of maximum force where the muscle 
produced maximum power) and age to hierarchical multiple regression analysis]. 
In the EDL, P0 explained 58% of the individual variability in Pmax (P0 + age, 66%).  
At 30%P0 the velocity of contraction explained 23% of Pmax (velocity + age, 49%), 
and when the two components (P0 and velocity at 30% P0) were combined 73% 
of Pmax variability was explained. Adding a third component, age, 75% of the 
variability in Pmax was explained. In the SOL, the P0 explains 59% of the 
individual variability (P0 + age, not significantly different). At 20%P0 the velocity of 
contraction explains 50% of the variability (velocity + age, no difference), and 
when combining the two components, 83% is explained (adding age yields 84% 
of the variability). (Online Resource 2, Figure S5)  
 
For simplicities sake, we will use the convention of V30 to represent velocity (v) 
as measured at 30% of P0 (30). Simple linear regression demonstrated a strong 
positive correlation, as would be expected, of EDL Pmax with P0 [R=0.79, 
r2=0.630, p-value<.001; equation: Pmax (mN*fl/s) = -33.48 + 1.36 * P0]; as well 
as with contractile velocity at 30%P0 [R=0.51, r2=0.260, p<.001; equation: Pmax 
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(mN*fl/s) = -0.90 + 102.43 * v30]. (Online Resource 2, Figure S5) We 
performed a factor analysis (promax rotation) to determine which of the collected 
outcome variables contributed most to the variability in the system (overall 
model). The results of our factor analysis yielded that P0, v30, v40 and v60 were 
the main sources of variability in Pmax. Interestingly, the only velocity that was not 
significantly correlated with the EDL Pmax was Vmax.  
 
After analyzing the velocities separately (Online Resource 2, Figure S1), v30 
was selected to be used in the multiple regression analysis and the combination 
of P0 and v30 explained 79% of the variability in the observed Pmax (R=0.853, 
r2=0.728, p<.001; equation: Pmax (mN*fl/s) = -316.33 + 1.22 * P0 + 77.8 * v30]). 
%P0@Pmax was correlated with Pmax (R=0.398, r2=0.159, p=.001), but did not 
significantly add information when combined with the above multiple regression 
(R=0.891). When age was incorporated into the model (multiple regression of 
Pmax with P0, V30 and age of mouse); however, the r2 was increased to 0.749 
(coefficient significance p=.032). %P0@Pmax was correlated with Pmax (R=0.398, 
r2=0.159, p=0.001), but did not significantly add information when combined to 
the multiple regression. 
 
Pmax in the SOL followed a similar pattern. Regression of Pmax with P0 (R=0.762, 
r2=.577, p<.001; equation: Pmax (mN*fl/s) = -17.65 + 0.46 * P0]; as well as with 
contractile velocity at v20 [R=0.714, r2=0.501, p<.001; equation: Pmax (mN*fl/s) = -
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13.78 + 46.78 * v20] showed strong correlations. A principle component factor 
analysis revealed that the top 4 factors, in descending order of R-values (in 
parenthesis), correlating to the Pmax in the SOL were: P0 (0.762), v20 (0.714), 
Vmax (0.71) and v30 (0.637). The most explanatory/predictive equation was 
derived from a regression of Pmax with P0 and v20 [R=0.915, r2=0.837, p<.001; 
equation: Pmax (mN*fl/s) = -58.412 + 0.359 * P0 + 34.842 * v30]. In the SOL, the 
%P0@Pmax was not significantly correlated with Pmax. 
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Figure S1 EDL Loaded Velocity Declined with Age. There was a significant negative correlation between 
velocity and age at the measured loads (20-90%P0). Vmax, however, (which was non-physiological and 
represented what velocity would be if a muscle was completely unloaded) did not change in a linear manner 
over the lifespan. Each diamond represents a measurement from an individual mouse. Age: Age of mouse 
in months. Equation: simple linear regression of velocity (y) as a function of age (x). fl/s = fiber lengths per 
second. x% P0 = percentage of maximum tetanic force when the velocity measurement was taken. Maximum 
Velocity: Vmax, maximum unloaded velocity. 
Online Resource 2  
Supplemental Figures S1-S7 
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Figure S2 SOL Loaded Velocity Declined with Age. There was a significant negative correlation between 
velocity and age at the measured loads (10-90%P0). Vmax (which was non-physiological and represented 
what velocity would be if a muscle was completely unloaded) did not change in a significant linear manner 
over the lifespan. Each diamond represents a measurement from an individual mouse. Age: Age of mouse 
in months. Equation: simple linear regression of velocity (y) as a function of age (x). fl/s = fiber lengths per 
second. x% P0 = percentage of maximum tetanic force when the velocity measurement was taken. Maximum 
Velocity: Vmax, maximum unloaded velocity. 
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Figure S3 EDL Power Declined with Age. There was a significant negative linear correlation between 
power production and age at the measured loads (10-90%P0) and at Pmax (maximum power). x% P0= “x” 
percentage of maximum tetanic force when the power measurement was derived. Each diamond represents 
a measurement from an individual mouse. Power measured in milliNewtons * fiber lengths per second (mN * 
fl/s). Age: age of mouse in months. Equation: simple linear regression of power (y) as a function of age (x).  
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Figure S4 SOL Power Production Declined with Age. There was a significant negative correlation 
between power and age at the measured loads (10-90%P0) and at Pmax. Power measured in milliNewtons * 
fiber lengths per sec (mN*fl/sec). x% P0= “x” percentage of maximum tetanic force when the power 
measurement was derived. Each diamond represents a measurement from an individual mouse. Age: age of 
mouse in months. Equation: simple linear regression of power (y) as a function of age (x).  
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Figure S5 Relationship of Pmax, P0 and Velocity. In both the EDL and SOL, Pmax (maximum power) and 
P0 (maximum tetanic force) (R=0.79 and 0.76, respectively, both p<0.001), and Pmax and Velocity (R=0.51 
and 0.71, both p<0.001) were correlated. In the EDL, Pmax and Vmax (maximum unloaded velocity) were not 
related. However, there was a significant correlation (R=0.71) between SOL Vmax and Pmax. Pmax measured 
in milliNewtons * fiber lengths per second (mN * fl/s) and velocity measured in fiber lengths per second (fl/s). 
Each symbol (diamond for EDL and circle for SOL) represents measurements taken from one mouse. 
Equation is of a simple linear regression of Pmax (y) being a function of the x-axis variable (P0, velocity x% of 
P0, or Vmax). x% P0 = “x” percentage of maximum force when measurement was taken. 
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Figure S6 MHC Composition with Age. A. Representative Gel Image. Silverstained 5% Acrylamide large 
format gel. B. EDL Expression of MHC2/ax increased by 6% in older (21%, n=25, mean age=28 months, 
p=0.009) compared to adult mice (15%, n=18, mean age=7 months) using Student’s t-test, implying a shift 
towards a slower isoform composition. Conversely, MHC2b expression is reduced by 6% with age (Adult 
85%, Old 79%, p=0.01). C. SOL There was no change in the SOL MHC expression profile (Adult: MHC2ax 
62%, MHC1 37%, n=15, mean age=7.8 months; Older: MHC2ax 61%, MHC1 39%, n=18, mean age=27.8). 
Each lane represents whole homogenized muscle of one mouse at the age listed on top. Age: age in months 
of mouse. STD DIA: standard from rat diaphragm (proteins identified using mass spectrometry). 
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Figure S7 MLC3f Percentage Decreased 21% with Age in EDL. A. Representative Gel Image. Silver-
stained 12% Acrylamide large format gel. B. EDL There was a 21% decline in MLC3f with age.  C. SOL 
There was no change in MLC3f. Adult group (EDL, 31% MLC3f, n=19, mean age=7.5; SOL % MLC3f, n=18, 
mean age=7.4) was compared to combined old/elderly group, Older (EDL, 24% MLC3f, n=23, mean age 
=27.9; SOL, % MLC3f, n=22, mean age=27.8) using Student’s t-test (EDL, p=0.03; SOL p=0.20). Each lane 
represents whole homogenized permeabalized muscle of one mouse at the age listed on top. Age= age in 
months of mouse. STD TA: rat tibialis anterior standard. STD SOL: rat SOL standard. Standard proteins 
identified via mass spectrometry. MLC (myosin light chain) is shown with three essential light chain isoforms 
(1s, 1f, 3f) and 2 two regulatory light chain isoforms (2s, 2f). s = slow. f = fast .Number in base of columns in 
chart equals average percentage of MLC3f out of total. Note: %MLC3f is out of the total of fast MLC [MLC3f 
/ (MLC1f+MLC3f)], in SOL MLC1s was not counted. 
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Interlude 2  Resistance Training to Improve Neuromotor 
and Contractile Function 
 
Age-related muscle dysfunction is evident in both humans and mice (Chapters 1-
3). Specifically in Chapters 2 and 3, with a comprehensive analysis of functional 
performance and muscle contractility we established an evident age-related 
decline in ability in the C57BL6 mouse. For the first time, age-related contractile 
dysfunction was demonstrated to manifest to a greater extent when the muscles 
were contracting against heavier load (at higher percentages of P0) then at lighter 
loads.  
 
Resistance training is an accepted treatment for sarcopenia, resulting in the 
improvement of strength, muscle mass and functional ability (explained in detail 
in Chapter 1). To the best of our knowledge, there is no model of voluntary 
resistance training for mice based upon human principles of weight lifting. We 
therefore provided the scientific community with a mouse model mimetic of 
human weight training, as would be performed in the gymnasium.  
 
Chapter 4 highlights this voluntary resistance training protocol for the mouse. We 
selected a comprehensive set of outcome measures. The tests were designed to 
determine if the mice would adapt as humans would if undergoing a similar 
exercise program. If the preponderance of evidence pointed to these positive 
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adaptations being made, we considered the protocol to be a valid mimetic of 
weight training. The validated model will be valuable for pre-clinical investigation 
of the synergistic effects of other treatments (e.g. pharmaceutical, nutritional, 
hormonal) with resistance training, and for mechanistic investigations of basic 
exercise biology. 
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Abstract  
 
The current hypertrophy models used to investigate cellular mechanisms in mice 
are less representative of voluntary human weight (resistance) training. Thus, the 
main purpose of this study was to establish a mouse model that mimics human 
weight training. This model has wide application to study not only exercise 
biology, but also to investigate the efficacy and mechanisms of resistance 
exercise as an intervention for conditions such as sarcopenia.  
 
Male C57BL/6 mice (12 months of age at study conclusion) were randomly 
separated into control (n=9) and trained groups (n=6). The trained group used 
progressive resistance (via a weight harness) and intensity (~4-10 RPM) on a 
custom motorized running wheel (possible speed from 1-10 RPM). The mice 
trained on a voluntary program similar to a human beginning workout regimen (4-
5 sets/session, 3 sessions/week, for 12 weeks). 
 
The trained mice demonstrated muscle hypertrophy (soleus mass and plantaris 
muscle fiber area), increased soleus force/power production (in vitro contractile 
physiology), and improvement in markers of training physiology (force and power 
output per session) and overall neuromuscular function (rotarod). The model 
produced results in the mice similar to what would be expected after humans 
engaged in a period of weight training, thus, this validated protocol has the 
potential to serve as a valuable tool for future pre-clinical and mechanistic 
investigations. 
 
 
Keywords:  Resistance Training, Mice, Exercise Physiology, Muscle 
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INTRODUCTION 
 
In order to evaluate the efficacy and safety of novel interventions and their 
synergistic effects with weight training prior to clinical testing in humans, an 
animal model of voluntary resistance training is needed. While some models of 
resistance training do exist in the rat such as: a squat rack mimic device, first 
characterized by Tamaki and colleagues (Tamaki, 1992; Krisan, 2004; 
Drummond, 2009), a weighted backpack and standing model  (Farrell, 1999; 
Flukey, 1995) or the tail weight ladder climb (Deschenes, 2000), they are not fully 
voluntary as participation is induced via operant condition (punishment 
avoidance) in the squat and backpack models with an electric shock to either the 
tail or the feet, respectively, or in the ladder climb with a spray of cold water. 
Other research has used food reward as an alternative to punishment for 
conditioning, but in these models the rats must be food restricted in order to 
induce hunger (Wirth, 2003), which involves its own external stressors. 
Therefore, the need exists for a mouse model that closely approximates human 
weight-lifting exercise, is voluntary, and follows physiological principles. 
  
To our knowledge, no representative mouse models of voluntary and 
physiological progressive weight training exist. However, there are models of 
hypertrophy (Always, 2005; Cholewa, 2014), such as synergistic ablation 
(Timson, 1985) or electrical stimulation (Ryan, 2010). Available mouse models of 
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hypertrophy are not fully ‘translational’ as models of voluntary resistance training 
because an optimal translational model follows principles of biomechanics, nerve 
and muscle physiology, and mimics voluntary human training.  
 
The C57BL/6 inbred mouse model is used extensively in research. The mouse 
has numerous advantages as a model organism including: 1) being a tractable 
model (Martin, 2011) with numerous transgenic models readily available for 
study, as well as the ability to produce novel genetic knock-outs and knock-ins 
(Yuan, 2011; Wurst, 2006), 2) having a relatively shorter lifespan (~3 years) that 
allows improved capacity to perform longitudinal aging studies, 3) a much lower 
price point in comparison to other mammalian models, both in initial cost and in 
per diem housing and husbandry (therefore allowing for a larger number of 
subjects per study, increasing the robustness of the results), and 4) are close 
genetically to humans (99% shared genome) (Bobuski, 2002). 
 
The main purpose of this study was to produce a mouse exercise protocol that 
mimics human weight training as would be performed in the gymnasium. We 
hypothesized that the effect of this training protocol would be to improve the 
physiology/morphology of the mice similarly to how a human would be improved 
after undergoing a training study based upon the same training principles. To test 
this hypothesis, we developed and constructed custom equipment (Figure 1), 
designed the protocol based upon basic human principles of weight training (see 
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Table 1 and Figure 2), and selected the following outcome measurements to 
assess adaptation: muscle hypertrophy (soleus muscle wet mass and plantaris 
muscle cell size), soleus muscle contractility (in vitro force, velocity and power), 
measurements of training performance adaptations (force, work and power 
output per training session, and correlations with muscle cell size), and animal 
performance (rotarod and inverted cling grip test). The successful validated 
protocol will serve in future investigations as a pre-clinical model of voluntary 
resistance training intervention.  
 
Important areas of research that will benefit from a mouse model of voluntary 
resistance training are aging muscle biology, sarcopenia, and frailty (Marzetti, 
2006; Sundell, 2011; Rolland, 2008; Breen, 2011; Janssen, 2002). Progressive 
resistance training, weight lifting as the gold standard, is an accepted treatment 
that slows the progression of sarcopenia (Marini, 2008; Fiaterone, 1990; Pillard, 
2011). In humans of any age resistance exercise reduces age-related muscle 
fiber apoptosis (Marzetti, 2006), induces gains in strength and muscle mass 
(Marzetti, 2006), improves functional outcome measurements and confers 
positive metabolic changes (Marini, 2008; Capodaglio, 2007; Fiaterone, 1990). 
While the strategy of resistance training has benefits, it does not totally reverse 
sarcopenia. Research has been conducted in other effective strategies such as 
protein or branch chain amino acid supplementation (Churchward-Venne, 2012; 
Dickinson, 2014; Walker, 2011).Therefore, it is likely that effective treatments for 
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sarcopenia in the 21st century will involve the synergy of multiple interventions 
(e.g., exercise, nutrition, pharmaceutical, and ergogenic) (Breen, 2011; Candow, 
2011, Walrand, 2011). The mouse model of resistance training will be a valuable 
resource for researchers to investigate both mechanisms of exercise response 
and to evaluate the efficacy of nutritional supplements, pharmaceuticals and 
ergogenic aids in conjunction with resistance training (Cholewa, 2014). 
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METHODOLOGY 
Animal Model 
C57BL/6 male mice from the NIA Aging Colony (adults, 12 months old=100% 
survival) were randomly selected to control (n=9) or exercise groups (n=6) and 
treated in accordance with approved IACUC protocol. The mice were group 
housed with 12-hour light cycle at 22°C and fed ad libitum. Mice were weighed 
(massed) before and after the training period and BMI (body mass index) was 
calculated as mass (g) / length (cm). 
 
Training Equipment and Protocol 
The main purpose of the study was to validate a resistance training protocol for 
mice that mimicked human weight training as would be performed in a 
gymnasium, specifically the effect of human weightlifting exercises such as the 
“farmer’s walk” or the “walking lunge”. Two critical pieces of equipment were 
custom-designed and fabricated (Figure 1). The first was a powered running 
wheel engineered by mounting a steel caged-in 11-inch running wheel to a rotary 
electric motor with a speed controller capable of rotating from 1-10 revolutions 
per minute (rpm). The second indispensable piece of equipment was a small 
Velcro weight harness to which small weights were applied. The mice adapted to 
the weighted harness and the powered running wheel. Principles of weight 
training were incorporated into the program: progressive resistance/intensity 
(ACSM, 2009; Kraemer, 2004), training frequency (ACSM, 2009), number of sets 
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per day (ACSM, 2009, Krieger, 2009), warm-up sets (ACSM, 2009), set duration 
(Toigo, 2006), and rest between sets (ACSM, 2009; de Salles, 2009). The 
program was designed to be similar in scope to a typical human weight training 
study or exercise program for beginners (ACSM, 2009; de Salles, 2009; Bird, 
2005; Kraemer, 2004; Schoenfeld, 2010; Schoenfeld, 2011). Principles involved 
in designing the training protocol for the mice are found in Table 1. 
 
Figure 2 describes the overall research design and time course in detail. In week 
one the mice underwent baseline testing for functional performance (rotarod and 
grip test). Following functional testing, the mice went through two different 
training periods, 1) acclimation training and 2) weight training. Acclimation 
training introduces both the weight harness and running wheel, and the mice are 
trained to use the equipment.  
 
Acclimation training 
In the first session of acclimation training, the mice underwent “scruff” training 
(scruffing being the standard method of picking up and controlling a mouse by 
firmly grasping the skin around the neck/front shoulders) where the mice were 
individually “scruffed” (held for approximately 5), 3 times in succession (about 30 
seconds between trials). The goal was to allow the mice to become accustomed 
to being handled and scruffed, because in the beginning of training mice often 
needed to be scruffed to administer the weight harness.  
153 
 
 
 
In the second session, the mice were introduced to the running wheel. The 
running wheel was set at a low speed (4rpm) and they quickly learned to walk on 
the wheel. Note, mice seem to innately/instinctively understand the running 
wheel concept and it is not difficult for them to master, even mice encountering a 
wheel in the wild will use one (40). Next, during the following training session, the 
mice were trained to accept the weight harness. In order to have a mouse accept 
the weight harness successfully, a modified single banded harness with no 
weights was placed over their shoulders and then removed after a short period 
(~5sec). This step is repeated 3 times during the training session. 
 
In the next training session, the harness (without weights) was placed on the 
mouse and the mouse was put into the powered running wheel (4 rpm) for 30 
seconds. Once again, this step was repeated 3 times. On the last day of 
acclimation training the mice wore the harness with a light weight (3.2g) and 
were then placed in the wheel for 3 repetitions of 30 seconds at 4 rpm. This last 
day of acclimation training was also the first session of the weight training 
described below. 
 
Weight Training 
In the weight training, the mice initially worked for the first week with the very light 
weight (3.2g). After the third day of using 3.2g, the mice were introduced to the 
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double-banded harness (Figure 1A) that was used throughout the remainder of 
the training. During this session the weight in the harness was increased to 4.5 
grams.  At this stage of the training, the weights placed in the harness increased 
10-15% every 3rd to 5th session (depending upon the progression of the mice 
cohort) with the goal of carrying ~50% body mass in the harness at the end of the 
study.  
 
Importantly, the intensity of the exercise was individualized such that the mice 
ran on the wheel at variable speeds according to their progression (4-10 rpm). 
The optimal goal for each set was to have the mouse “fail” at less than 60 
seconds (~30 to no more than 75sec) by increasing the rpm. Because the 
training was individualized the time, distance, and weight were recorded for each 
set during every training session. 
 
Failure 
Failure was defined in 3 ways: 1) the mouse was incapable of maintaining the 
rpm. The inability to maintain the velocity resulted in the vertical position of the 
mouse at the back of the wheel. 2) The mouse stumbled 3 times.  3) The mouse 
refused to run and grasped the grid of the wheel or threw off the harness (note, 
the mice participate voluntarily and can refuse to participate). The first time the 
vertical position of the mouse was observed, the mouse grasped the grid or the 
mouse stumbled (first and second time) the rpm was adjusted to a lower setting. 
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If the vertical position was observed a second time or the mouse stumbled a 3rd 
time, the set was considered complete (went to failure). 
 
Noncompliance 
A mouse was considered noncompliant when he refused to run or removed his 
harness. A mouse was given 3 opportunities to participate successfully in the 
specific training session. If not successful, the mouse was excused. As a result of 
this voluntary aspect of the training, if a mouse needed extra time to rest or to 
heal from a minor injury, it could refuse to train for a session without 
consequence to the study. If a mouse were to refuse to perform for 3 consecutive 
sessions, it would be removed from the study. No mice had to be removed from 
the study for repetitive noncompliance. 
 
Outcome Measurements 
Tissue and Cellular Response to Training 
Muscle Function- Contractility 
In vitro contractile physiology has been previously published (Graber, 2013). In 
brief: The soleus (SOL) and extensor digitorum longus (EDL) were isolated and 
perfused with 95% O2/5% CO2 in heated (25°C) Krebs solution. The muscle was 
tied to a force transducer (Aurora 300b) with 4-gauge silk suture attached at 
either myotendinous junction and suspended between two platinum electrodes. 
Using an Aurora High Power Bi-Phase Current Stimulator and a Dual-System 
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Signal Interface controlled by DMC (v.4.1.6), the muscles were stimulated in 
various protocols to examine peak twitch force (Pt), optimal length (L0), pre-load 
tension, maximum isometric contractile force (P0), and force/max force (P/ P0) 
from 10 Hz to 180 Hz stimulus frequency. After P0 was determined, the load 
clamp technique was used to determine velocity of contraction. The force 
transducer was set at various percentages of P0 (10%-90%) and the muscle was 
set to L0 and maximally stimulated at the frequency determined to produce P0. 
Upon producing enough force to overcome the set load (clamped at 10-90% P0), 
the muscle concentrically contracted against the load. Velocity of contraction was 
determined by finding the first derivative of the time-distance curve derived from 
the muscle contraction. Maximum unloaded velocity was calculated using a 
derivation of the Hill Equation [(V+b)(P/P0 ± a/P0 )= b(1+a/P0), a and b are 
constants, V = max. velocity at fractional load] (9). The data was curve fit (only 
r2>0.98) using MatLab. Data presented here only reflects the determination of 
SOL contractile parameters. 
 
Muscle Hypertrophy 
Soleus Wet Mass 
After in vitro physiology the soleus was blotted dry and massed. We determined 
physiological cross-sectional area (PCSA) with the average density of skeletal 
muscle by using the standard formula: PCSA (cm2) = Muscle mass (g) / [L0 (cm) * 
1.06 (g/cm3)]. 
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Fiber Size-Histochemistry of Plantaris Muscle 
These methods have been previously published (Graber, 2014). In brief: A 
subset of plantaris muscles was flash-frozen in isopentane, then liquid nitrogen. 
10 micron sections were sliced as cross-sections on a cryostat and subsequently 
stained with hematoxylin and eosin (H&E). The sections were imaged with a 
microscope and then the perimeter of each fiber was circled using ImageJ to 
determine cross-sectional area. 
 
Anabolic Signaling 
Western Blotting technique was used to probe for the relative abundance in the 
level of phosphorylation in Akt (at the threonine 308 and the serine 473 sites) and 
in p70s6k (at the threonine 389 site). A brief description of the procedure follows. 
 
Sample Preparation 
The muscle (quadriceps femoris) was removed from the mouse while under deep 
anesthesia and instantly frozen in liquid nitrogen, then stored at -80° C. 
Homogenization was done by cutting an approximately 0.02 g piece of muscle, 
massing it, dicing it into 1 mm cubes and then putting it in a chilled glass 
homogenization tube. The ice cold Mueller buffer (consisting of ultra-purified 
H2O, 0.05 M HEPES (pH 7.4), 0.1% V/V Triton-X 100, 0.004 M EGTA (pH 8.0), 
0.01 M EDTA (pH 8.0), 0.015 M Na4P2O7, 0.1M β-glycerophosphate (β-
glycerophosphate disodium salt hydrate), 0.025 M NaF, 0.005 Na3VO4 (sodium 
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orthovanadate), 0.002 M PMSF (phenylmethanesulfonyl fluoride), 5 µg/µl 
leupeptin, 1 µg/µl pepstatin, 5 µg/µl aprotinin) was then added to the tube at a 
concentration of 100 µl of buffer / 100 µg of muscle tissue. The tissue was then 
homogenized, while kept in ice, using a low speed (300 RPM) for a total of 1 
minute (forward at 70, 80 and 90% speed for 10 seconds each and then switch to 
reverse at 70, 80 and 90% speed for 10 seconds each). The supernatant was 
then carefully transferred to an Eppendorf tube, kept ice-cold at all times and 
then centrifuged 10 minutes at 10000 rpm at 4°C. The supernatant was then 
collected (avoiding any floating fat and without disturbing the pellet), measured 
and put into a second tube (retaining the pellet fraction as well). The chilled 
diluent buffer (consisting of 50% V/V glycerol, 0.05 M Na4PO7, 0.0025 M EGTA 
(pH 8.0), 0.001 M β-glycerophosphate, 0.002 M PMSF, 5 µg/µl leupeptin, 1 µg/µl 
pepstatin, 5 µg/µl aprotinin) was then added at a concentration of ½ the volume 
of supernatant obtained. The resulting mixture was then vortexed for 10 seconds 
on high, centrifuged for 5 seconds at 2000 RPM and stored at -80° C. Protein 
concentration was determined with the bicinchoninic acid method using the kit 
(product # 23225) from ThermoScientific, Rockford IL. 
 
Western Blotting 
For the Akt, electrophoresis was run on 10% acrylamide gels with a protein load 
of 22 µg on a minigel system (Hoefer SE250, Holliston MA) at 200 mV for 
approximately 1.5 hours using a water cooling system set at 12°C and standard 
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Laemli buffer. The same blot control sample was added in the last lane on every 
gel. Positive and negative controls were (#9273, Cell Signaling Technology, 
Danvers, MA) and the molecular weight ladder was Kaleidoscope (Biorad). The 
gel was then transferred to a PVDF membrane blot using a Biorad semidry 
transfer system (#170-3940), set at 14V for 24 minutes with Bjerrum and 
Schafer-Nielsen transfer buffer (pH 9.2 , ultrapure H2O, 48 mM Tris, 39 mM 
glycine, 1.3 mM SDS, 20% V/V methanol). The blots were blocked in 5% dry 
milk/TBS-T for 1 hour at room temperature (RT), and washing steps (4x 5 
minutes at RT) used TBS-T. The blots were incubated with the primary antibody 
dilution in sealed baggies on a rotator at 4°C overnight. The next day the blots 
were washed again and incubated for 1 hour at room temperature with the 
secondary antibody (goat anti-rabbit IgG, Cell Signaling Technology #7074s, 
1:1000 dilution in 5% BSA/TBS-T with1% goat serum). The blots were washed 
again, the substrate was applied (Western Dura-Signal Plus, ThermoScientific) 
for 5 minutes, and were imaged on a Biorad Chemidoc XRS. The images were 
then analyzed for densitometry using QuantityOne software (BioRad).  
 
Each blot was first probed with the phosphorylated antibody and then the same 
blot was stripped and re-probed with the Akt antibody. The blot was then re-
stripped and re-probed for lane control with a GAPDH antibody. Antibodies and 
dilutions were: 1:500 p(THR308)-Akt, 1:1000 Akt, 1:5000 GAPDH (diluted in 5% 
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BSA/Tris Buffered Saline-0.1%Tween (TBS-T) (antibodies from Cell Signaling 
Technology: #2965, #9272, #14C10, respectively).  
 
The p(THR389)-p70S6K and the p70S6K blots were run in a similar fashion. The 
electrophoresis was performed using a Biorad running at V for 45 minutes. The 
antibodies were diluted 1:500, p-p70S6K and 1:1000 p70S6K, (Cell Signaling 
Technology, #9205, #9202, respectively). 
 
Whole Body Adaptations to Training 
Training Effect- Whole Body Training Physiology 
We tracked the individual performance of the mice over the training period. 
Training force, normalized training force, training power and normalized training 
power were all tracked through the duration of the study.  See Table 2 for 
definitions and calculation equations. 
 
Animal Functional Performance 
Animal performance measures are described in detail previously (Graber, 2013). 
Because the maximum ability of the mice is necessary to assess performance, 
we tested each mouse three times and then used the average of the two best 
scores as the outcome measurement (therefore excluding the worst time). In 
brief: 
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Rota-Rod tested overall motor function (balance, coordination, stamina, power) 
using the acceleration mode, from 4 RPM to 40 RPM over 5 minutes (Lsi Letica 
Rota-Rod R/S). The latency to fall from the device was recorded. Mice were 
acclimated to the device by doing random sessions 3x/day for 3 days prior to the 
testing day. 
 
Grip Test is an indicator of muscle strength and stamina, determined by the 
inverted cling grip test (custom testing device). The animal was placed on a wire 
grid lid and the lid was then closed to invert the mouse. The latency to fall from 
the lid (to the padded floor of the device 20 cm below) was recorded as the 
outcome measure. 
 
Statistics 
Data presented as means ± standard error, as appropriate. Repeated measures 
general linear model (compare within subject in the rotarod and grip test), 
Student’s t-tests (independent and paired), ANCOVA and linear regressions use 
α<0.05 as significant and α<0.10 as showing strong evidence to refute the null 
hypothesis and representing a trend. Least Significant Difference (t-test) used for 
post-hoc testing (only 2 groups). ANCOVA adjusted for body mass in grip test 
and rotarod. Pearson correlation used to determine relationship between 
variables. 2-sample Kolmogorov-Smirnov and the independent samples median 
test were used to compare distributions of plantaris muscle fiber cross-sectional 
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area. Symbols: “*” denotes p<0.05, significant and “#” denotes p<0.10, trend. IBM 
SPSS v20 used for statistical analysis.   
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RESULTS 
 
Tissue and Cellular Response to Training 
Muscle Function- Soleus Contractility 
Soleus (SOL) Maximum Isometric Force (mN, P0) and Normalized Force 
(P0/gbm) 
Although absolute P0 and P0 normalized to the cross sectional area of the muscle 
(P0/PCSA) were not different, the normalized force production in the exercise 
group (8.35 ± 0.34 mN/gbm) was 11% greater than the control group (7.55 ± 0.32 
mN/gbm) (T-test, p=0.097, Figure 3A).  
 
SOL Contractile Velocity 
The velocity of contraction in the exercise group was faster when measured while 
contracting against the higher percentages (higher loads) of P0 (60%P0, +17%, 
p=0.044; 80%P0, +36%, p=0.024; 90%P0, +44%, p=0.051).  An indicator of the 
shape of the force-velocity curve based on the Hill equation, a/P0, was 21% lower 
in the exercise group than in the control group (0.018±0.002 and 0.023±0.002 
respectively, p=0.055)(Figure 3B). 
 
SOL Power Production 
The shape of the force-power curve shifted to the right and up with exercise. With 
exercise, power production increased 39% at 80%P0 and 47% at 90%P0 
(p=0.019 and 0.048, respectively, Figure 5C), representing the upward shift. The 
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%P0 where peak power occurred increased by 7% with exercise (control 
27.3±0.6% and exercise 29.2±0.5%, p=0.045), representing the rightward shift. 
Although the %P0 where peak power occurred increased, Pmax was not 
statistically increased with exercise (exercise, 97.7±10.5 mN*fl/s, and control, 
89.1±4.7 mN*fl/s, p=0.47). (Figure 3C) 
 
Muscle Hypertrophy 
SOL Wet Mass (Figure 4A) 
The mean SOL muscle mass of the exercise group (14.5 ± 0.8 mg) was 15% 
larger (p=0.019) than the control group (12.6 ± 0.7 mg). When the SOL was 
normalized to the size (end point body mass) of the animal, the exercise group 
(0.39 mg/gbm) was 26% larger (p=0.004) than the control group (0.31 g/gbm). 
 
Fiber cross-sectional area of the Plantaris (Figure 4B) 
Single fiber cross-sectional area increased 4% with exercise (exercise: 2006.4 ± 
16.7 µm2, n=3175; control: 1933.7 ± 22.8 µm2, n=1762, T-test, p<0.001). A close 
analysis of the distribution of the cross-sectional areas revealed a rightward shift 
(2-sample Kolmogorov-Smirnov, p=0.001) with exercise, notably more large cells 
were present in the exercise group. Specifically, the median cell cross-sectional 
area in the exercise group (1920.5 µm2) was 7% larger than the control group 
(1793.0 µm2) (independent samples median test, p=0.002). 
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Anabolic Signaling: Akt and p70S6k 
The exercise group demonstrated an increase of 30% in phosphorylation of 
p70s6k (p-p70s6k) at the Threonine 389 position (p=0.059) when compared to 
the control group (Figure 5). The exercise group demonstrated no significant 
increase in phosphorylation of Akt at the Threonine 308 position (p=0.155) when 
compared to the control group (Figure 6). There was no significant change in the 
ratio of either p-p70s6k/p70s6k or p-Akt/Akt (data not shown). 
 
Whole Body Adaptations to Training 
Training Force (mN), Normalized Training Force (mN/gbm), Training Power 
(mW), and Normalized Training Power (mW/gbm):  
Training Force improved over the training sessions (Force = 4.56 * (training 
session) + 380.5, R=0.992, r2=0.984, p<0.001) (Figure 7A). Normalized Training 
Force also improved (Force = 0.126 * (training session) + 0.703, R=0.992, 
r2=0.984, p<0.001) (Figure 7B). Training Power (Power = 0.503 * (training 
session) + 34.9, R=0.936, r2=0.879, p=0.002) and Normalized Training Power 
(Normalized Power = 0.014 * (training session) + 0.963, R=0.937, r2=0.879, 
p=0.002) both increased over the training period. (Figures 7C, 7D).  
 
Mean Training force increased by 39.3% between session 3 (387.1 ± 9.6 mN) 
and session 31 (539.3 ± 9.6 mN), an increase of 152.2 ± 0.0002 mN (p<0.001). 
Likewise, mean normalized training force increased by 443% between session 3 
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(0.836 ± 0.021 mN/GBM) and session 31 (4.54 ± 0.12 mN/GBM), a difference of 
3.70 ± 0.094 mN/gbm (p<0.001). Mean training power increased by 30.5% 
between session 3 (38.0 ± 1.8 mW) and session 31 (49.6 ± 1.3 mW), a difference 
of 11.5 ± 1.7 mW (p<0.001). Mean normalized training power increased by 
23.4% from session 3 (1.05 ± 0.04 mW/gbm) to session 31 (1.37 ± 0.03 
mW/gbm), a difference of 0.322 ± 0.048 mW/gbm (p<0.001).  
 
Animal Functional Performance 
For the functional performance measures, 2x2 Repeated Measures ANCOVA (2 
groups, 2 times, pre- and post- intervention, time in seconds) and 1-way 
ANCOVA (mean % change), adjusted for body mass, were used for 
comparisons. 
 
Rotarod (overall neuromuscular performance, balance, coordination, 
stamina, power) 
The exercise mice increased function (%change) compared to the control group 
(p=0.031), adjusted for mass (Figure 8A). Notable, the control mice had reduced 
function in number of seconds prior to falling (-20%, p=0.037) whereas the 
exercise mice did not change significantly (+12%, p=0.573) (Figure 8B, repeated 
measures, adjusted for mass).  
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Inverted Cling Grip Test (overall muscle strength and stamina):  
The control mice lost 52% of grip function, but the exercise mice only lost 19% 
function. This represents a 212% reduction in ability in the control mice 
compared to the exercised mice. The changes, however, were not significantly 
different after adjusting for body mass (Figure 8C).  
 
The control mice lost functional ability, but ability was relatively preserved in the 
exercise group. In terms of seconds, the control mice (n=9) lost a mean of 143.8 
seconds (within group, p=0.006) compared to a 16.6 loss (within group, p=0.372) 
in the trained mice (n=6) (between groups, p=0.046) (repeated measures, Figure 
8D).  
 
The percentage difference between the grip test before and after the intervention 
period was correlated with both the mass of the mouse pre-intervention (from 
simple linear regression, p<0.001) and with the mass after intervention 
(p=0.023). Body mass was not correlated with grip test changes in seconds 
within subject (repeated measures).  
 
Animal Mass 
There was no change with the intervention in the relative proportion of mass 
between the control and exercise group. Specifically, at baseline, body mass was 
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significantly different between the two groups with the control mice being 8.4% 
heavier (p=0.037). The mean mass of the control after the intervention was 8.6% 
greater than the mass of the trained group, p=0.001. Within each group, there 
was a 25% change between the pre- and post-intervention (control p=0.001, 
trained p=0.003).  
 
There was a significant association of SOL muscle mass to body mass in both 
the trained group (R=0.796, p=0.029) and the control group (R=0.575, p=0.032).  
169 
 
 
DISCUSSION 
Current hypertrophy models used to investigate cellular mechanisms in mice are 
less representative of voluntary human weight (resistance) training. Thus, the 
main purpose of this study was to produce and validate a voluntary mouse 
exercise protocol that mimics human weight training as would be performed in 
the gymnasium. Weight training improves performance and physiological 
parameters including: muscle strength, endurance, power output, speed, 
balance, coordination, motor performance, and induces hypertrophy (Kraemer, 
2005; Kraemer, 2000). Thus, we hypothesized that many of these same 
adaptations would occur in our resistance trained mice, and, if so, would 
successfully validate the protocol as a mimic of human resistance exercise. 
 
This study had two main findings. 1) Positive results occurred after undergoing 
the resistance training protocol in most of the traditional outcome measurements 
of muscle hypertrophy, muscle force, velocity and power, increased anabolic 
signaling in the p70S6K pathway, gross neuromotor function (rotarod), and in the 
derived measurements of training physiology--training force and power, both 
absolute and normalized to body mass. 2) These results demonstrated the 
protocol is a mimic of human weight lifting, with both face and construct validity. 
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Training Specificity 
Training specificity refers to the actions of an exercise producing adaptations that 
facilitate functional improvement in activities similar to the exercise (Morrissey, 
1995). For example, in order to become better adapted for sprinting, practicing by 
running at a rapid pace induces more positive effects than would long-distance 
swimming. Specificity can also refer to the muscle groups targeted by an 
exercise. For example biceps curls activate, stimulate and induce plasticity in the 
biceps (arm flexor), but would do little or nothing to the gastrocnemius (plantar 
flexor). Hence, in the current study training specificity refers to the mode of 
exercise (running with a weighted pack), which muscles are influenced, and what 
functional changes would be expected to occur. Specifically, the outcome 
measures more closely related to the exercise modality were expected to have 
greater relative change after training (rotarod would improve more than the 
inverted cling grip test). The muscle groups used for plantar flexion 
(gastrocnemius complex consisting of the gastrocnemius, soleus and plantaris) 
or leg extension at the knee (quadriceps) would be the most affected muscles. 
Thus, within the limits of training specificity we expected to see evidence of 
improvement in the outcome measures we selected as an indication that our 
training protocol for mice was indeed a mimic of human weight training. 
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Tissue and Cellular Response to Training 
SOL in vitro Contractile Physiology (absolute strength and power 
production) 
The SOL improved in force output, velocity of contraction and power output, 
which is expected because as a plantar flexor, the SOL was directly activated 
during the exercise. These improvements have, of course, been reported in 
humans after resistance training (Pillard, 2011; Kraemer, 2000).  
 
The direct in vitro stimulation of the muscle is similar to a 1 rep maximum test in 
a human study because it is measuring the absolute strength of the muscle. 
Notably, the reported increases in velocity and power output occurred at the 
upper limits of the force-velocity and the force-power curves. These increases in 
ability to perform more difficult tasks (e.g. at higher percentages of maximum 
force) would be considered a hallmark of weight training programs, where one of 
the most important goals is to facilitate performance under increasingly heavy 
load. 
 
Hypertrophy (whole muscle and cellular): 
Muscle Size (SOL Mass) and Fiber Size (Plantaris) 
The exercise protocol resulted in both an increase in SOL muscle mass and 
single fiber hypertrophy in the Plantaris. This result was expected due to training 
specificity. Both muscles are plantar flexors and are activated by the exercise 
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modality. The muscle mass outcome measure represents an increase in all 
tissues within the muscle (muscle fibers, nerves, fat, connective tissue), whereas 
single fiber hypertrophy (the increase in muscle fiber cross-sectional area) 
reflects increases of only the sarcoplasm and contractile elements within the 
fibers. The increase in both muscle and fiber size is consistent with reported 
human studies of resistance exercise programs (Mitchell, 2013; McCall, 1996; 
Tesch, 1988).  
 
The fiber type composition of the muscle influenced the extent of hypertrophy. 
Type II fibers respond robustly to resistance training, whereas type I fibers 
typically hypertrophy to a much smaller extent (Tesch, 1988). In mice, the SOL is 
composed of both fiber types, approximately 60% type I (Burkholder, 1994). In 
spite of this large amount of type 1 fibers, there was a significant mass increase 
in the SOL with training in our current study. In contrast, while the soleus muscle 
in the rat also has both fiber types, the fiber type percentages are widely different 
(approximately 90% type I) (Armstrong, 1984). Hence, the literature on rat 
resistance training models report limited overall response in the SOL, 
presumably because of the larger percentage of relatively hypertrophy resistant 
type I fibers. In one example, weights were attached to a tail cuff and the rats 
climbed a ladder. This study failed to produce SOL hypertrophy at a significant 
level. However, when analyzed separately, the SOL type 2 fibers showed some 
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evidence (trend, p=0.09) of increased cross-sectional area after training 
(Deschenes, 2000).  
 
Anabolic Signaling Pathways 
In order to have muscle hypertrophy there must be an increase in anabolic 
signaling that initiates RNA translation and protein synthesis. The mTORc1 
pathway is central to regulating protein synthesis (Glass, 2010) and is 
responsible for phosphorylating p70S6K, which must be phosphorylated at the 
Threonine389 position for translation to occur. Measuring signaling pathways is a 
way to examine whether anabolic signaling was increased by exercise at the time 
point in which the sample was gathered (one to two days post-training). 
 
Indeed, the evidence of increased anabolic signaling (more overall 
phosphorylation of p70S6K) in the exercise group is consistent with basic 
biology--mTOR is stimulated by exercise to phosphorylate p70S6K, which 
downstream turns on protein translation (Hornberger, 2011; Baar, 1999). Training 
has been shown to result in increased p70S6K phosphorylation for up to 24 (in 
trained individuals) to 72 hours (in untrained people) after training (Drummond, 
2010). A resistance training model of the squat for rats found increases in 
p70S6K phosphorylation after an acute bout of training that was significant at 12 
hours, but not significant at 6 or 24 hours after the training session (Drummond, 
2010). 
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We found no change in the phosphorylation of Akt at the threonine 308 site, at 
least at the time point tested. A study of anabolic response to acute bouts of 
exercise in humans showed an increase in phosphorylated AKT (308) that 
occurred one hour post exercise (Dreyer, 2010). It is therefore quite possible that 
our samples were taken during a time point that simply missed this particular 
signaling cascade. Traditionally, activation of Akt at this site is thought to occur 
as a result of upstream activation of PI3K by growth factors (such as IGF-1) 
(Glass, 2010). Recent research has suggested that mechanical loading does not 
directly activate Akt via PI3k to phosphorylate mTOR to initiate transcription, but 
rather acts (via an as-of-yet unknown action) by upregulating diaglycerol kinase 
(DGKζ) to facilitate binding of phosphatidic acid (PA) to the mTORc1 complex 
(You, 2014; Zanchi, 2008). Mechanical stimuli circumvent Akt activation of mTor. 
Thus, not finding change in Akt activation, after resistance training, is not 
inconsistent with a training-induced anabolic state. Future investigations should 
investigate the DGKζ and PA connection to mechanically induced increases in 
protein synthesis, as well as to take samples closely following the exercise bout 
(within 3 hours), to establish if the timeframe of phosphorylation at the Akt 
threonine 308 site was simply missed. Additionally, since Akt is also 
phosphorylated at the serine 473 site (by mTORc2), this additional signaling 
event should be examined. 
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Thus, we conclude the basic signaling pathways investigated give evidence that 
the stimulus of the training protocol resulted in expected signaling outcomes 
(increased phosphorylation of p70S6K at the threonine 389 site, which is 
required for downstream translation initiation). More research into resistance 
training-induced signaling pathways is needed. We suggest, beyond investigating 
DGK and other anabolic components, the catabolic side of the protein synthesis 
equation be addressed by examining E3 ligases such as MURF1 to determine if 
there is a corresponding decrease in catabolic signals to complement the 
increase in anabolic signaling. 
 
Whole Body Adaptations to Training and Functional Performance 
Training Physiology (training induced changes in force and power) 
In order to assess whether the mice adapted positively in their ability to perform 
the exercise we recorded the weight used, distance moved, time and velocity of 
each mouse for every session. With this information we then calculated the force 
and power produced by the mice. Over time the mice were expected to gain 
increased ability, as their physiology adapted to the increasingly demanding 
exercise protocol. Indeed, we found that both training force and power increased 
over the sessions. These increases validated the ability of the training to 
stimulate responses in strength and power as would be expected after 
undertaking a weight training regimen. 
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Functional Performance 
Rotarod (overall neuromuscular motor function) 
We found that exercise increased rotarod ability. The rotarod tests multiple 
aspects of neuromotor and muscular function, and could be considered the 
equivalent of a human functional test. One such common functional test is the 
timed up and go (subject gets up from a chair and then moves a certain distance, 
with the outcome measure being the time elapsed) (Frenken, 2014), which would 
be expected to improve after an exercise regimen.  
 
Running on the powered running wheel with a weighted harness is similar to 
running on the rotarod (training specificity), and utilizes many of the same 
muscles. We therefore expected a positive adaptation from the training. 
Improvement of this outcome measure in the exercise group contributed to 
validating the ability of the training protocol to invoke expected positive change in 
balance, coordination, endurance, gait speed, and power production.  Resistance 
training in humans also shows improvement in these parameters (Kraemer, 
2000).  
 
Inverted Cling Grip Test (strength/endurance) 
This outcome parameter is similar to a human pull-up test in scope (Graber, 
2013). Based upon training specificity, we would not expect a large change in 
this parameter because the exercise, running with weights, is not similar to the 
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functional task, suspending upside down, and primarily stresses different muscle 
groups. The grip strength muscles were only partially activated during the motion 
of the exercise. In human terms, the situation is similar to training a group with 
push-ups and then testing them on pull-ups.  
 
There was also high individual variability in this measurement (coefficient of 
variation in the training group was 463). In comparison to the exercise group, the 
control mice had a higher mean level of ability at baseline, driven by a few very 
high performers. The control mice lost much more ability than the exercise mice. 
The exercise mice had a relative preservation of function. Therefore, this 
measurement demonstrated that there was a reduction in functional decline with 
training. Because a lower amount of positive change may have been 
experienced by the exercise mice because of the lack of training specificity of the 
exercise for the functional task, a similar result could be expected in a similarly 
conducted human study. 
 
In future studies, we suggest evaluating an additional grip test measurement. In 
this test the mouse is assessed for strength by having it grasp a trapeze-type bar 
attached to a force transducer and pulling it by its tail until it releases the bar 
(Aartsma, 2014; Smith, 1995). The maximum force when the mouse releases the 
bar is the outcome. It is possible that we may see less variation in the results 
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than in the inverted cling grip test because this measurement is less dependent 
upon body mass, although it does have a degree of user induced variability.  
 
Caveats to Consider 
In future work we propose the use of DEXA (dual-energy x-ray absorptiometry) to 
track body composition and bone mineral density as an additional outcome 
measure. We hypothesize that adjusting for lean body mass instead of total body 
mass will result in better estimation of muscle quality. In addition, the mice were 
not matched for body mass prior to initiating training. They were completely 
randomly selected to each group. In the future, prior to randomization and 
functional testing, matching by mass would be an improvement in study design. 
 
CONCLUSION 
We found that our resistance training protocol demonstrated evidence of 
improving many performance and physiological parameters including muscle 
strength, endurance, power output, speed, balance, coordination, motor 
performance, reduced loss of function in the grip test, and induced hypertrophy. 
The voluntary resistance training protocol for mice results in many of the same 
adaptations post-interventions that would be expected in a group of humans 
undergoing a training program designed with similar exercise principles 
(Kraemer, 2000; Kraemer, 2005). Thus, our strategy of using human principles of 
weight training to design our mouse protocol resulted in numerous expected 
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adaptations and supports that our objective of creating a mouse model mimetic 
of human weight training was successful. This validated protocol will serve a 
valuable future function in pre-clinical investigations and in basic science 
research surrounding resistance exercise adaptation. Our future direction will be 
to use this protocol on an aging mouse cohort to investigate its efficacy in the 
aged population and to discern if there is evidence of anabolic resistance to the 
stimulus in the elderly mice. 
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Table Captions 
 
Table 1 Training Principles used in Protocol 
 
Table 2 Training Physiology Definitions Units: mN=milliNewtons, 
g=acceleration due to gravity 9.8 meters/second, gbm=grams of body mass, 
mW=milliWatts, mJ=milliJoules  
 
 
Figure Captions 
 
Figure 1 Weight Training Apparatuses A. Weight Harness 3 main 
components: 1) padded elastic band, 2) Velcro strips connecting the bands, 3) 
lead weights that can be added in various combinations to increase resistance B. 
Powered Running Wheel 3 main components: 1) enclosed running wheel with 
door, 2) electric motor, 3) speed controller (1-10 rpm). 
 
Figure 2 Training Schedule Functional testing consists of rotarod and grip test. 
Acclimation Training starts in week 2 and consists of exposure to the running 
wheel and weight harness. The Training Period begins in week 4 and is 
individualized to the performance of each mouse, using progressive weight and 
intensity. Testing follows the training period and consists of post-intervention 
rotarod, grip test and muscle contractile physiology. 
 
Figure 3 SOL Muscle Function Improved in Trained Mice A. Soleus peak 
tetanic force per gram of body mass improved after exercise. B. Contractile 
velocity increased at loads above 60 %P0. C. Power output improved at 80 and 
90 %P0. Symbols: “*”=p<0.05, “#”=p<0.10, numbers within bar graphs are the 
mean, each symbol in the plots is the mean from each group at the given %P0, 
P0=peak tetanic force, mN=milliNewtons, gbm=grams body mass, fl/s=fiber 
lengths per second.  
 
Figure 4 Exercise Increased Muscle Size A.  Soleus mass increased. B. 
Plantaris muscle fiber size median and mean increased, and size distribution 
shifted right in exercise mice (p<0.05). Fibers measured: n=3175 and 1762; 
means: 2006.4 and 1933.7; medians: 1920.5 and 1793; standard deviations: 
939.3 and 955.2; exercise and control, respectively. Frequency %=100 * 
[(number of fibers in each bin) / (total number of fibers measured)]. Symbols: 
“*”=p<0.05, numbers at base in bar graphs are the mean, CSA=cross sectional 
area in micrometers, mg=milligrams, gbm=grams body mass. 
 
Figure 5 p70S6k Signaling A. Increase in normalized relative abundance of 
phosphorylated p70S6K at the threonine 389 position (p-p70S6k). B. No change 
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in total p70S6k. C. Representative Blots. On p70S6k blot the top band in each 
lane is phosphorylated and the bottom is non-phosphorylated (total of both used 
for B.) GAPDH used for lane control.  Symbols: “*”=p<0.05, numbers in bar 
graphs are the mean, each symbol in plots is the result from an individual mouse 
(except for “means”). MWL=molecular weight ladder (Kaleidoscope), 75 kDa= 
MLW mark at 75 kDa (kiloDaltons), p70S6k is at 70 kDa, BC=blot control, PC= 
positive control for p-p70S6k, NC=negative control for p-p70S6k, E=exercise 
group, C=control group. N=5 and 6 for exercise and control respectively. Relative 
abundance normalized to the mean control value. 
 
Figure 6 Akt Signaling Unchanged with Exercise A. No increase in relative 
abundance of phosphorylated Akt at the threonine 308 position (p-Akt). B. No 
change in total p70S6k. C. Representative Blots. GAPDH used for lane control.  
Symbols: “*”=p<0.05, numbers in bar graphs are the mean, each symbol in plots 
is the result from an individual mouse (except for “means”). BC=blot control, 
PC=positive control for p-Akt, NC=negative control for p-Akt, E=exercise group, 
C=control group. n=5 and 6 for exercise and control respectively. 
 
Figure 7 Training Physiology Improved over the Course of Training A. 
Training force increases. B. Training force normalized to mass of the mouse also 
improves. C. Training power output increases. D. Training power normalized to 
body mass also increases. Symbols: each symbol in scatter plots is the mean of 
all mice at the given session, mN=milliNewtons, gbm=grams body mass, mW= 
milliWatts, equation is simple linear regression. 
 
Figure 8 Performance Measures Improved with Training A. Rotarod improves 
with training. B. Rotarod loss of function mitigated with exercise. C. Grip test 
declines in both groups. D. Grip test loss of function mediated by exercise.  
Symbols: “*”=p<0.05, numbers in bar graphs are the mean, each symbol in 
scatter plots is the result from an individual mouse (except for “means”). 
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Table 1 Training Principles used in Protocol 
 
 
 
 
 
  
Term Explanation/Description Application in Study 
Progressive 
Resistance 
Exercise performed with increasingly heavier 
weights over time 
Increased weights 
every 3-5 sessions  
Progressive 
Intensity 
Exercise performed at a faster pace or with 
reduced resting time 
~4-10 RPM, by 
individual ability 
Rest Period 
Time between sets to recover for the next set, 
typical strength emphasis rest is 4-5 minutes, less 
for hypertrophy 
4-5 minutes rest 
Frequency Number of exercise sessions performed each week 
1 session per day, 3 
days per week 
Sets 1 continuous bout of numerous repetitions of exercise 4-5 sets per session 
Set Duration 
Number of repetitions per set, Humans: 
hypertrophy 8-15 repetitions, power 3-6 reps, 
usually not more than 1 minute (15 reps at ~4 
seconds) 
~30 to <60 seconds, 
anaerobic, to equal 
typical human set 
duration 
Training 
Period 
Length of training.  Many human studies are 3-4 
months. First 1-4 weeks, mainly neural adaptions. 
Hypertrophy main effect after 4 weeks.  
12 weeks 
Warm-up 
Sets 
Initial sets performed at very light weight and/or 
intensity to prevent injury and prime for heavier 
lifting  
1 or 2 warm-up sets 
per session 
Failure The last repetition of an exercise that can be safely performed in good form 
Stumble 3x or reach 
vertical position twice 
184 
 
 
Table 2 Training Physiology Definitions Units: mN=milliNewtons, g=acceleration due to gravity 
9.8 meters/second, gbm=grams of body mass, mW=milliWatts, mJ=milliJoules  
  
    
 
  
Training 
Parameter Definition Equation 
Training 
Force (mN) 
Total mass of the mouse 
plus weight used in each 
session. 
Mass in grams (mouse mass + weight and 
harness) * acceleration (g) 
Normalized 
Training 
Force 
(mN/gbm) 
Total weight the mice lifted 
(including body mass) per 
gram of body mass. 
[mass in grams (weight harness + mouse) * 
acceleration (g)] / grams of body mass 
(gbm) 
Training 
Power 
(mW) 
Work performed per 
second. 
Training Power (mW) = Work (mJ) / time (s)  
 
[Work (mJ) = Training force (mN) * distance 
run (m)]; 
Normalized 
Training 
Power 
(mW/gbm) 
Power produced per gram 
of body mass. [work (mJ) / time (s)] / gbm 
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Figure 1 Weight Training Apparatuses A. Weight Harness 3 main components: 1) padded 
elastic band, 2) Velcro strips connecting the bands, 3) lead weights that can be added in various 
combinations to increase resistance B. Powered Running Wheel 3 main components: 1) 
enclosed running wheel with door, 2) electric motor, 3) speed controller (1-10 rpm). 
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Figure 2 Training Schedule Functional testing consists of rotarod and grip test. Acclimation 
Training starts in week 2 and consists of exposure to the running wheel and weight harness. The 
Training Period begins in week 4 and is individualized to the performance of each mouse, using 
progressive weight and intensity. Testing follows the training period and consists of post-
intervention rotarod, grip test and muscle contractile physiology. 
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Figure 3 SOL Muscle 
Function Improved in Trained 
Mice A. Soleus peak tetanic 
force per gram of body mass 
improved after exercise. B. 
Contractile velocity increased at 
loads above 60 %P0. C. Power 
output improved at 80 and 90 
%P0. Symbols: “*”=p<0.05, 
“#”=p<0.10, numbers within bar 
graphs are the mean, each 
symbol in the plots is the mean 
from each group at the given 
%P0, P0=peak tetanic force, 
mN=milliNewtons, gbm=grams 
body mass, fl/s=fiber lengths 
per second.   
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Figure 4 Exercise Increased Muscle Size A.  Soleus mass increased. B. Plantaris muscle fiber 
size median and mean increased, and size distribution shifted right in exercise mice (p<0.05). 
Fibers measured: n=3175 and 1762; means: 2006.4 and 1933.7; medians: 1920.5 and 1793; 
standard deviations: 939.3 and 955.2; exercise and control, respectively. Frequency %=100 * 
[(number of fibers in each bin) / (total number of fibers measured)]. Symbols: “*”=p<0.05, 
numbers at base in bar graphs are the mean, CSA=cross sectional area in micrometers, 
mg=milligrams, gbm=grams body mass. 
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Figure 5 p70S6k Signaling A. Increase in normalized relative abundance of phosphorylated 
p70S6K at the threonine 389 position (p-p70S6k). B. No change in total p70S6k. C. 
Representative Blots. On p70S6k blot the top band in each lane is phosphorylated and the 
bottom is non-phosphorylated (total of both used for B.) GAPDH used for lane control.  Symbols: 
“*”=p<0.05, numbers in bar graphs are the mean, each symbol in plots is the result from an 
individual mouse (except for “means”). MWL=molecular weight ladder (Kaleidoscope), 75 kDal= 
MLW mark at 75 kDal (kiloDaltons), p70S6k is at 70 kDal, BC=blot control, PC=positive control 
for p-p70S6k, NC=negative control for p-p70S6k, E=exercise group, C=control group. n=5 and 6 
for exercise and control respectively. Relative abundance normalized to the mean control value. 
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Figure 6 Akt Signaling Unchanged with Exercise A. No increase in relative abundance of 
phosphorylated Akt at the threonine 308 position (p-Akt). B. No change in total p70S6k. C. 
Representative Blots. GAPDH used for lane control.  Symbols: “*”=p<0.05, numbers in bar 
graphs are the mean, each symbol in plots is the result from an individual mouse (except for 
“means”). BC=blot control, PC=positive control for p-Akt, NC=negative control for p-Akt, 
E=exercise group, C=control group. n=5 and 6 for exercise and control respectively. 
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Figure 7 Training Physiology Improved over the Course of Training A. Training force 
increases. B. Training force normalized to mass of the mouse also improves. C. Training power 
output increases. D. Training power normalized to body mass also increases. Symbols: each 
symbol in scatter plots is the mean of all mice at the given session, mN=milliNewtons, 
gbm=grams body mass, mW=milliWatts, equation is simple linear regression. 
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Figure 8 Performance Measures Improved with Training A. Rotarod improves with training. B. 
Rotarod loss of function mitigated with exercise. C. Grip test declines in both groups. D. Grip test 
loss of function mediated by exercise.  Symbols: “*”=p<0.05, numbers in bar graphs are the 
mean, each symbol in scatter plots is the result from an individual mouse (except for “means”). 
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Interlude 3 
Chapter 4 described the voluntary resistance training protocol for mice. Because 
our ultimate purpose is to establish an exercise model to investigate sarcopenia 
and treatments for sarcopenia, the next logical step was to apply the newly 
validated protocol to a cohort of older mice. These mice were 28 months of age 
at the conclusion of the study--similar in age, in terms of lifespan, to 78-80 year 
old humans.  
 
In Chapter 5, Voluntary Resistance Training in Elderly Mice and Signs of 
Anabolic Resistance, we tested the hypothesis that elderly mice undergoing this 
training would have positive adaptations, but the effects would be somewhat 
modulated, or muted. In other words, we expected some evidence of anabolic 
resistance.  
 
If the older mice had fewer, or of lesser magnitude, positive adaptations than the 
adult mice we concluded this was an age-associated blunting of response to 
anabolic stimuli. Using the same outcomes measures as in Chapter 4, with the 
addition of DEXA to determine body composition, we determined that indeed less 
adaptation was achieved in the older mice, thus providing evidence to support 
our hypothesis. 
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Abstract  
 
Sarcopenia, age-related loss of muscle mass and strength, contributes to frailty 
onset, loss of independence and reduced quality of life in the elderly. Resistance 
training is an accepted treatment that slows the progression of sarcopenia. We 
previously validated mouse exercise protocol that mimics human weight training. 
In this study we hypothesized that applying the protocol to a cohort of aged mice 
would demonstrate evidence of anabolic resistance when the outcome 
measurements were compared to those of the adult mice from the previous 
study. 
 
An age cohort of male C57BL/6 mice was used (28 months of age at study 
conclusion; n= 24). The mice were randomly separated into control and trained 
groups. The trained groups used progressive resistance (via a weight harness) 
and intensity (~4-10 RPM) on a custom motorized running wheel (possible speed 
from 1-10 RPM). The mice trained on a program similar to a human beginning 
workout regimen (4-5 sets/session, 3 sessions/week, for 14 weeks).  
 
There was evidence of anabolic resistance because the elderly mice examined in 
this study did not improve to the same degree as the adult group from the prior 
investigation. Overall, we did find evidence of significant positive change after 
undergoing the training intervention in many outcome measurements, including: 
overall neuromuscular function (rotarod), strength/endurance (inverted-cling grip 
test), training physiology (force output per session), muscle size (soleus mass), 
anabolic signaling (p79s6k phosphorylation), and power production (in vitro 
contractile physiology). Future research is needed to develop strategies to 
improve exercise response in elderly subjects. 
 
 
Keywords:  Sarcopenia, Resistance Training, Mice, Anabolic Resistance, 
Exercise Physiology, Muscle 
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INTRODUCTION 
The world is experiencing an unprecedented demographic shift with the number 
of people over the age of 60 having quadrupled since 1950 and estimated to 
triple from again by 2050 (UNDESA, 2011). With increasing age come the onset 
of age-associated disease, syndromes and potential disability. Sarcopenia, the 
age associated loss of muscle mass and strength, contributes to the 
development of frailty and directly leads to a reduced quality of life, loss of 
independent living and increased mortality. Sarcopenia at the clinical level of 
impairment is estimated to have a prevalence of approximately 5-13% in 60-70 
year olds, but rises to up to 50 percent of seniors over 80; though estimates vary 
widely across the literature (Janssen, 2002; Cruz-Jentoft, 2014). With no current 
cure for sarcopenia, it is imperative to investigate potential treatment strategies to 
both extend healthspan and independent living, and before our healthcare and 
assisted living infrastructure is crippled with masses of sarcopenic and frail 
elderly. 
 
Resistance training has been shown to improve muscle mass, strength, and 
function in even the oldest and most frail individuals (Fiaterone, 1990; Fragala, 
2014). Anabolic stimuli, such as exercise or nutrient intake, have a reduced effect 
in older individuals, contributing to sarcopenia (Haran, 2012). Targeting the multi-
level etiology of sarcopenia and anabolic resistance by combining nutritional 
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and/or pharmaceutical interventions with exercise training may be a good 
strategy to improve exercise response in older individuals. 
 
In order to research the underlying mechanisms of anabolic resistance and to 
begin to develop/test new strategies to combat sarcopenia and frailty we need to 
develop animal models. In the current study, we apply our voluntary resistance 
training protocol for mice (Graber, 2015 B) to a cohort of elderly mice (50% 
survival, 28 months old at study completion; which is roughly equivalent to 78-80 
year old humans) (Graber, 2013) and assess a carefully selected battery of 
outcome measures designed to determine the efficacy of the training protocol to 
induce positive changes in the old mice. Many of these measurements were also 
incorporated into our previous work with adult mice and so we are able to directly 
compare the data from the elderly to the adult data from the earlier investigation. 
We hypothesized that applying our protocol to a cohort of aged mice would 
demonstrate evidence of anabolic resistance in comparison to the adult mice 
from the previous study. 
 
While the elderly mice do, in fact, improve in many of the outcome 
measurements, they do so to a lesser extent than the adult animals did. They 
also show very little improvement or no change in some of the measurements. 
We present evidence herein that the mice may be experiencing anabolic 
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resistance, in that they are receiving a lesser response than the adult mice to the 
same exercise stimuli.  
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METHODOLOGY 
Animal Model 
The mice used were C57BL/6 males purchased from the NIA Aging Colony 
(elderly, 28 months old at study completion=75% survival). The mice were 
randomly selected to exercise (n=9) or control groups (n=12). For purposes of 
comparison with the elderly mice, adult mice described in (Graber, 2015 B) are 
also reported (n=15), a detailing of direct comparisons with 2x2 ANOVA is in the 
Supplement, and a comparison of the significant effects of exercise in the adult 
and old mice is detailed on Table 3. Both comparisons are discussed briefly. All 
mice were handled and treated humanely in accordance with approved IACUC 
protocols. All of the mice were fed ad libitum and group housed at 22°C with a 
12-hour light, 12-hour dark cycle. The mice were weighed both prior to and after 
completion of the training period. BMI (body mass index) was calculated as mass 
(kg) / length2 (m2). 
 
Training Equipment and Protocol 
This study uses the resistance training protocol that was previously validated 
(Graber, 2015 B). The specialized training equipment used was also previously 
described. Briefly: 
 
The goal of this study was assess the effects of the resistance training protocol 
as previously described in adult mice on a cohort of elderly mice. The protocol 
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itself was designed a mimetic of human weight training and emulates the human 
bodybuilding exercises of “walking lunges” or the “farmers walk”. It could also be 
compared to a “weighted sprint” at lighter loads. The custom equipment was 
used--a weight harness and a powered running wheel. 
  
The weight harness consisted of two padded elastic bands connected with two 
Velcro strips. Lead shot (weights of varying mass) could be loaded onto the 
Velcro strips to increase the load carried by the mouse. The powered running 
wheel was made from a caged-in 25 cm running wheel (with hinged door) 
attached to an electric motor, with a speed controller from 1-10 RPM to increase 
intensity. Two critical pieces of equipment were custom-designed and fabricated. 
The mice underwent an adaptation period to the harness and running wheel and 
then resistance trained for 14 weeks (Figure 1).  
 
The resistance training program was designed with principles of human weight 
training in mind (Garber, 2011; Desalles, 2009; ACSM, 2009; Bird, 2005; 
Kraemer, 2004; Schoenfeld, 2010): progressive resistance/intensity (ACSM, 
2009; Kraemer, 2004), number of sets per day (ACSM, 2009; Krieger, 2009), set 
duration (Toigo, 2006), warm-up sets (ACSM, 2009), training frequency (ACSM, 
2009), 2009), and rest between sets (ACSM, 2009; Desalles, 2009).  Specific of 
the training regimen can be found in Chapter 4. 
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It is important to note that just as human subjects in an exercise study would 
progress at different rates and start at a different ability level, so did the mice. 
Because of this it was necessary to progress each mouse individually which most 
often meant exercising individuals at the same resistance but using different 
intensity (speed, modulated by controlling the RPM of the running wheel) and/or 
set length. However, in some instances varying of weights were necessary as 
some mice progressed either faster or slower than the norm. The mass of the 
weight carried, time elapsed, the distance moved and the speed was recorded 
for every second of every session of exercise for each mouse throughout the 
study. The mice ran to failure during working sets (defined as non-warm-up sets) 
with failure being defined in three ways: 1) the mouse stumbles three times (RPM 
reduced after the first 2 instances, 3rd occurrence equals failure), 2) the mouse 
refuses to run further and grasps the wheel (1st time RPM reduced, 2nd time 
equals failure), or 3) the mouse cannot maintain velocity and reaches a vertical 
position at the back of the wheel (1st time the RPM is reduced and the 2nd time 
the mouse is finished for that set). Since this is a voluntary protocol, the mice can 
refuse to participate. They did so mainly in two ways: 1) grasping the wheel and 
refusing to run (see failure description above), or 2) “shrugging” out of the 
harness. Mice were allowed 3 opportunities to participate in the training session. 
After the 3rd refusal, the mouse was recorded as noncompliant on the training 
record and was returned to his cage. Any mouse that refused 3 consecutive 
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training sessions was to be removed from the study. In the cohort of the current 
study no mice had to be removed for continued noncompliance. 
 
OUTCOME MEASUREMENTS 
The same outcome measurements were used as previously reported (Graber, 
2015 B) with some additions. A brief description of each measurement follows. 
 
Whole Body Adaptations to Training 
Animal Functional Performance 
Animal performance measures are described in detail previously (Graber, 2013). 
Because the maximum ability of the mice is necessary to assess performance, 
we tested each mouse three times and then used the average of the two best 
scores as the outcome measurement (therefore excluding the worst time). In 
brief: 
 
Rota-Rod tested overall motor function (balance, coordination, stamina, power) 
using the acceleration mode from 4 RPM to 40 RPM over 5 minutes (Lsi Letica 
Rota-Rod R/S, Figure 2 A). The latency to fall from the device was recorded. 
Mice were acclimated to the device by doing random sessions 3x/day for 3 days 
prior to the testing day. 
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Grip Test is an indicator of muscle strength and stamina, determined by the 
inverted cling grip test (using a custom testing device, Figure 2 B). The animal 
was placed on a wire grid lid and the lid was then closed to invert the mouse. The 
latency to fall from the lid (to the padded floor of the device 20 cm below) was 
recorded as the outcome measure. 
 
Body Composition (DEXA) 
Dual X-ray Absorptiometry (DEXA) measures fat percentage, lean mass, bone 
mineral density and bone mineral content (GE  Lunar PixiMus I). We report only 
fat percentage and lean mass herein. (Figure 2 C) 
 
Training Effect- Whole Body Training Physiology 
We tracked the individual performance of the mice over the training period. 
Training Force (milliNewtons, mN), Normalized Training Force (mN/gbm, 
gbm=gram body mass), Training Power (milliWatts, mW), and Normalized 
Training Power (mW/gbm) were all tracked through the duration of the study. We 
report normalized training force as an affirmation of the progressive resistance 
aspect of the training protocol and normalized training power to assess relative 
intensity of exercise over time. 
 
Training Force represented the total sum of force applied by the mouse while 
working out [equation: Training Force = mass (mass of weight harness + mass of 
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mouse) * acceleration due to gravity (g)]. Normalized Training Force divided 
training force by the mass of the mouse to give an indication of the quality of 
force produced (amount of force produced per gram of the mouse). Training 
Power represented the total amount of work done per second by the mouse while 
training {equation: Training Power (milliWatts, mW) = Work (mJ, milliJoules) / 
seconds exercised [Work, or Training force (mN) * distance run (meters)]}. 
Normalized Training Power was the training power performed per gram of body 
mass of the mouse, another measure of the quality of muscle performance. 
 
Cellular Adaptations to Training 
Muscle Function- Contractility 
The specifics have been previously detailed (Graber, 2013; Graber, 2015 A). In 
brief: The extensor digitorum longus (EDL) and soleus (SOL) muscles were 
removed and then perfused in Krebs/Ringer buffer with 95% O2/5% CO2  at 25°C. 
A #4 gauge silk suture line was tied to the muscles at the myotendinous 
junctions, the muscle was then hung by the suture line from a force transducer 
(Aurora 300b) at the origin end and attached to a static clamp at the insertion 
end. The muscle was suspended between two platinum electrodes that were 
stimulated (Aurora High Power Bi-Phase Current Stimulator and a Dual-System 
Signal Interface, software: DMC v.4.1.6) under a variety of protocols to determine 
optimal length (L0), maximum isometric contractile force (P0), and velocity of 
contraction using the force clamp technique. Maximum unloaded velocity (Vmax) 
205 
 
 
was calculated using a derivation of the Hill Equation [(V+b)(P/P0 ± a/P0 )= 
b(1+a/P0), a and b are constants, V = max. velocity at fractional load] (Brooks & 
Faulkner, 1988). The data was curve fit (only r2>0.98) using MatLab. Velocities of 
contraction at various percentages of P0 were used to calculate power and the 
force-power curve. We report only the data from the SOL herein. 
 
Muscle Hypertrophy 
Soleus Wet Mass 
Following in vitro physiology, the SOL was massed after being blotted dry.  
  
Fiber Size-Histochemistry of Plantaris Muscle 
We have previously published details of this method (Graber, 2014). Briefly: 
Super-cooled isopentane, and subsequently liquid nitrogen, were used to freeze 
isolated plantaris muscles. 10 micron thick sections cut on a cryostat were then 
stained using H&E (hematoxylin and eosin). Microscope images were 
photographed and circled with ImageJ software (NIH) to find the cross sectional 
area of fibers. 
 
Anabolic Signaling 
The level of phosphorylation in p70S6K (at the threonine 389 site) and Akt (at the 
threonine 308) was determined using a fairly standard Western Blot protocol 
previously detailed (Graber, 2015 B). We report the values from densitometry 
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analysis in the normalized format (all values normalized to the mean of the age-
matched control). In the Supplement we normalize all values to the adult control 
to compare the phosphorylation states of the proteins in all four groups of mice. A 
brief description of the procedure follows: 
 
Quadriceps femoris muscles were isolated and frozen in liquid nitrogen, and 
stored at -80° C. The muscles were homogenized in Mueller Buffer (Graber, 
2015 B), which contains both protease and phosphatase inhibitors. The 
bicinchoninic acid kit (# 23225, ThermoScientific, Rockford IL) was used to 
determine protein concentration. Electrophoresis of both the AKT (Hoefer SE250, 
Holliston MA, water cooled, ~1.5 hours at 200 mV) and p70S6k blots (Biorad 
Mini-Protean,#165-8000, 45 minutes at 200 V) were on 10% acrylamide gels in 
Laemli buffer with the same blot control on every gel. Proteins on the gels were 
transferred to a PVDF membrane (blocked with 5% milk in TBS-T) using a Biorad 
semidry transfer (#170-3940), set at 14 V for 23 minutes with Bjerrum and 
Schafer-Nielsen transfer buffer. The Akt blot was first probed for p(308)-Akt, 
stripped and re-probed for Akt, then striped and reprobed for GAPDH. The 
p70S6K blots were handled in the same order. Lane control was accomplished 
using a 1:5000 dilution GAPDH antibody (Cell Signaling Technology #14C10). 
Akt, p(threonine308)-Akt, p70S6K, and p(threonine 389)-p70S6k were from Cell 
Signaling Technology, product #9272, #2965, #9202, #9205, respectively, with 
dilutions of 1:1000, 1:500, 1:1000 and 1:500 in % BSA/TBS-T with1% goat 
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serum; all incubated overnight at 4°C. All blots used a goat anti-rabbit horse 
radish peroxidase conjugated secondary antibody (Cell Signaling Technology 
#7074s) incubated for 1hour at room temperature, Western Dura-Signal Plus 
(ThermoScientific) as the substrate (5 minutes duration), were imaged using a 
Biorad Chemidoc XRS and densitometry analyzed using QuantityOne (Biorad). 
 
Statistics 
Data is shown as means ± standard error, as appropriate. Repeated measures 
general linear model (compare within subject in the rotarod and grip test), 
Student’s t-tests (independent and paired), Student’s T-Test, 2x2 ANOVA, 
ANCOVA use and report α<0.05 as significant and α<0.10 as showing strong 
evidence to refute the null hypothesis and representing a trend. For post-hoc 
testing LSD (Least Significant Difference) was used. To determine the 
relationship between two variables the linear regression analysis was used 
(p<0.05=significant). Comparison of linear regressions was done using the 
General Linear Model (GLM). Distributions of Plantaris fiber cross-sectional area 
was compared with independent samples median test and the 2-sample 
Kolmogorov-Smirnov. Direct comparisons of data from previous work (Graber, 
2015 B) to the data from the current study using 2-way ANOVA and ANCOVA is 
reported in the supplement, but discussed in the Discussion section. This same 
data also is used for secondary analysis in Table 3 and discussed in the main 
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paper. Symbols: “*” denoted p<0.05 (significant) and “#” denoted p<0.10 (trend). 
IBM SPSS v20 was used for the analysis.   
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Results 
Table 1 reports the results of repeated measurements and their absolute values. 
Table 2 reports the results of the [non-repeated measures] outcome 
measurements. The 2x2 ANOVA and ANCOVA comparisons of the main 
outcome measurements between the adult and old groups is detailed in the 
Supplemental Section, along with the appropriate figures and tables, and briefly 
discussed in the Discussion section in the main paper and p-values for main 
effects of age, training and the age-training interaction on Table 3. The main 
paper reports the results of the old mice exclusively, except in the case of 
parameters that were not reported previously (in Graber, 2015 B), with the 
exception of Table 3, which details the comparison of the outcomes in both adult 
(previously reported) and old exercise groups (percent difference between age-
matched control and exercise groups, and the results of the 2x2 
ANOVAs/ANCOVAs--detailed in the Supplement), to examine for evidence of 
possible anabolic resistance.  
 
WHOLE BODY TRAINING ADAPTATIONS 
Animal Performance 
Rota-Rod (Figure 3, Table 1 and Table 2) 
Rotarod time difference in seconds (s), -17.7 s, between the two old groups was 
not statistically different (old exercise +8.67±7.68 s; old control -9.05±10.85 s; t=-
1.28, p=0.218) (Figure 3 A). The percentage change with training in the older 
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groups was not significantly different (t=-0.942, p=0.359) (Figure 3 B). There 
was a wide data spread, however, with a few high-performing control mice 
driving the mean upward. Likewise, one low performing exercise mouse reduced 
the mean. There was no correlation of rotarod difference with either mass at sac 
(R=0.700, p=0.768) or initial mass (R=0.141, p=0.554). Mass was also not a 
significant predictor of percentage change (R=0.105, p=0.660). 
 
Inverted Cling Grip Test (Figure 4, Table 1 and Table 2)  
Grip time difference in seconds (Figure 3 C) between the two old groups was not 
statistically different (old training +52%) [t=-0.782, p=0.444], but there was 
significant increase from the first grip test to the post-intervention test within the 
old groups with control mice function gaining a mean of 20% and the exercised 
mice gaining 55%, though the gains were not statistically different between 
groups (2x2 Repeated Measures, F=4.936, p=0.039; but no significant interaction 
of grip with training status, p=0.444). Grip percentage change was not statistically 
improved in the old control mice (-22±11.9%) compared to in the exercised mice 
(+5±18.7) (Figure 3 D). Body mass was not a significant predictor of grip test 
difference in the older mice. 
  
Body Composition (Fat Percentage) - DEXA (Figure 4, Table 1) 
Body mass was not different in the old control and exercise groups either before 
or after the intervention period. Body composition was significantly improved by 
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the training intervention with a -19.5±5.5% change in fat percentage in the elderly 
exercise group compared to old control, -0.4±8.1%, and adult control, +58±8.3%. 
Adult exercise mice were unfortunately not tested (DEXA not available at training 
initiation). Lean mass was not different between the groups. The statistics from 
this section were: 1-way ANOVA to compare %Change in fat %: f= 24.403, 
p<0.001. AC>OC, p<.001; AC>OE, p<.001; OC>OE, p=.072. 
 
Training Effect- Whole Body Training Physiology 
Normalized Training Force (mN/gbm) 
We report only normalized force and power, since the non-normalized values 
revealed no additional information. As would be expected, the old exercise 
groups improved normalized force output over the training sessions. (Figure 5 
A). 
 
Training Velocity (m/s) 
We measured the velocity (to derive power) maintained by both the adult and old 
mice during their exercise sessions. Since the mean training velocity was not 
previously reported (in Graber, 2015 B), we report it here. The mean training 
velocity maintained by the adult exercise group (0.092±0.00181 m/s) was 158% 
faster over the training sessions than the old group (0.058±0.00498 m/s) 
(Student’s T-test, t=13.3, p<0.001). 
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Normalized Power (mW/gbm) 
Normalized training power (Figure 5 B) increased over the training period for the 
old exercise mice, but only if the exceptional influence of a single outlier is not 
removed. The session number 36 group power (mean 30.39±8.16 mW) and 
normalized power  (mean 0.885±0.23 mW/gbm) were driven by a single very 
high performing mouse (78.7 mW, 2.25 mW/gbm). This mouse was a definite 
outlier, considering the standard deviation (power SD 21.6 mW, and normalized 
power SD 0.61 mW/gbm), being 2.24 SD away from the mean. If the data is re-
analyzed excluding this outlier, the session number 36 old group power (mean 
22.3±1.51 mW) and normalized power (mean 0.657±0.037 mW/gbm) result in 
very different outcome measurements. The regressions become non-significant 
for both power and normalized power with respect to training session (R=0.111, 
p=0.794; and R=0.149, p=0.795, respectively). We present the data in Figure 5 B 
including the outlier, but denote normalized power in the older exercise mice as 
being questionably significant on Table 3 because of the undue influence of the 
outlier. 
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TISSUE and CELLULAR RESPONSE to TRAINING 
 
Muscle Function- Contractility 
SOL Maximum Force (P0) and Normalized Force (P0/gbm)  
P0 was not different with training (Figure 6 A) [control 178.2±9.7 mN; exercise 
193.1± 7.3 mN; t=-1.153, p=0.263].  Normalized P0 was also not different (Figure 
6 B) [control=5.4±0.3 mN/gbm; exercise=5.8±0.3 mN/gbm; t=-0.922, p=0.368].  
 
SOL Force-Velocity Curve and a/P0  
a/P0 was reduced in the old exercise (0.026±0.001) compared to the control 
(0.031±0.002) old groups, indicating an alteration in the force-velocity curve 
(Student’s T-test, p=0.059). However, none of the individual velocities (ranging 
from Vmax to 90%P0) were significantly different between the old exercise and old 
control groups (Table S2 and Figure 7 A). 
 
SOL Power Production, Pmax, and %P0@Pmax 
There was no evidence that training improved power output in the old mice when 
the power output at 10%-90%P0, Pmax and %P0@Pmax were compared 
individually (Table S3). The force-power curve is shown on Figure 7 B. 
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Muscle Hypertrophy 
 
SOL Wet Mass  
SOL mass increased +15% with exercise in the older mice (Student’s T-test, 
p=0.089) (Figure 8 A). The mean normalized SOL mass (g/gbm) was not 
significantly larger (+15%) in the old exercise animals compared to the controls 
(Figure 8 B). SOL fiber length had a small (8%) but significant increase 
(Student’s T-test, p=0.04). Sol PCSA was not significantly increased after 
training. 
 
Plantaris Muscle Fiber Hypertrophy  
There was no significant change in plantaris muscle fiber CSA with training, 
when examined using the means of the CSA for each (Figure 9 A). There was 
large individual variability and a low number of subjects (n=4 OC; n=5 OE). 
However, as previously reported, the effect size of 0.80 in the adult group 
suggested that there was a change from the intervention, which may have not 
been detected because of the high variation (type 2 error, false negative). We 
had thus examined the distribution of the 2 adult groups in detail and reported in 
our previous work that there was a significant increase in the mean, median and 
overall distribution (rightward shift) in the exercise adult group compared to the 
control adult (Figure S10, also reported in Graber, 2015 B). Therefore, in the 
current study we also examined the pooled fiber data of the old groups (Figure 9 
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B). The old exercise mice (mean CSA, 1203.9±17.9 µm2) were 4.8% larger than 
the old control (mean CSA, 1148.0±11.5 µm2) (Student’s T-test p=0.033).  
 
 
We also compared the distributions of the CSA of the old control and old exercise 
groups (Figure 9 C). The distributions were different, with the control group 
skewed left. The median increased 9.6% with training (OC= 984.5, OE =1078.8).  
[Mann-Whitney U Test, p=0.043; Independent Samples Median Test, p=0.005] 
 
Anabolic Signaling (Akt and p70S6K)  
The relative densities of each mouse were normalized to the control mean 
(p70S6K values on Table 2; Akt values not shown).  
 
p70S6K 
There was a 32% treatment-related increase with training in the relative amount 
of p70S6K, p=0.032 (Figure 10 A). The phosphorylation (p-p70S6K) at the 
Threonine (THR) 389 position (THR389) was dependent upon training with 
exercise group having relatively more (+55%) phosphorylated protein than the 
control, p=0.005 (Figure 10 B).The ratio of p-p70S6K/p70S6K also had a 
significant 19% increase in the exercised group (p=0.005). Representative blots 
shown in Figure 10 C. 
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Akt 
There was no difference in Akt (p=0.765), p(THR308)-Akt (p=0.267), or in the 
ratio of p-Akt/Akt, (p=0.305) (no figure representation, data not shown). 
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Discussion 
 
Our weight training protocol was previously validated as a mimetic of human 
weight training for the mouse (Graber, 2015 B). The adult trained mice 
demonstrated evidence of improvement in all measured areas. In the current 
study we applied the training protocol to a cohort of elderly mice to determine the 
effect of training in aged animals. Our hypothesis was that we would see multiple 
areas of improvement with training, but that the effect would be modulated by the 
age of the mice. In other words, we expected to see evidence of resistance to 
anabolic stimuli manifested in a reduced or non-response in some of the 
outcome measures, particularly when compared to the response of the adult 
mice from the prior study. Indeed, there was a lessened effect in some of the 
measures that was sometimes obscured by high individual variability in the t-
tests, hence in the Supplement we compare the means of all four groups of mice  
(adult control, adult exercise, old control and old exercise) using 2x2 ANOVA or 
ANCOVA, which has more power to detect change. Figures detailing the results 
of the Supplement are also included. Table 3 highlights the adaptations from 
training experienced by both ages of trained mice. While it is clear that both ages 
of mice received benefit from the exercise protocol, the overall effect was 
lessened in the older cohort. 
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Anabolic resistance  
The aged mice had less of a response to the training than the adult mice, 
possibly due to age-related anabolic resistance. Table 3 details the results of the 
older exercise group when compared to the adult exercise group. In most cases 
(11 of 17) the adult mice experience a greater percentage difference in 
comparison to the age-matched control, and in many more cases this difference 
is significant (14 significant changes in AE versus only 6 for OE). Furthermore, 
the adult mice changes are directly improved in comparison to the old mice in __ 
of 17 measurements. 2X2 ANOVA and ANCOVA results of a head to head 
comparison of all 4 groups of mice are detailed in the Supplement, but the main 
effects are listed on Table 3. Though high variability may obscure some of the 
differences between the old and adult groups, there was a main effect of age for 
most relevant comparisons (11 of 15), other than the functional measurements 
and a couple of others (discussed below), indicating age associated dysfunction. 
Training was a main effect in 13 of 15 measurements indicating that training 
resulted in improvements. Only contractile velocity and power production had 
significant interaction of age*training that would indicate training was affected by 
the age of the mouse and vice versa. In total, Table 3 presents a compelling case 
that the older mice did experience a degree of anabolic resistance, the extent of 
which may have been possibly obscured by a high level of individual variability.  
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Anabolic resistance is defined as a reduced capacity for an organism to respond 
to stimuli that would generally result in an increase of protein synthesis. An age-
associated decline in the ability to respond to anabolic stimuli has been 
chronicled with both nutrient sensing pathways and exercise (Burd, 2013; Fry, 
2011; Koopman, 2009; Kumar, 2009; Degens, 2003). It has been suggested 
recently that the elderly possess potentially equivalent response mechanisms but 
may require a higher signal level to achieve the same benefit as younger adults 
(Symons, 2011; Moore, 2015; Bickel, 2011). 
 
Possible Mechanisms Contributing to Anabolic Resistance  
The systemic physiological environment may be less conducive towards muscle 
hypertrophy in the elderly, thus contributing to anabolic resistance. A good 
example is age-related global inflammation, which contributes to reduced 
exercise response (Merritt, 2013). Furthermore, multiple changes occur with age 
in the endocrine system including a global reduction in free testosterone and 
somatotropin, each being important anabolic hormones (Sipila, 2013; Valenti, 
2010; Gray, 1991; Van den Beld, 2000). At the cellular level, impaired protein 
synthesis signaling with age has been implicated as a possible source of 
anabolic resistance (Fry, 2011 B). There is evidence that activation of mTORC1, 
the primary protein synthesis pathway (Glass, 2010), by resistance training is 
compromised in aging (Fry, 2011 A). In addition, nutrient signaling pathways 
involving amino acid transporters have recently been implicated in reduced 
220 
 
 
anabolic response (by mTOR activation) to exercise (Dickenson, 2013). Another 
example would be that the ability of the satellite cell to activate, proliferate, 
differentiate, and ultimately fuse with existing fibers to promote muscle repair 
and/or to contribute to hypertrophy is also compromised with age (Conboy, 2005; 
Gopinath, 2008). Thus, anabolic resistance is multi-etiological, as is sarcopenia, 
and thus multiple strategies may be needed to improve response to anabolic 
stimuli in the elderly. 
 
By utilizing multiple combinations of interventions acting upon different 
mechanisms of anabolic resistance, sarcopenia may be more treatable.  
Resistance training in combination with nutritional and ergogenic support may be 
a more potent anabolic agent than any single therapy alone (Devries, 2014; 
Forbes, 2012; Candow, 2012). Our working hypothesis was that impaired 
anabolic signaling pathways contribute to age-associated anabolic resistance, 
whether the impaired arises from increased noise or from a dysfunctional 
systemic environment. 
 
Evidence of Anabolic Resistance in the Current Study  
At the level of the whole organism we examined functional performance, body 
composition and training physiology. The rotarod (overall neuromuscular motor 
function) and inverted cling grip test (strength/endurance) were used to assess 
functional performance. In the both measurements the old mice showed some 
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evidence of improvement (main effect of training, see Table 3 and the 
supplement, Figures S1 and S2) to level statistically indistinguishable from the 
adult exercise group. However, when the older mice groups were analyzed alone 
there was little evidence of improvement as a result of training (Table 1 and 2), 
though there was some evidence that the control mice performed worse in the 
grip test than the exercise group after the intervention period (Table 1). 
Therefore we conclude that elderly animals can improve functionally to a similar 
extent as do adults. This has been evidenced in human studies of exercise and 
function as well (Fragala, 2014; Seynnes, 2004). In previous work (Graber, 
2014), we demonstrated that voluntary wheel running resulted in similar 
adaptations of increase rotarod ability in both adult and old mice. Since functional 
ability can benefit from neurological adaptations, improvements in balance and 
coordination, and other non-muscular and non-anabolic processes, the similar 
level of adaptation in both age groups does not necessarily reflect a lack of 
anabolic resistance. It is entirely possible, and deserving of future study, that the 
adult animals gained more functional ability from increases in contraction while 
the older mice gained more ability from increases in the more neurological 
aspects of the training.  
 
The exercised mice improved in body composition, consistent with human 
literature (Peterson, 2011). Unfortunately we cannot compare the level of 
improvement to the adult exercise mice, since a DEXA machine was not 
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available to measure that group. However, the training physiology measurements 
do show evidence of blunted exercise response with training force increases 
during training lessened and the mean training velocity lower in the old animals 
(Figure S3 A). Training power increases were lower in the old mice when 
compared to the adults (Figure S3 B and C), but, perhaps more importantly, if 
the outlier is removed, training power did not increase at all in the older cohort. 
 
At the cellular and tissue level, there was additional evidence of a blunted 
response to the exercise stimulus. SOL in vitro contractile physiology measured 
absolute isometric force, contractile velocity, and power production (Figures S4, 
S5 and S6). P0 did not increase statistically in either the adult or old groups 
(Figure S4). However, when the soleus P0 was normalized to body mass, there 
was a main training effect giving credence to an improved response overall, 
though response in the older mice was blunted in comparison to the adults group 
(Figure S4). Normalizing soleus force to body mass is important because a 
linear relationship exists between the two (soleus being a postural muscle). 
 
There were no statistical increases in isometric force, contractile velocity or 
power production in the older mice. The adult mice, however, experienced 
increases in both velocity and power at higher percentages of P0 (Figures S5 
and S6). There was, however, a main effect of training that gave some evidence 
to a limited increase in velocity and in power, particularly at higher percentages 
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of P0, which we have previously found to be increasingly (compared to lower 
%P0) impaired in older mice (Graber, 2015 A).  
 
Hypertrophy was measured using the wet mass of the SOL and the CSA of 
plantaris fibers. The soleus increased in mass to a similar extent in the older 
mice when comparing exercise to control (Figure S7). However, the length of the 
SOL fibers was increased to a greater proportion (though not significant) in the 
older mice (Table 3). Thus the SOL grew by adding serial sarcomeric units and 
force output is increased by increasing the diameter of the sarcomeres, not the 
length. This might be reflected in the lack of significant contractile function 
improvement in the older mice despite hypertrophy. The plantaris fibers 
demonstrated small increases in size with the adults gaining slightly more 
(though the differences were not significant), though the median shift was slightly 
larger in the older mice (Figure S8). The results are consistent with the prevailing 
exercise literature. Compared to young controls, older subjects have 
demonstrated a reduced capacity to increase muscular strength in human 
training studies (Kosek, 2006) as well in some animal models of hypertrophy 
such as synergistic ablation (Blough, 2000). If given adequate stimulus older 
muscle can hypertrophy to a similar extent (percentage increase) as younger 
(Thompson, 1994).  
 
224 
 
 
Surprisingly, we found an increased signaling response to exercise when 
measured by the phosphorylation level of p70s6k in comparison to the age-
matched control (+30% AE, versus +55%, OE) (Table 3). However, because the 
absolute levels of response compared to the adult control were similar, the 
massive increase may be due to the much lower basal level of activity in the old 
control mice (Figure S9). 
 
Conclusion 
Both the older and adult mice benefitted by undergoing positive adaptations to 
the training stimulus. However, the older mice experienced a blunted response in 
some of the measurements, evidence of anabolic resistance. Surprisingly the 
older mice had a high level of p70s6k phosphorylation, indicating an upregulated 
level of protein translation, in comparison to the age-matched controls. We 
hypothesize that since training greatly increased mTORC1 signaling response in 
the older animals, extending the training time might allow the older mice to 
receive similar benefits as the adult mice achieved in the shorter time period. It 
would be interesting to directly measure protein fractional synthesis rates of the 
mice using tracers before and after the training period to assess if the signaling 
changes correlate directly to increases in protein production. Thus, it is likely that 
the older mice may have needed more training time to improve to a similar level 
as their younger counterparts. Our future goals include investigating the synergy 
of additional intervention strategies, such as nutritional supplementation of 
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branched chain amino acids, with resistance training to determine if the age-
blunted response can be modulated.   
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Table Legends 
 
Table 1 Repeated Measurements of Absolute Values Grip test was significantly reduced in the 
control mice and fat% was significantly reduced in the exercise mice after the training period. No 
other repeated measures were significantly changed. Symbols and Abbreviations: OC=old 
control, OE=old exercise; 1=pre-intervention measurement, 2=post-intervention measurement; p-
val=p-value from paired t-test (significance in bold); mass (either pre- or post-intervention) was 
not a significant adjustor for either grip or rotarod. 
 
Table 2 Details of Outcome Measurements The numbers given for the Control and Exercise 
groups represent means plus or minus the standard err. Effect size was calculated by subtracting 
the control mean from the exercise mean and dividing by the pooled standard deviation. Effect 
sizes of less than 0.20 were considered irrelevant at the clinical level; 0.20-0.40 somewhat 
relevant, 0.40-0.80 moderately to strongly relevant, whereas effect sizes greater than 0.80 were 
considered very strong clinically relevant increases in the exercise group. Bold indicates either 
significant at p<0.05, or strong evidence and a trend at p<0.10; p-value from Independent 
samples t-test. Abbreviations: Ini.=initial pre-intervention value; Sac.=value at sacrifice (post-
intervention); Dif.=difference between pre- and post-intervention values; SOL=soleus muscle; 
PSCA=physiological cross-sectional area; P0=maximum isometric force; Plant. =plantaris; Plant. 
Median CSA= plantaris median cross sectional area compared with independent samples median 
test; Quad=quadriceps muscle. Units: g=gram, kg/m2=kilograms/meters squared, %=percent, 
s=seconds, mg=milligrams, gbm=grams of body mass, mm=millimeter, mN=milliNewton, 
µm2=micrometer squared, nrd=normalized (to mean of control) relative density. 
 
Table 3 Summary of Anabolic Response Findings The adult mice demonstrated improvement 
in all categories, but the old had a more limited response. The percentage change for each 
exercise group in comparison to the age matched controls is listed in the appropriate cell and 
(from t-test). The p-value compares the fold change in each category, normalized by the mean of 
the age-matched control, in the adult exercise group to the change in the old exercise group. 
Main Effects are from 2x2 ANOVA or ANCOVA (see supplement for details), with p-values bolded 
if significant, . Total significance adds the number of categories in which there was a significant 
change or trend (p<0.10). Abbreviations: Diff=difference in seconds; N. TR Power=normalized 
training power, N. TR. Force=normalized training force, p-values from general Linear Model 
comparison of the regression lines; SOL=soleus muscle; N.=normalized to grams of body mass; 
PCSA=physiological cross-sectional area; P0=maximum isometric force; a/P0=measurement of 
shape of the force velocity graph; Velocity=contractile velocity improved at at least one 
percentage of P0, Power= contractile power improved at at least one measured percentage of P0; 
%P0@Pmax=percentage of P0 where maximum power is produced; Plant.=plantaris, 
Quad=quadriceps; CSA=cross-sectional area; ME Age=main effect of age, ME Training=main 
effect of training, ME Int.=interaction term of age*training, from 2x2 ANOVA or ANCOVA (details 
of statistical methods and results found in supplement); N/A=not applicable. Other Symbols: 
parenthesis indicate a non-significant change; “Up Arrow” = significant improvement in at least 
one subcategory; “?” = improvement shown unless outlier is removed, then no improvement; 
“Dash”= no significant improvements; ⱡ=from General Linear Model comparison of regression 
curves; items Bolded if the difference in means was significant at p>0.05, in Italics if p<0.10. 
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Figure Legends 
 
Figure 1 Research Design 
 
Figure 2 Whole Body Outcome Measures A. Rotarod device (Lsi Rota-Rod RS). B.  Custom-
built inverted cling grip test device. C. Sample of Output from DEXA machine (Lunar PixiMus) 
 
Figure 3 No evidence of functional improvement with training A. Rotarod Difference (s) Old 
Control and Old Exercise pre- versus post-training. Diamonds (OC) and squares 
(OE)=differences of individual mice. B. Rotarod Percentage Change Old Control and Old 
Exercise pre- versus, post-training, showed no significant change when analyzed alone. 
Diamonds (OC) and squares (OE)=percent change of individual mice. C. Grip Difference (s) no 
difference, Diamonds (OC) and squares (OE)= differences of individual mice.  D. Grip 
Percentage Change no difference, Diamonds (OC) and squares (OE)=percent change of 
individual mice. 
 
Figure 4 Body Composition Percent Change of Fat Percentage Improves with Training 
Spread of Data Symbols: diamond=AC=adult control, square=OC=old control, triangle=OE=old 
exercise; unfilled symbol=means; error bars signify standard error; “*” indicates significance at 
p<0.05 and “#” indicates a trend of p<0.10. Lines indicate significance. 
 
Figure 5 Training Physiology A. Normalized Training Force Equation is simple linear 
regression of training force normalized to body mass (y value) in respect to the training session 
(x-value). B. Normalized Training Power Equation: Simple linear regression, y= normalized 
power and x= number of the training session in which the data was recorded. Symbols: 
Symbols: squares=OE=old exercise (n=6); mN=milliNewtons; gbm=grams of body mass; 
mW/gbm=milliWatts per gram of body mass. 
 
Figure 6 Contractile Force Graphs do not begin at zero in order to better delineate data spread. 
A. P0 Unchanged Spread of Old cohort data B. P0 Normalized to Body Mass Unchanged 
Spread of Old cohort data Symbols: diamonds=OC=old control, squares=OE=old exercise; error 
bars indicate standard error; mN=milliNewtons; gbm= grams of body mass; number at base of 
bar graphs=means. 
 
Figure 7 A. Force-Velocity Curve No changes at individual measured velocities. B. Force-
Power Curve No changes at individual measured power. Symbols: “triangle”=OC= old control, 
“x”=OE= old exercise; %P0= percentage of maximum isometric tetanic force; fl/s= fiber lengths 
per second (velocity of contraction); mN*fl/s= milliNewtons (force) multiplied by fiber lengths per 
second (velocity of contraction). 
 
Figure 8 A. Soleus Mass Larger in Trained Mice Graph does not begin at zero in order to 
better delineate data spread. B. SOL Normalized Wet Mass Not Different in Exercise Group. 
Normalized to body mass of animal, because the size of the SOL (being a postural muscle) is 
directly related to the size of the mouse. Symbols: Diamonds=OC=old control, Squares=OE=old 
exercise; unfilled symbols=mean of group, error bars indicate standard error; “#” indicates a trend 
of p<0.10; mg=milligrams; gbm=grams of body mass; number in base of bars=mean. 
 
Figure 9 Plantaris CSA A. Means by Mouse  OC, n=4; OE, n=4 B. Pooled Fibers by Group 
Mean is +5% with exercise. OC, n=3173; OE, n=1524 C. Histogram Distribution of the 
frequency percentage of CSA The median was 10% larger in the exercise group and there was 
a significant shift rightwards in the distribution of the exercise group CSA, indicating that there 
were more larger fibers in the exercise group than in the control group. Notes: OC=old control, 
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OE=old exercise; Frequency % = percentage of fibers out of the total number measured; light 
boxes=control, dark=exercise; µm² = micrometers squared, CSA=cross sectional are of plantaris 
fibers. 
 
Figure 10 Anabolic Signaling A. Phosphorylated p70S6K B. p70S6K C. Representative 
Blots In p70S6K blot the top band is phosphorylated and the bottom band is not, both were 
combined for total p70S6K content. Symbols: OC=old control, OE=old exercise; number in bar 
graphs are means; “*” indicate significant differences at p<0.05. Relative abundance is 
normalized to the level of the control group; BC=blot control, PC=positive control for p-p70s6k, 
NC=negative control for p-p70s6k; GAPDH is loading control; E=old exercise, C=old control; 
MWL=molecular weight ladder (Kaleidoscope, BioRad #161-0375), kDa= kiloDaltons. 
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Table 1 Repeated Measurements of Absolute Values Grip test was significantly reduced in the 
control mice and fat% was significantly reduced in the exercise mice after the training period. No 
other repeated measures were significantly changed. Symbols and Abbreviations: OC=old 
control, OE=old exercise; 1=pre-intervention measurement, 2=post-intervention measurement; p-
val=p-value from paired t-test (significance in bold); mass (either pre- or post-intervention) was 
not a significant adjustor for either grip or rotarod. 
 
measure unit OC 1 OC 2 p-val OE 1 OE 2 p-val 
grip s 97.1±15.2 64.8±8.8 0.023 116.1±27.7 100.6±20.7 0.434 
rotarod s 95.8±9.4 86.8±4.5 0.424 83.2±6.1 91.9±9.0 0.292 
Lean m g 24.7±0.6 24.7±0.4 0.930 25.8±0.7 25.2±0.9 0.511 
fat % 17.8±1.2 17.2±1.4 0.654 18.3±1.7 14.6±1.5 0.013 
mass g 32.7±0.6 32.3±1.0 0.589 34.0±0.9 32.3±1.5 0.298 
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Table 2 Details of Outcome Measurements The numbers given for the Control and Exercise 
groups represent means plus or minus the standard err. Effect size was calculated by subtracting 
the control mean from the exercise mean and dividing by the pooled standard deviation. Effect 
sizes of less than 0.20 were considered irrelevant at the clinical level; 0.20-0.40 somewhat 
relevant, 0.40-0.80 moderately to strongly relevant, whereas effect sizes greater than 0.80 were 
considered very strong clinically relevant increases in the exercise group. “-“ indicates effect size 
not applicable (baseline measurement). Bold indicates either significant at p<0.05, or strong 
evidence and a trend at p<0.10; p-value from Independent samples t-test. Abbreviations: 
Ini.=initial pre-intervention value; Sac.=value at sacrifice (post-intervention); Dif.=difference 
between pre- and post-intervention values; SOL=soleus muscle; PSCA=physiological cross-
sectional area; P0=maximum isometric force; Plant.=plantaris; Plant. Median CSA=plantaris 
median cross sectional area compared with independent samples median test; n/a=statistic not 
applicable; Quad=quadriceps muscle. Units: g=gram, kg/m2=kilograms/meters squared, 
%=percent, s=seconds, mg=milligrams, gbm=grams of body mass, mm=millimeter, 
mN=milliNewton, µm2=micrometer squared, nrd=normalized (to mean of control) relative density. 
 
 
Measurement Unit Control 
n=12 
Exercise 
 n=9 
Percent 
Dif. 
Effect 
Size 
p-value 
Body Mass Ini. g 32.7±0.7 34.0±0.8 +4 - 0.237 
Body Mass Sac. g 32.3±0.6 32.9±0.9 +2 0.15 0.770 
BMI at sac. kg/m2 3.3±0.1 3.5±0.1 +6 0.68 0.157 
Fat% Change % -0.4±8.3 -19.5±5.5 -480 1.15 0.072 
Rotarod Time Dif. s -9.1±10.9 +8.7±7.7 +196 0.77 0.218 
Grip Test Time Dif. s -32.0±12.2 -15.5±18.8 +52 0.52 0.444 
SOL Mass mg 9.5±0.6 10.9±0.5 +15 0.79 0.089 
SOL Mass/gbm mg/gbm 0.296±0.019 0.342±0.031 +7 0.69 0.213 
SOL Length mm 11.16±0.26 11.94±0.21 +7 3.75 0.040 
SOL Fiber Length mm 7.8±0.2 8.4±0.1 +8 0.97 0.04 
SOL PCSA mm2 0.80±0.04 0.96±0.04 +20 0.12 0.321 
 SOL P0 mN 178.2±9.7 184.6±7.3 +4 0.22 0.263 
SOL P0/gbm mN/gbm 5.4±0.3 5.8±0.3 +8 0.02 0.368 
a/P0 mN-1 0.031±0.002 0.026±0.001 -16 0.32 0.059 
Plant. Median CSA µm2 984.5 1078.8 +10 n/a 0.005 
Quad p-p70S6K nrd 1.000±0.122 1.546±0.129 +55 1.50 0.009 
Quad p70S6K nrd 1.000±0.090 1.319±0.081 +32 1.18 0.032 
Quad p-p70/p70 nrd 1.000±0.005 1.186±0.006 +19 1.72 0.005 
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Table 3 Summary of Anabolic Response Findings The adult mice demonstrated improvement 
in all categories, but the old had a more limited response. The percentage change for each 
exercise group in comparison to the age matched controls is listed in the appropriate cell and 
(from t-test). The p-value compares the fold change in each category, normalized by the mean of 
the age-matched control, in the adult exercise group to the change in the old exercise group. 
Main Effects are from 2x2 ANOVA or ANCOVA (see supplement for details), with p-values 
bolded if significant at p<0.05 and in italics if p<0.10. Total significance adds the number of 
categories in which there was a significant change or trend (p<0.10). Abbreviations: 
Diff=difference in seconds; N. TR Power=normalized training power, N. TR. Force=normalized 
training force, p-values from general Linear Model comparison of the regression lines; 
SOL=soleus muscle; N.=normalized to grams of body mass; PCSA=physiological cross-sectional 
area; P0=maximum isometric force; a/P0=measurement of shape of the force velocity graph; 
Velocity=contractile velocity improved at at least one percentage of P0, Power=contractile power 
improved at at least one measured percentage of P0; %P0@Pmax=percentage of P0 where 
maximum power is produced; Plant.=plantaris, Quad=quadriceps; CSA=cross-sectional area; ME 
Age=main effect of age, ME Training=main effect of training, ME Int.=interaction term of 
age*training, from 2x2 ANOVA or ANCOVA (details of statistical methods and results found in 
supplement); N/A=not applicable. Other Symbols: parenthesis indicate a non-significant change; 
“Up Arrow” = significant improvement in at least one subcategory; “?”=improvement shown 
unless outlier is removed, then no improvement; “Dash”=no significant improvements; ⱡ=from 
General Linear Model comparison of regression curves; items Bolded if the difference in means 
was significant at p>0.05, in Italics if p<0.10. 
 
Measurement AE 
n=6 
OE 
 n=9 
p-value ME 
Age 
ME 
Training 
ME 
INT. 
Rotarod Time Dif. +127 (+196) 0.560 0.395 0.026 0.509 
Grip Test Time Dif. +81 (+52) 0.650 0.992 0.080 0.556 
N. Tr. Force   <0.001ⱡ N/A N/A N/A 
N. Tr. Power  ? <0.001ⱡ N/A N/A N/A 
Final Body Mass (-9) (+2) 0.090 0.001 0.359 0.197 
SOL Mass +15 +15 0.996 <0.001 0.016 0.134 
N. SOL Mass +26 (+15) 0.410 0.160 0.009 0.465 
SOL Fiber Length +6 +8 0.567 0.093 0.020 0.771 
SOL PCSA (+10) (+20) 0.792 <0.001 0.088 0.661 
SOL P0 (+1) (+4) 0.111 <0.001 0.440 0.583 
N. SOL P0 +11 (+8) 0.577 <0.001 0.071 0.473 
a/P0 -22 -16 0.359 <0.001 0.008 0.987 
Velocity  - <0.05 All @ 50,60,and 80%P0 @ 80 and 90%P0 
Power  - <0.05 All @ 60, 80 and 90%P0 @ 90%P0 
%P0 @ Pmax +7 (+2) 0.043 0.188 0.022 0.188 
Plant. Mean CSA +5.4 +4.8 0.500 0.001 0.001 0.172 
Quad p-p70s6k +30 +55 0.184 0.042 0.044 0.939 
Total Significance 14 6 6 11 13 2 
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Figure 1 Research Design 
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Figure 2 Whole Body Outcome Measures A. Rotarod device (Lsi Rota-Rod RS). B.  Custom-
built inverted cling grip test device. C. Sample of Output from DEXA machine (Lunar PixiMus) 
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Figure 3 No functional improvement with training A. Rotarod Difference (s) Old Control and 
Old Exercise pre- versus post-training. Diamonds (OC) and squares (OE)=differences of 
individual mice. B. Rotarod Percentage Change Old Control and Old Exercise pre- versus, post-
training, showed no significant change when analyzed alone. Diamonds (OC) and squares 
(OE)=percent change of individual mice. C. Grip Difference (s) no difference, Diamonds (OC) 
and squares (OE)=differences of individual mice.  D. Grip Percentage Change no difference, 
Diamonds (OC) and squares (OE)=percent change of individual mice. 
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Figure 4 Body Composition Percent Change of Fat Percentage Improves with Training 
Spread of Data Symbols: diamond=AC=adult control, square=OC=old control, triangle=OE=old 
exercise; unfilled symbol=means; error bars signify standard error; “*” indicates significance at 
p<0.05 and “#” indicates a trend of p<0.10. Lines indicate significance. 
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Figure 5 Training Physiology A. Normalized Training Force Equation is simple linear 
regression of training force normalized to body mass (y value) in respect to the training session 
(x-value). B. Normalized Training Power Equation: Simple linear regression, y=normalized 
power and x=number of the training session in which the data was recorded. Symbols: Symbols: 
squares=OE=old exercise (n=6); mN=milliNewtons; gbm=grams of body mass; 
mW/gbm=milliWatts per gram of body mass. 
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Figure 6 Contractile Force Graphs do not begin at zero in order to better delineate data spread. 
A. P0 Unchanged Spread of Old cohort data B. P0 Normalized to Body Mass Unchanged 
Spread of Old cohort data Symbols: diamonds=OC=old control, squares=OE=old exercise; error 
bars indicate standard error; mN=milliNewtons; gbm=grams of body mass; number at base of bar 
graphs=means;  
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Figure 7 A. Force-Velocity Curve No changes at individual measured velocities. B. Force-
Power Curve No changes at individual measured power. Symbols: “triangle”=OC=old control, 
“x”=OE=old exercise; %P0=percentage of maximum isometric tetanic force; fl/s=fiber lengths per 
second (velocity of contraction); mN*fl/s=milliNewtons (force) multiplied by fiber lengths per 
second (velocity of contraction). 
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Figure 8 A. Soleus Mass 15% Larger in Trained Mice Graph does not begin at zero in order to 
better delineate data spread. B. SOL Normalized Wet Mass Not Different in Exercise Group. 
Normalized to body mass of animal, because the size of the SOL (being a postural muscle) is 
directly related to the size of the mouse. Symbols: Diamonds=OC=old control, Squares=OE=old 
exercise; unfilled symbols=mean of group, error bars indicate standard error; “#” indicates a trend 
of p<0.10; mg=milligrams; gbm=grams of body mass; number in base of bars=mean. 
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Figure 9 PLANTARIS CSA A. Means by Mouse  OC, n=4; OE, n=4 B. Pooled Fibers by 
Group Mean is +5% with exercise. OC, n=3173; OE, n=1524 C. Histogram Distribution of the 
frequency percentage of CSA The median was 10% larger in the exercise group and there was 
a significant shift rightwards in the distribution of the exercise group CSA, indicating that there 
were more larger fibers in the exercise group than in the control group. Notes: OC=old control, 
OE=Old Exercise; Frequency %=percentage of fibers out of the total number measured; light 
boxes=control, dark=exercise; µm²=micrometers squared, CSA=cross sectional are of plantaris 
fibers. 
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Figure 10 Anabolic Signaling A. Phosphorylated p70S6K B. p70S6K C. Representative 
Blots In p70S6K blot the top band is phosphorylated and the bottom band is not, both were 
combined for total p70S6K content. Symbols: OC=old control, OE=old exercise; number in bar 
graphs are means; “*” indicate significant differences at p<0.05. Relative abundance is 
normalized to the level of the control group; BC=blot control, PC=positive control for p-p70S6K, 
NC=negative control for p-p70S6K; GAPDH is loading control; E=old exercise, C=old control; 
MWL=molecular weight ladder (Kaleidoscope, BioRad #161-0375), kDa=kiloDaltons. 
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Supplemental Section Results of Side by Side Analysis of the Adult 
Exercise and Adult Control Groups (previously reported  in Graber, 2015 B) 
with the Old Exercise and Old Control Groups. 
Note: Statistical comparisons will be detailed under the appropriate section 
in brackets. 
 
Table S1 details animal characteristics of body mass, changes in body mass, 
muscle mass, P0, Pmax, Vmax and p-values of the main effects of a 2x2 ANOVA (2 
ages and 2 treatment statuses) comparison of the adult mice detailed in Graber, 
2014 B to the old mice, with LSD multiple-comparison posthoc tests represented 
by letters and symbols. The following convention will be used to denote the 
different groups (used interchangeably throughout): AC=adult control, AE=adult 
exercise, OC=old control, and OE=old exercise. 
 
WHOLE BODY TRAINING ADAPTATIONS 
Animal Performance 
Rota-Rod (Figure S1) 
This outcome tested overall motor function (gait speed, balance, coordination, 
stamina, power). After training the control mice had reduced function compared 
to exercise mice. 
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There was a significant main effect of training (+146%) when comparing all four 
groups (overall control -16.8±6.8 s, overall exercise +7.8±8.1 s), with no 
significance for age or age*training interaction (Figure S1 A and B).  
[2x2 ANOVA F=2.327, p=0.093; Main Effects: Age, p=0.395; Training, p=0.026; age*training interaction: 
p=0.509; LSD Posthoc: AE>AC, p=0.055; AE=OC, p=0.326; AE=OE, p=0.900; AC=OC, p=0.240; OE>AC, 
p=0.023] 
 
When all 4 groups were analyzed for percentage change, there was a main effect 
of training (+197%) (overall control -11.2±7.8%, overall exercise +10.9±9.3%, 
values adjusted for mass), with no significance for main effect of age or 
age*training interaction (Figure S1 C). 
[2x2 ANCOVA, adjusted for body mass at sacrifice, F=2.181, p=0.094; Main Effects: Age, p=0.992; Training, 
p=0.080; age*training interaction: p=0.556; LSD Posthoc: AE=AC, p=0.129; AE=OC, p=0.250; AE=OE, 
p=0.696; AC=OC, p=0.711; OE=AC, p=0.265] 
 
Simple linear regression of difference in seconds dependent upon mass at sac 
(R=0.325, p=0.053) was not statistical when all four groups were compared 
(Figure S1 D).  There was also no correlation (R=0.065, p=0.703) with initial 
mass. Mass at sacrifice was correlated with rotarod percent change analyzed for 
all four groups.  
[R=0.367, p=0.028, % = 75.791 – 2.185 (mass at sac in grams)] 
 
Inverted Cling Grip Test (Figure S2)  
This outcome measurement tested overall muscle strength and stamina. After 
training the control mice had reduced function compared to exercise mice. 
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There was a significant training effect (74.3% improvement) when comparing all 
4 groups (Figure S2 A and S2 B), with no effect of age or age*training 
interaction. 
[2x2 General Linear Model ANCOVA, adjusted for body mass at sac, F=4.230, p=0.008 Main Effects: Age, 
p=0.151; Training, p=0.025; age*training  interaction, p=0.115; LSD Posthoc: AE (n=6) > AC (n=9) , p=.093; 
AC < OC (n=12) p=0.096; AC<OE (n=9) p=0.043; AE=OC, p=0.917; AE=OE, p=0.773] 
 
Grip percentage change was not statistically improved when comparing all four 
groups (AC -51±13.5% and AE -19±20.5%) (Figure S2 C).  
[2x2 ANOVA, F=2.756, p=0.107. Main Effects: Age, p=0.107; Training, p=0.075; age*training interaction: 
p=0.875] 
 
When all four groups were analyzed together, body mass at sacrifice had a 
moderate Pearson correlation, R=-0.433, to the grip difference (in seconds) 
(Figure S2 D). Mass was not a significant predictor of the grip percent change 
(R=0.261, p=0.125). Initial body mass, was not correlated with either grip 
difference or percent change.  
[Linear Regression, R=-0.433, p=.004, linear equation: grip difference (seconds) = 155.676 -5.844 (mass at 
sac in grams)] 
 
 
Training Effect- Whole Body Training Physiology 
 
Training Force (mN) and Normalized Training Force (mN/gbm) 
As would be expected, both the old and the adult exercise groups increased 
normalized force output over the training sessions. The adults ultimately 
improved to a greater degree and at a faster rate in training force. (Figure S4 A 
and B) 
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[Training Force: slopes of the linear regressions were significantly different with the mean increase 
(adjusted) of 7.6% with training in the adult group; Univariate GLM ANCOVA, adjusted for training session, 
F=368, p<0.001; Main Effect of Age group, p<0.001, training session as adjustor, p<0.001] 
 
Mean Training Velocity (m/s), Training Power (mW) and Normalized 
Training Power (mW/gbm) 
The mean training velocity maintained by the adult exercise group 
(0.092±0.00181 m/s) was 158% faster over the training sessions than the old 
group (0.058±0.00498 m/s).  
[Student’s T-test, t=13.3, p<0.001] 
 
Training power increased in both the adult and old exercised mice, although 
more so in the adult (Figure S5 B). The regression curve of training power in 
relation to training session number (Figure S5 C) were significantly different with 
a mean increase (adjusted) of 171% with training in the adult group (mean 
training power 43.1±0.98 mW) compared to the old (25.1±0.98 mW).   
[Univariate GLM ANCOVA, adjusted for training session, F=93, p<0.001; Main Effect of Age group, p<0.001, 
training session as adjustor, p<0.001] 
 
Normalized training power also increased over the training period for both the old 
and adult mice. The regressions were significantly different with the mean 
increase (adjusted) of 162% with training in the adult group (mean training power 
1.19±0.028 mW/gbm) compared to the old (0.74±0.028 mW/gbm) (Figure S5 D). 
[Univariate GLM ANCOVA, adjusted for training session, F=93, p<0.001; Main Effect of Age group, p<0.001, 
training session as adjustor, p<0.001] 
 
IMPORTANT NOTE: The session number 36 old group training power (mean 
30.39±8.16 mW) and normalized training power  (mean 0.885±0.23 mW/gbm) 
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were driven by a single very high performing mouse ( 78.7 mW, 2.25 mW/gbm). 
This mouse was a definite outlier, considering the standard deviation (training 
power SD 21.6 mW, and normalized training power SD 0.61 mW/gbm), being 
2.24 SD away from the mean. If the data is reanalyzed excluding this outlier, the 
session number 36 old group training power (mean 22.3±1.51 mW) and 
normalized training power (mean 0.657±0.037 mW/gbm) result in very different 
outcome measurements. The regressions become non-significant for both power 
and normalized power with respect to training session (R=0.111, p=0.794; and 
R=0.149, p=0.795, respectively). 
 
TISSUE and CELLULAR RESPONSE to TRAINING 
Muscle Function- Contractility 
SOL Maximum Force (P0) and Normalized Force (P0/gbm)  
When comparing all 4 groups there was an age main effect, 25% reduction in 
force with age (combined adult 248.2±8.4 mN; old 185.6±7.3 mN) (Figure S6 A). 
Neither the training effect nor the training*age interaction was significant. There 
was a significant moderate linear relationship (R=0.690, p<0.001) between body 
mass and P0 (Figure S6 C).  
[P0: 2x2 ANOVA F=400, p<0.001; Main Effects: Age, p<0.001; Training, p=0.440; age*training interaction: 
p=0.583; LSD Posthoc: AE=AC, p=0.881; AE>OC, <0.001.; AE>OE, p=0.003; AC>OC, p<0.001; AC>OE, 
p=0.001] 
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Normalized force production was 39% higher in the adult compared to the old 
mice (main effect age) (Figure S6 B). There was also a main effect of training 
(+9.4%), but no significant interaction between age and training. 
[Normalized P0: 2x2 ANOVA F=396, p<0.001. Main Effects: Age, p=<0.001; Training, p=0.063; age*training 
interaction: p=0.408; LSD Posthoc: AE>AC, p=0.081; AE>OC, p=<0.001; AE>OE, p<0.001; AC>OC, 
p<0.001; AC>OE, p=0.002] 
 
 
SOL Force-Velocity Curve and a/P0 (Figure S7) 
When analyzing all four groups there was a mean increase of 38% in a/P0 with 
age and a mean decrease of 19% with training (main effects). There was an age 
effect, but no age-training interaction. The post hoc revealed that the old exercise 
group had a similar curve to the adult control group. 
[a/P0 2x2 ANOVA F=236, p<0.001. Main Effects: Age, p<0.001; Training, p=0.008; age*training interaction, 
p=0.987; LSD Posthoc: AE<AC, p=0.69; AE<OC, p<0.001; AE<OE, p=0.006; AC<OC, p=0.001; AC=OE, 
p=0.213; OE<OC, p=0.043] 
 
None of the individual velocities (from Vmax to 90%P0) were significantly different 
between old exercise and old control groups. There were differences between 
the old and adult mice (Table S2, Figure S7 A, B, and C). Specifically, the main 
effect of age was significant (p<0.001) for all velocities Vmax through 90%P0 and 
there was evidence of the main effect of training at 50, 60, and 80%P0 (p=0.098, 
0.046 and 0.009, respectively) and the age*training interaction at 80 and 90%P0 
(p=0.087, 0.085 respectively) (Figure S7 A, C, and Table S2). Additionally, as 
was previously reported (Graber, 2015 B), there were differences with training 
between the adult groups.  
[2x2 ANOVA with LSD posthoc testing, Details on Table S1] 
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SOL Power Production, Pmax, and %P0@Pmax 
There was no evidence that training improved power output in the old mice when 
the power output at 10%-90%P0, Pmax and %P0@Pmax were compared 
individually (Table S3). However, overall, when comparing all four groups (Table 
S3 and Figure S8), there were age-related differences (main effect age, 
adult>old) at all parameters (10%-90%P0, Pmax and %P0@Pmax) and main training 
effects (training>control) from 60-90%P0 and %P0@Pmax. The 90%P0 power was 
the only value with evidence of an interaction (training*age, p=0.070) with the 
adult exercise group increasing 32% over the adult control, but there was no 
change in the old mice.   
 
Muscle Hypertrophy 
SOL Wet Mass (Figure S9 A and B) 
SOL mass increased +15% with exercise in the older mice. [Student’s T-test, 
p=0.089] When comparing all 4 groups, the main effects of age (+23% in adults), 
and training (+18%) were significant. There was no significant interaction 
(age*training). (Figure S9 A) 
[2x2 ANOVA F=10.271, p<0.001 Main Effects: Age, p<0.001; Training, p=0.014; age*training  interaction: 
p=0.617; LSD Posthoc: AE (n=6) Soleus 15% > AC (n=13) , p=.019; AC>OC (n=12) p=0.001; AC=OE (n=7) 
p=0.159; AE>OC, p<.001; AE>OE, p=0.002] 
 
 
The mean normalized SOL mass (g/gbm) was not significantly larger (+7%) in 
the old exercise animals compared to the controls, but the 2X2 ANOVA revealed 
a significant training effect (+16.8% after training). There was no significant 
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interaction, but there was a trend in the main effect of age term (-8.7% in older 
mice) (Figure S9 B).  
[2x2 ANOVA F=3.053, p=0.042 Main Effects: Age, p=0.077; Training, p=0.019; age*training interaction: 
p=0.279; LSD Posthoc: AE 26%>AC, p=0.021; AE>OC, p=0.007; AE>OE, p=.085; AC=OC, p=0.566; 
AC=OE, p=0.637] 
 
 
Plantaris Muscle Fiber Hypertrophy  
There was no significant change in plantaris muscle fiber CSA with training, but 
there was evidence of age-associated atrophy, when the 4 groups were 
examined using the means of the CSA for each mouse in the subsets measured 
(Figure S10 A). There was large individual variability and a low number of 
subjects.  
 
However, the effect size of 0.80 in the adult group suggests that there was a 
large change from the intervention, which may have not been detected because 
of the high variation (type 2 error, false negative). We had thus examined the 
distribution of the 2 adult groups in detail and reported in our previous work that 
there was a significant increase in the mean, median and overall distribution 
(rightward shift) in the exercise adult group compared to the control adult (Figure 
S10 C, also reported in Chapter 3). Therefore, in the current study we also 
examined the pooled fiber data of all four groups (Figure S10 B). The adult 
exercise mice CSA was 5.4% larger than the adult control and the old exercise 
mice (mean CSA, 1203.9±17.9 µm2) were 4.8% larger than the old control (mean 
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CSA, 1148.0±11.5 µm2), with a +5% main effect of training. The old mice, overall, 
had fibers 40% smaller than the adult (main effect of aging).  
[Pooled CSA 2x2 ANOVA F=742, p<0.001. Main Effects: Age, p<0.001; Training, p=0.001; age*training 
interaction: p=0.172; LSD Posthoc: AE>AC, p<0.001; AE>OC, p<0.001; AE>OE, p=0.001; AC>OC, 
p<0.001; AC>OE, p<0.001; OE>OC, p=0.033] 
 
We also compared the distributions of the CSA of the old control and old exercise 
groups (Figure S10 D). The distributions were different, with the control group 
skewed left. The median increased 9.6% with training (OC= 984.5, OE =1078.8).  
[Mann-Whitney U Test, p=0.043; Independent Samples Median Test, p=0.005] 
 
Anabolic Signaling (Akt and p70S6k)  
p70S6k 
There were no treatment related changes in the relative amount of p70S6K, 
though there was an effect of age (-60% in the old) (Figure S11 B). However, the 
phosphorylation of (p-p70S6K) at the Threonine (THR) 389 position (THR389) 
was dependent upon training with the adult (+30%) and old (+55%) exercise 
groups having relatively more phosphorylated protein than the age-matched 
controls (Figure S11 A). In addition, there was an age effect with -18% 
phosphorylation of p70S6K overall in the older quadriceps. The ratio of p-
p70S6K/p70S6K only showed a significant difference in comparison of the adult 
control to the old exercise group, with the old exercise group showing an 
increase of 43% (means: AC 1.00±0.16; AE 1.21±0.14; OC 1.21±0.05; OE 
1.00±0.06). However, there was a main effect of training, +21%; and a main 
effect of age, +22% in the older mice.  
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[Normalized p70: 2x2 ANOVA F=5.94, p=0.004. Main Effects: Age, p=0.001; Training, p=0.199; age*training 
interaction: p=0.665; LSD Posthoc: AE=AC, p=0.572; AE>OC, p=0.001; AE>OE, p=0.020; AC>OC, 
p=0.004; AC>OE, p=0.058, OE=OC, p=0.185] 
  
[Normalized p-p70: 2x2 ANOVA F=6.03, p=0.004. Main Effects: Age, p=0.029; Training, p=0.002; 
age*training interaction: p=0.629; LSD Posthoc: AE>AC, p=0.056; AE>OC, p=0.001; AE=OE, p=0.210; 
AC>OC, p<0.055; AC=OE, p=0.377, OE>OC, p=0.005] 
 
[Normalized p-p70/p70 ratio: 2x2 ANOVA F=3.408, p=0.035. Main Effects: Age, p=0.042; Training, p=0.044; 
age*training interaction: p=0.939; LSD Posthoc: AE=AC, p=0.188; AE=OC, p=0.990; AE=OE, p=0.132; 
AC=OC, p=0.150; OE>AC, p=0.004, OE=OC, p=0.102] 
 
 
Akt 
There was no difference between any of the groups in normalized Akt (p=0.765), 
normalized p(THR308)-Akt (p=0.267), or in the ratio of p-Akt/Akt, (p=0.305) (no 
figure representation).  [One-Way ANOVA] 
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Supplemental Table Legends 
 
Table S1 Animal Characteristics Symbols: ME Age=main effect of age, ME Trained=main 
effect of training, ME Inter.=interaction effect of age*training (numbers in columns=p-value from 
2x2 ANOVA with bold indicating significance); different letters indicate differences at p<0.10; “ ⱡ  
“≠OC, p<0.05; “ § “≠AE, p<0.05; “ ¥ ”=AE; BMI=body mass index; sac.=sacrifice; gbm=grams of 
body mass; PCSA=physiological cross sectional area; P0=maximum tetanic force; g=grams; mg= 
milligram; mN=milliNewton; kg/m2=kilogram divided by meters squared . 
 
 
Table S2 Velocity of Contraction Data presented as means ± standard error. Symbols: 
AC=adult control, AE=adult exercise, OC=old control, OE=old exercise, different letters indicate 
differences at p<0.10; “ ⱡ  “≠OC, p<0.05; “ § “≠AE, p<0.05; “ ¥ ”=AE; Age=main effect of age, 
Training=main effect of training; Inter.=interaction of age*training, p-value, from 2x2 ANOVA, bold 
indicating significance; fl/s=fiber lengths/sec.  
 
Table S3 Power Production Data presented as means ± standard error. Symbols: 
Pmax=maximum power output, %P0@Pmax=the percentage of P0 (maximum force) where Pmax 
occurs; AC=adult control, AE=adult exercise, OC=old control, OE=old exercise, different letters 
indicate differences at p<0.10; “ ⱡ  “≠ OC, p<0.05; “ § “≠AE, p<0.05; “ ¥ ”=AE; ME Age=main effect 
of age, ME Training=main effect of training, Inter.=interaction of age*training, numbers are p-
values from 2x2 ANOVA, bold highlighting p<0.10; mN*fl/s=milliNewtons*fiber lengths/sec; 1n=7 
for OE. 
Supplemental Figure Legends 
Figure S1 Rotarod A. Rotarod Difference in Seconds Means of all four groups. B. Rotarod 
Percent Change Means of all four groups. C. Regression Equation is simple linear regression of 
rotarod difference in seconds (y value) in respect to mass of mouse in grams at sacrifice (x-
value).  D. Rotarod Main Effect of Training From 2x2 ANOVA Symbols: AC=adult control, 
AE=adult exercise, OC=old control, OE=old exercise; “*” indicates significance at p<0.05 and “#” 
indicates a trend of p<0.10; lines delineate significance. 
 
Figure S2 Grip Test A. Grip Test Difference in Seconds Means of all four groups. B. Grip Test 
Percent Change Means of all four groups. C. Regression Equation is simple linear regression of 
grip test difference in seconds (y value) in respect to mass of mouse in grams at sacrifice (x-
value). D. Grip Test Main Effect of Training From 2x2 ANOVA Symbols: AC= adult control, 
AE= adult exercise, OC=old control, OE=old exercise; s=seconds, g=grams, number at base in 
bar graphs=means; “*” indicates significance at p<0.05 and “#” indicates a trend of p<0.10; lines 
delineate significance. 
 
Figure S3 Training Physiology A. Normalized Training Force Equation is simple linear 
regression of training force normalized to body mass (y value) in respect to the training session 
(x-value). B. Training Power B. Equation: Simple linear regression, y=power and x=number of 
the training session in which the data was recorded. C. Normalized Training Power Equation: 
Simple linear regression, y=normalized power and x=number of the training session in which the 
data was recorded. Symbols: Symbols: diamonds=AE=adult exercise (n=7), squares=OE=old 
exercise (n=6); mN=milliNewtons, gbm=grams of body mass; mW=milliWatts; mW/gbm= 
milliWatts per gram of body mass. 
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Figure S4 Contractile Force A. P0 All 4 group means. B. P0 Normalized to Body Mass All 4 
group means. C. Regression of P0 with respect to Body Mass Equation: simple linear 
regression y=P0 and x=body mass at sacrifice. Symbols: AC=adult control, AE=adult exercise, 
OC=old control, OE=old exercise; “*” indicates significance at p<0.05 and “#” indicates a trend of 
p<0.10; lines delineate significance; mN=milliNewtons, gbm=grams of body mass; number at 
base of bar graphs=means. 
 
Figure S5 Contractile Velocity A.  Force-Velocity Curve B. Expanded view 0-40%P0 C. 
Expanded View 40-100%P0 Symbols: AC=adult control, AE=adult exercise, OC=old control, 
OE=old exercise; fl/s=fiber lengths per second; %P0=percentage of maximum isometric tetanic 
force. 
 
Figure S6 Contractile Power Symbols: AC=adult control, AE=adult exercise, OC=old control, 
OE=old exercise; “*” indicates significance at p<0.05; %P0=percentage of maximum isometric 
tetanic force; mN*fl/s=milliNewtons (force) multiplied by fiber lengths per second (velocity of 
contraction). 
 
Figure S7 SOL Wet Mass A. SOL Mass B. Normalized SOL Mass in relation to body mass. 
Symbols: AC=adult control, AE=adult exercise, OC=old control, OE=old exercise; “*” indicates 
significance at p<0.05 and “#” indicates a trend of p<0.10; lines delineate significance; mg= 
milligrams; gbm=grams of body mass; number in base of bars=mean. 
 
Figure S8 Plantaris Fiber CSA A. Individual Mice Means Mean is +5% Adults, +5% in Old with 
exercise. AC, n=5; AE, n=4, OC, n=4; OE, n=4 B. Pooled Fiber Means C. Adult Fiber 
Distribution Histogram of Distribution of Adult CSA Also reported in Chapter 3, reprinted for 
comparison purposes, median +7%, significant rightward shift after exercise. D. Old Fiber 
Distribution Histogram Distribution of Old CSA, median +10%, significant rightward shift after 
exercise. Symbols: AC=adult control, AE=adult exercise, OC=old control, OE=old exercise; in 
histograms light boxes=control, dark=exercise; letters indicate significant differences; 
Frequency%=percentage of fibers out of the total number measured; µm²=micrometers squared, 
CSA=cross sectional area of plantaris fibers. 
 
Figure S9 Anabolic Signaling A. Phosphorylated p70S6K B. p70S6K C. Representative 
Blots In p70S6K blot the top band is phosphorylated and the bottom band is not, both were 
combined for total p70 content. Symbols: AC=adult control, AE=adult exercise, OC=old control, 
OE=old exercise; number in bar graphs are means. Abundance is normalized to the level of the 
adult control group; BC=blot control, PC=positive control for p-p70S6K, NC=negative control for 
p-p70S6K; E=old exercise, C=old control.  
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Table S1 Animal Characteristics Symbols: ME Age=main effect of age, ME Trained=main 
effect of training, ME Inter.=interaction effect of age*training (numbers in columns=p-value from 
2x2 ANOVA with bold indicating significance); different letters indicate differences at p<0.10; “ ⱡ  
“≠OC, p<0.05; “ § “≠AE, p<0.05; “ ¥ ”=AE; BMI=body mass index; sac.=sacrifice; gbm=grams of 
body mass; PCSA=physiological cross sectional area; P0=maximum tetanic force; g=grams; 
mg=milligram; mN=milliNewton; kg/M2=kilogram divided by meters squared.  
 
 Unit Adult 
Control 
Adult 
Exercise 
Old 
Control 
Old 
Exercise 
ME 
Age 
(p) 
ME Trained 
(p) 
ME 
Inter. 
(p) 
Body Mass 
initial 
g 32.6±0.7 a 29.9±0.9 b 32.7±0.7 a 34.0±0.8 a 0.014 0.368 0.018 
Body Mass 
at sac. 
g 40.9±0.9 a 37.1±0.4 a 32.3±0.6 b 32.9±0.9 b 0.001 0.359 0.197 
Body Mass 
change 
% 24.7±4.0 a 24.4±11.6 
a 
-1.4±2.5 b -3.3±2.8 b <0.001 0.765 0.816 
BMI 
at sac. 
kg/m2 4.0±0.1 a 3.7±0.1 a 3.3±0.1 b 3.5±0.1 b 0.001 0.853 0.041 
SOL Mass* mg 12.6±0.7 a 14.5±0.8 b 9.5±0.6 c 10.9±0.5 cⱡ <0.001 0.016 0.134 
SOL Mass/ 
gbm 
mg/ 
gbm 
0.31±0.01 a 0.39±0.01 
b 
0.30±0.02 
a§ 
0.32±0.03 
a 
0.160 0.009 0.465 
SOL Fiber 
Length 
mm 8.2±0.2 a 8.7±0.2 a 7.8±0.2 a§ 8.4±0.1 aⱡ 0.093 0.020 0.771 
SOL PCSA mm2 1.00±0.03 a 1.10±0.06 
a  
0.80±0.04 
b 
0.96±0.04 
b 
<0.001 0.088 0.661 
P0 mN 246.9±12.9 
a 
249.5±9.9 
a 
178.2±9.7 
c§ 
184.6±7.3 
c§ 
<0.001 0.440 0.583 
P0/gbm mN/ 
gbm 
7.6±0.3 a 8.4±0.3 b 5.4±0.3 c§ 5.8±0.3 c§ <0.001 0.071 0.473 
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Table S2 Velocity of Contraction Data presented as means ± standard error. Symbols: 
AC=adult control, AE=adult exercise, OC=old control, OE=old exercise, different letters indicate 
differences at p<0.10; “ ⱡ  “≠ OC, p<0.05; “ § “≠AE, p<0.05; “ ¥ ”=AE; Age=main effect of age, 
Training=main effect of training; Inter.=interaction of age*training, p-value, from 2x2 ANOVA, bold 
indicating significance; fl/s=fiber lengths/sec.  
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Velocity 
fl/s 
AC AE OC OE 2x2 ANOVA 
p-value 
Age 
 
Training 
 
Inter. 
Vmax 4.5±0.3 
a 
4.2±0.2 
a 
3.7±0.2 
b¥ 
3.7±0.2 
b¥ 
<0.001 0.014 0.549 0.488 
10%P0 2.44±0.096 
a 
2.59±0.139 
a 
2.14±0.112 
b 
2.17±0.116 
a 
<0.001 0.005 0.447 0.618 
20%P0 1.61±0.061 
a 
1.74±0.094 
a 
1.43±0.078 
b 
1.45±0.071 
a§ 
<0.001 0.006 0.360 0.515 
30%P0 1.13±0.041 
a 
1.24±0.068 
a 
0.99±0.052 
b 
1.02±0.051 
a§ 
<0.001 0.002 0.214 0.479 
40%P0 0.81±0.029 
a 
0.90±0.050 
a 
0.71±0.038 
b 
0.73±0.036 
a§ 
<0.001 0.001 0.155 0.363 
50%P0 0.57±0.020 
a 
0.65±0.038 
b 
0.49±0.027 
c 
0.51±0.026 
a§ 
<0.001 <0.001 0.098 0.288 
60%P0 0.39±0.016 
a 
0.46±0.028 
b 
0.33±0.018 
c 
0.34±0.018 
c 
<0.001 <0.001 0.046 0.224 
80%P0 0.13±0.011 
a 
0.18±0.015 
b 
0.10±0.008 
c 
0.11±0.008 
a 
<0.001 <0.001 0.009 0.087 
90%P0 0.048 
±0.006 a 
0.069 
±0.008 b 
0.032 
±0.005 c 
0.031 
±0.006 c 
<0.001 <0.001 0.115 0.085 
a/P0 x 102 2.3±0.2 a 1.8±0.1 b 2.7±0.2 c 2.3±0.1 a <0.001 <0.001 0.008 0.987 
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Table S3 Power Production Data presented as means ± standard error. Symbols: 
Pmax=maximum power output, %P0@Pmax=the percentage of P0 (maximum force) where Pmax 
occurs; AC=adult control, AE=adult exercise, OC=old control, OE=old exercise, different letters 
indicate differences at p<0.10; “ ⱡ  “≠ OC, p<0.05; “ § “ ≠AE, p<0.05; “ ¥ ”=AE; ME Age=main effect 
of age, ME Training= main effect of training, Inter.=interaction of age*training, numbers are p-
values from 2x2 ANOVA, bold highlighting p<0.10; mN*fl/s=milliNewtons*fiber lengths/sec; 1n=7 
for OE 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Power 
mN*fl/s 
AC 
n=9 
AE 
n=6 
OC 
n=12 
OE 
n=9 
2x2 ANOVA 
p-value 
ME 
Age 
ME 
Training 
Inter. 
Pmax1 89.1±4.7 
a 
97.7±10.5 
a 
54.7±5.3 
b 
61.9±46.5 
b 
<0.001 <0.001 0.240 0.918 
10%P0 61.5±4.0 
a 
65.1±5.5 
a 
42.7±3.7 
b 
42.7±4.0 
b 
<0.001 <0.001 0.396 0.983 
20%P0 81.1±5.0 
a 
87.2±7.3 
a 
53.0±5.1 
b 
56.8±4.8 
b 
<0.001 <0.001 0.382 0.845 
30%P0 85.6±5.2 
a 
93.5±7.7 
a 
54.1±5.2 
b 
59.9±5.0 
b 
<0.001 <0.001 0.245 0.860 
40%P0 81.6±4.8 
a 
90.7±7.5 
a 
51.3±5.0 
b 
56.8±4.7 
b 
<0.001 <0.001 0.196 0.743 
50%P0 72.1±4.2 
a 
81.9±6.9 
a 
44.6±4.5 
b 
49.7±4.1 
b 
<0.001 <0.001 0.144 0.635 
60%P0 59.9±3.4 
a 
69.1±6.1 
a 
35.5±3.7 
b 
40.0±3.3 
b 
<0.001 <0.001 0.081 0.501 
80%P0 26.1±1.7 
a 
36.3±3.9 
b 
14.5±1.8 
c 
17.2±1.5 
c 
<0.001 <0.001 0.005 0.217 
90%P0 10.6±1.2 
a 
15.5±2.1 
b 
5.5±1.1 
c 
5.4±1.0 
c 
<0.001 <0.001 0.078 0.070 
%P0 at 
Pmax 1 
(%) 
27.3±0.6 
a 
29.1±0.5 
b 
27.3±0.4 
c 
27.9±0.3 
c 
<0.001 0.188 0.022 0.188 
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Figure S1 Rotarod Improves with Training A. Rotarod Difference in Seconds Means of all 
four groups. B. Rotarod Percent Change Means of all four groups. C. Mass and Rotarod 
Difference Unrelated Equation is simple linear regression of rotarod difference in seconds (y 
value) in respect to mass of mouse in grams at sacrifice (x-value). P-value is non-significant. D. 
Rotarod Main Effect of Training From 2x2 ANOVA Symbols: AC=adult control, AE=adult 
exercise, OC=old control, OE=old exercise; “*” indicates significance at p<0.05 and “#” indicates 
a trend of p<0.10; lines delineate significance. 
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Figure S2 Grip Test A. Grip Test Difference in Seconds Means of all four groups. B. Grip Test 
Percent Change Means of all four groups. C. Regression shows Relationship of Mass and 
Grip Difference Equation is simple linear regression of grip test difference in seconds (y value) in 
respect to mass of mouse in grams at sacrifice (x-value). D. Grip Test Main Effect of Training 
From 2x2 ANOVA Symbols: AC=adult control, AE=adult exercise, OC=old control, OE=old 
exercise; s=seconds, number at base in bar graphs=means; “*” indicates significance at p<0.05 
and “#” indicates a trend of p<0.10; lines delineate significance. 
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Figure S3 Body Composition improves with Training (means) Symbols: AC=adult control 
(n=12), OC= old controls (n=7) and OE= old exercise mice (n=11); number at base in bar graphs 
=means; “*” indicates significance at p<0.05 and “#” indicates a trend of p<0.10. Lines indicate 
significance. [1-way ANOVA f=24.403, p<0.001. AC>OC, p<.001; AC>OE, p<0.001; OC>OE, 
p=0.072]. 
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Figure S4 Training Force A. Training Force over Training Period Equation is simple linear 
regression of training force (y value) in respect to the training session (x-value).  Regressions 
significantly different with the mean increase (adjusted) of 7.6% with training in the adult group 
[Univariate GLM ANCOVA, adjusted for training session, F=368, p<0.001; Main Effect of Age 
group, p<0.001, training session as adjustor, p<0.001] B. Normalized Training Force Equation 
is simple linear regression of training force normalized to body mass (y value) in respect to the 
training session (x-value). Trend for Regressions to be different, with the mean increase 
(adjusted) of 1.4% with training in the adult mice (Univariate GLM ANCOVA, adjusted for training 
session, F=361, p<0.001; Main Effect of Age group, p=0.095, training session as adjustor, 
p<0.001) Symbols: Symbols: diamonds=AE=adult exercise (n=7), squares=OE=old exercise 
(n=6); mN=milliNewtons, gbm=grams of body mass. 
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Figure S5 Training Power A. Training Power B. Equation: Simple linear regression, y=power 
and x=number of the training session in which the data was recorded. Normalized Training 
Power Equation: Simple linear regression, y=normalized power and x=number of the training 
session in which the data was recorded. Symbols: Adult=diamonds=adult exercise, 
Old=squares=old exercise; mW=milliWatts; mW/gbm=milliWatts per gram of body mass. 
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Figure S6 Contractile Force A. P0 All 4 group means. C. P0 Normalized to Body Mass All 4 
group means. C. Regression of P0 with respect to Body Mass Equation: simple linear 
regression y=P0 and x=body mass at sacrifice. Symbols: AC=adult control, AE=adult exercise, 
OC=old control, OE=old exercise; “*” indicates significance at p<0.05 and “#” indicates a trend of 
p<0.10; lines delineate significance; mN=milliNewtons, gbm=grams of body mass; number at 
base of bar graphs=means. 
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Figure S7 Contractile Velocity A.  Force-Velocity Curve AC group significantly increased at 
velocities measured at 50% of P0 and higher. OE is not different from OC. Age related differences 
are at all velocities. B. Expanded view 0-40%P0 C. Expanded View 40-100%P0 Symbols: 
AC=adult control, AE=adult exercise, OC=old control, OE=old exercise; fl/s=fiber lengths per 
second; %P0=percentage of maximum isometric tetanic force. 
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Figure S8 Contractile Power output is increased in AE at 80 and 90% P0. Symbols: AC=adult 
control, AE=adult exercise, OC=old control, OE=old exercise; “*” indicates significance at p<0.05; 
%P0=percentage of maximum isometric tetanic force; mN*fl/s=milliNewtons (force) multiplied by 
fiber lengths per second (velocity of contraction). 
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Figure S9 SOL Wet Mass A. SOL Mass Increased with Training [2x2 ANOVA F=10.271, 
p<0.001 Main Effects: Age, p<0.001; Training, p=0.014; age*training  interaction: p=0.617; LSD 
Posthoc: AE (n=6) Soleus 15%>AC (n=13) , p=0.019; AC>OC (n=12) p=0.001; AC=OE (n=7) 
p=0.159; AE>OC, p<0.001; AE>OE, p=0.002; % change with training (main effect)= 18.2%, % 
change with aging (main effect)= 23.7%] B. Normalized SOL Mass Increased with Training 
Mass of the SOL in relation to body mass. [2x2 ANOVA F=3.053, p=0.042 Main Effects: Age, 
p=0.077; Training, p=0.019; age*training  interaction: p=0.279; LSD Posthoc: AE 26%>AC, 
p=0.021; AE>OC, p=0.007; AE>OE, p=0.085; AC=OC, p=00.566; AC=AE, p=0.637; % change 
with training (main effect)= 16.8%, % change with aging (main effect)= -8.7%] Symbols: 
AC=adult control, AE=adult exercise, OC=old control, OE=old exercise; “*” indicates significance 
at p<0.05 and “#” indicates a trend of p<0.10; lines delineate significance; mg=milligrams; 
gbm=grams of body mass; number in base of bars=mean. 
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Figure S10 Plantaris Fiber CSA A. Individual Mice Means Mean is +5% Adults, +5% in Old 
with exercise. AC, n=5; AE, n=4; OC, n=4; OE, n=4 B. Pooled Fiber Means C. Adult Fiber 
Distribution Histogram of Distribution of Adult CSA Also reported in Chapter 3, reprinted for 
comparison purposes, median +7%, significant rightward shift after exercise. D. Old Fiber 
Distribution Histogram Distribution of Old CSA, median +10%, significant rightward shift after 
exercise. Symbols: AC=adult control, AE=adult exercise, OC=old control, OE=old exercise; in 
histograms light boxes=control, dark=exercise; letters indicate significant differences; 
Frequency%=percentage of fibers out of the total number measured; µm²=micrometers squared, 
CSA=cross sectional area of plantaris fibers 
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Figure S11 Anabolic Signaling A. Phosphorylated p70S6K B. p70S6K C. Representative 
Blots In p70S6K blot the top band is phosphorylated and the bottom band is not, both were 
combined for total p70 content. Symbols: AC=adult control, AE=adult exercise, OC=old control, 
OE=old exercise; number in bar graphs are means; error bar=standard error; Abundance is 
normalized to the level of the adult control group; BC=blot control, PC=positive control for p-
p70S6K, NC=negative control for p-p70S6K; E=old exercise, C=old control; different letters 
indicate significance.  
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Epilogue: Conclusion and Summary 
Sarcopenia, the age-related loss of muscle mass and strength, is an important 
health concern that affects large numbers of older adults. Sarcopenia can lead to 
a lower quality of life, poor prognoses after procedures, low gait speed, functional 
disability, difficulties with activities of daily living, increased incidence of falls, 
increased mortality, development of frailty, and the eventual loss of 
independence. To date, even after much study the exact etiology of sarcopenia 
has not been identified, though there are many and varied sources that do 
contribute at least partly to the development and progression of the condition. In 
addition, there is no cure.  
 
Though there is no cure for sarcopenia, exercise has much promise as a 
countermeasure. Resistance training, in particular, increases muscle mass and 
strength, and improves functional ability in adults of any age. One challenge in 
the search for treatment strategies to mitigate sarcopenia is the blunting of 
response to anabolic stimuli often observed in the older adult population. The 
term for this is age-related anabolic resistance. Thus, not only does muscle mass 
and strength decline with age, but the response to anabolic stimuli also declines 
in effectiveness. 
 
Animal models are the first step in investigating both mechanisms and for the first 
trial of novel treatment strategies, particularly pharmaceutical. This thesis 
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focused on describing and developing a mouse model that will be used to 
investigate treatments for sarcopenia, synergistic effects of multiple treatment 
strategies to overcome anabolic resistance, and basic biology of exercise. As the 
first step, assessment strategies and tools were developed and the mouse model 
baseline values evaluated. Second, a mouse model of resistance training was 
created and validated. Finally, the resistance training protocol was tested in an 
older cohort of mice to determine evidence of anabolic resistance.   
 
Collectively, Chapters 2 and 3 present a story where functional ability and 
contractile parameters decline with age. Functional and contractile ability was 
improved through resistance exercise, as described in Chapter 4. Chapter 5 
demonstrated that older mice improved in some parameters after undergoing 
exercise training, sometimes to the same degree as in adults. However, in other 
parameters the degree of improvement was blunted in the older, or in some 
cases insignificant. Thus, a stimulus sufficient to improve outcomes in the adult 
mice does not always produce equivalent results in the older mice.  
 
Interventions with longer duration and/or increased intensity may lead to better 
adaptations in the older mice; however, it is also possible that older mice simply 
may not have the ability to respond to anabolic stimuli younger mice. Thus, 
investigating the etiology of anabolic resistance by examining age-associated 
phenotypic differences at the cellular and systemic level might lead to strategies 
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that ultimately could be combined to work in synergy with exercise training to 
improve both anabolic response and natural repair/rehabilitation mechanisms. 
Future studies will address these questions. 
 
Individual variability in outcome measurements is a glaring confounder in aging 
studies. One early goal of this thesis work was to build a mathematical construct 
that would serve to reduce the effect of the variability on detecting changes in 
means. The “C57BL/6 Neuromuscular Healthspan Scoring System”, a composite 
scoring system described in Chapter 2, is an important tool that can be used to 
delineate changes in neuromuscular health after intervention with a much greater 
power than the individual outcome measurements (rotarod, grip test, and 
maximum isometric force of the EDL muscle) that make up the composite can 
alone. The strategy used to produce the score can easily be adapted to other 
types of measurements by substituting/adding validated outcomes to the 
composite of scores. Chapter 2 adds not only this valuable tool to the literature, 
but also for the first time provides a linear regression analysis of functional ability 
and contraction across the lifespan of the C57BL/6 mouse. 
 
Chapter 2 elucidated functional loss in the aging mouse and gave insight in loss 
of contractile force in the EDL muscle. In Chapter 3 “C57BL/6 Lifespan Study: 
Age-Related Declines in Muscle Power Production and Contractile Velocity”, the 
focus was on investigating changes over the lifespan in velocity of contraction 
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and power production in both the EDL and soleus muscles along the entire 
continuum of concentric contraction. Previous literature examined contractile 
velocity function below 50% of maximum isometric force (P0) mainly in order 
determine unloaded maximum velocity. Likewise, many prior investigations into 
power production concentrated on maximum power (around 30-40% P0), not 
power over the entire force-power curve. 
  
Movement in life requires contraction over the entire range of the force-velocity 
and force-power curves. Thus, for the first time, comprehensive results 
encompassing the entire range of contraction over the lifespan of the mouse are 
reported. Data from Chapter 3 describes both higher levels of concentric 
contraction (60, 80 and 90% P0) and also regresses the results over the mouse 
adult lifespan from 6-32 months of age. The data strongly suggests that age 
more prominently affects concentric contraction at more difficult tasks, i.e. at 
loads above 50% P0. 
 
At this point the stage was set for the creation of a protocol in the mouse model 
that would serve as a mimetic for human resistance exercise studies. Therefore, 
Chapter 4, “Voluntary Resistance Training in Adult Mice” describes and validates 
a training system that serves as a mouse model mimetic for human resistance 
exercise. A number of outcome measurements were chosen in order to assess 
whether or not the training protocol (designed utilizing human principles of weight 
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training) would result in adaptations in the mice similar to what would be 
expected in humans. Indeed, the preponderance of evidence suggested 
adaptations occurred, thus validating the protocol. Prior to this study there was 
no such mimetic of human voluntary weight lifting in the mouse.    
 
Finally, Chapter 5, “Voluntary Resistance Training in Elderly Mice and Signs of 
Anabolic Resistance”, applied the protocol designed and validated in Chapter 4 
to an aged cohort of mice. The mice that underwent training in Chapter 4 were 12 
months of age (100% survival) at the study completion, whereas the older cohort 
of mice was 28 months of age at the end of their training (50% survival). In 
human terms, the younger adult mice were the equivalent of 30 year olds and the 
older adult mice were like 78-80 year olds. Adaptations occurred in the older 
mice, but the adaptations were not as extensive as those in the younger. These 
findings were consistent with the well-established concept of anabolic resistance 
in older individuals. More importantly, the results confirm the strength of this 
model as an exceptional tool to investigate anabolic resistance. Future directions 
using this model include investigating the synergy of other interventions (whether 
pharmaceutical, nutritional, or hormonal) with resistance training to determine 
strategies to overcome age-related anabolic resistance. In addition, basic 
exercise biology mechanism research will benefit from have this novel model of 
voluntary resistance exercise in the mouse available. Overall this thesis has 
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added valuable research tools and information to the body of literature in the field 
that will enable future research to progress better as a result of our efforts. 
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